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Preface
This second edition represents a thorough updating and revision of the first 
edition. The structure remains similar, but includes an additional chapter 
on humanitarian coordination. All chapters have been revised to reflect 
changes in best practices, improvements in technologies, availability of new 
tools, and changes in WHO recommendations. 
The interagency handbook was developed to set out effective malaria con-
trol responses in humanitarian emergencies, particularly during the acute 
phase when reliance on international humanitarian assistance is greatest. 
It provides policy-makers, planners, and field coordinators with practical 
advice on designing and implementing measures to reduce malaria morbid-
ity and mortality in both man-made and natural disasters. Such measures 
must address the needs of all affected population groups and accommo-
date changing needs as an acute emergency evolves into either recovery or 
chronic emergency phase. The handbook is organized as follows:
Chapter 1: Introduction introduces complex humanitarian emergencies and 
malaria control.
Chapter 2: Coordination describes essential coordination, advocacy and 
resource mobilization.
Chapter 3: Assessment and operational planning describes how to assess malaria 
burden in an emergency, identify those most at risk, and use the informa-
tion collected to design an effective response.
Chapter 4: Surveillance discusses establishment of disease surveillance sys-
tems to monitor the malaria situation.
Chapter 5: Outbreaks describes how to prepare for and respond to a sudden 
increase in malaria cases.
Chapter 6: Case management describes methods of diagnosis, treatment, and 
patient care in humanitarian emergencies.
Chapter 7: Prevention describes approaches and tools for vector control and 
personal malaria protection during emergencies.
Chapter 8: Community participation discusses how to mobilize affected com-
munities to improve malaria control interventions.
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Chapter 9: Operational research and associated routine monitoring discusses con-
ducting research to improve the effectiveness of prevention and treat-
ment in humanitarian emergencies.
A glossary is provided at the beginning of the handbook. Suggestions for 
further reading are included at the end of several chapters.
Ideal, or gold standard, approaches to malaria control are not always fea-
sible in humanitarian emergencies. Interventions must be adapted to the 
realities of each emergency. Using this handbook should help humanitarian 
workers implement effective and concerted responses to malaria problems.
As new information becomes available, updates to this handbook will be 
published. Comments and suggestions are welcome and should be sent to 
WHO/Global Malaria Programme (infogmp@who.int).
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Glossary
The definitions given below apply to the terms as used in this handbook. 
They may have different meanings in other contexts.
A
acute emergency phase Begins immediately after the impact of the disaster 
and may last for up to 3 months. Characterized by initial chaos and a 
high crude mortality rate (CMR) and ends when daily CMR drops below 
1/10 000 people.
adherence (compliance) Health-related behaviour that abides by the rec-
ommendations of a doctor or other health care provider or of an investi-
gator in a research project.
agranulocytosis Severe deficiency of certain white blood cells as a result of 
damage to the bone marrow by toxic drugs or chemicals.
anaemia A reduction in the quantity of the oxygen-carrying pigment hae-
moglobin in the blood. The main symptoms are tiredness, breathlessness 
on exertion, pallor and poor resistance to infection.
Anopheles A genus of widely distributed mosquitoes, occurring in tropical 
and temperate regions and containing some 400 species. Malaria para-
sites (Plasmodium) are transmitted to humans through the bite of female 
Anopheles mosquitoes.
Anopheles, infected Female Anopheles with oocysts of malaria parasites on 
the midgut wall (with or without sporozoites in the salivary glands).
Anopheles, infective Female Anopheles with sporozoites in the salivary 
glands (with or without oocysts in the midgut).
antipyretic A drug that reduces fever by lowering the body temperature. 
anthropophilic Descriptive of mosquitoes that show a preference for feed-
ing on humans even when non-human hosts are available. A relative term 
requiring quantification to indicate the extent of the preference.
asymptomatic Not showing any symptoms of disease, whether disease is 
present or not. (See parasitaemia for “asymptomatic malaria”.)
attack rate The cumulative incidence of infection in a group observed over 
a period during an epidemic.
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auscultation Listening, usually with the aid of a stethoscope, to the sounds 
produced by the movement of gas/air or fluid within the body, to diag-
nose abnormalities, for example in the lungs.
B
bacteraemia Presence of bacteria in the blood.
bias Any trend in the collection, analysis, interpretation, publication or 
review of data that can lead to conclusions that are systematically differ-
ent from the truth.
blood meal Ingestion by a female mosquito of blood obtained from a ver-
tebrate host; also, the ingested blood.
bradycardia Slowing of the heart rate to less than 50 beats per minute. 
breeding site (place) Site where eggs, larvae or pupae of mosquitoes are 
found; larval habitat.
C
case A person who has the particular disease, health disorder or condition 
that meets the case definition.
case definition A set of diagnostic criteria that must be fulfilled for an indi-
vidual to be regarded as a “case” of a particular disease for surveillance 
and outbreak investigation purposes. Case definitions can be based on 
clinical criteria, laboratory criteria or a combination of the two.
case-fatality rate The proportion of cases of a specified condition that are 
fatal within a specified time (usually expressed as a percentage).
census Enumeration of a population. A census usually records the identi-
ties of all persons in every place of residence, with age or date of birth, 
sex, occupation, national origin, language, marital status, income, and 
relationship to head of household, in addition to information on the 
dwelling place.
chemoprophylaxis Administration of a chemical to prevent either the 
development of an infection or the progression of an infection to active 
manifest disease.
cluster sampling A sampling method in which each selected unit is a group 
of people (e.g. all persons in a city block, a family) rather than an indi-
vidual.
community health worker (CHW) A member of the community who is 
integrated into primary health care programmes after a short training 
on health-related issues, and who acts as intermediary between the com-
munity and the health services. CHWs may be paid staff or volunteers 
(CHVs).
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compliance See adherence.
confidence interval A computed interval with a given probability (e.g. 
95%) that the true value of a variable (e.g. a mean, proportion or rate) is 
contained within that interval.
conjunctival Relating to the conjunctiva, the thin mucosa covering the 
inside of the eyelids and the sclera (the white part of the eye).
contact (of an infection) A person or animal that has been in such associ-
ation with an infected person or animal or a contaminated environment 
as to have had opportunity to acquire the infection.
coverage A measure of the extent to which services cover the potential 
need for these services in a community. It is expressed as a proportion in 
which the numerator is the number of services rendered and the denom-
inator is the number of instances in which the service should have been 
rendered.
cross-sectional study (disease frequency survey; prevalence study) A 
study that examines the relationship between diseases (or other 
health-related characteristics) and other variables of interest as they exist 
in a defined population at one particular time. The presence or absence of 
disease and the presence or absence (or, if they are quantitative, the level) 
of the other variables are determined in each member of the study pop-
ulation or in a representative sample at one particular time. The relation-
ship between a variable and the disease can be examined in terms both 
of the prevalence of disease in different population subgroups defined 
according to the presence or absence (or level) of the variables and of the 
presence or absence (or level) of the variables in the diseased versus the 
non-diseased. A cross-sectional study usually records disease prevalence 
rather than incidence and cannot necessarily determine cause-and-effect 
relationships.
D
demography The study of populations, especially with reference to size 
and density, fertility, mortality, growth, age distribution, migration and 
vital statistics, and the interaction of all these with social and economic 
conditions.
district hospital A hospital with the capacity to manage first-referral cases 
but with medical services usually limited to emergency obstetrical and 
surgical care and follow-up, and inpatient and rehabilitative care. In 
principle, facilities include laboratory, blood bank, and X-ray services.
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E
effectiveness A measure of the extent to which a specific intervention, pro-
cedure, regimen or service, when deployed in the field in routine cir-
cumstances, does what it is intended to do for a specified population; a 
measure of the extent to which a health care intervention fulfils its objec-
tives.
efficacy The extent to which a specific intervention, procedure, regimen or 
service produces a beneficial result under ideal conditions; the benefit or 
utility to the individual or population of the service, treatment regimen 
or intervention. Ideally, determination of efficacy is based on the results 
of a randomized controlled trial.
efficiency The effects or end results achieved in relation to the effort 
expended in terms of money, resources and time; the extent to which the 
resources used to provide a specific intervention, procedure, regimen or 
service of known efficacy and effectiveness are minimized; a measure of 
the economy (or cost in resources) with which a procedure of known 
efficacy and effectiveness is carried out; the process of making the best 
use of scarce resources.
endemic Description applied to malaria when there is a constant measura-
ble incidence both of cases and of natural transmission in an area over a 
succession of years.
endophagy Tendency of mosquitoes to feed indoors.
endophily Tendency of mosquitoes to rest indoors.
epidemic Description applied to malaria when the incidence of cases (oth-
er than seasonal increases) in an area rises rapidly and markedly above 
its usual level or when the infection occurs in an area where it was not 
previously present.
epidemic curve A graphic plotting of the distribution of cases by time of 
onset.
epidemiology The study of the distribution and determinants of health- 
related conditions or events in specified populations, and the application 
of this study to the control of health problems.
essential drugs Therapeutic substances that are indispensable for rational 
care of the majority of diseases in a given population.
evaluation A process that attempts to determine as systematically and 
objectively as possible the relevance, effectiveness and impact of activ-
ities in relation to their objectives.
exophagy Tendency of mosquitoes to feed outdoors.
exophily Tendency of mosquitoes to rest outdoors.
GLOSSARY
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F
focus group Small convenience sample of people brought together to dis-
cuss a topic or issue with the aim of ascertaining the range and intensi-
ty of their views, rather than arriving at a consensus. Focus groups are 
used, for example, to appraise perceptions of health problems, assess the 
acceptability of a field study or refine the questions to be used in a field 
study.
G
gamete Mature sexual form, male or female. In malaria parasites, the 
female gametes (macrogametes) and the male gametes (microgametes) 
normally develop in the mosquito.
gametocytes Parent cell of a gamete. In malaria parasites, the female and 
male gametocytes develop in the red blood cell. Very young gametocytes 
cannot usually be distinguished from trophozoites.
H
haemoglobinuria The presence of haemoglobin in the urine
haemolysis The destruction of red blood cells.
health care system The organization of health care services within a desig-
nated geographical area (e.g. country, province, district, camp).
hepatic Relating to the liver.
host A person or other living animal, including birds and arthropods, har-
bouring or providing subsistence to a parasite. In an epidemiological 
context, the host may be the population or group; biological, social and 
behavioural characteristics of this group that are relevant to health are 
called “host factors”.
host, definitive In parasitology, the host in which sexual maturation 
occurs. In malaria, the definitive host is the mosquito (invertebrate host).
host, intermediate In parasitology, the host in which asexual forms of the 
parasite develop. In malaria, the intermediate host is a human or other 
mammal or bird (vertebrate host).
household One or more persons who occupy a dwelling; may or may not 
be a family. The term is also used to describe the dwelling unit in which 
the persons live.
hypersensitivity Responding exaggeratedly to the presence of a particular 
antigen.
xix
I
immunity, acquired Resistance acquired by a host as a result of previous 
exposure to a natural pathogen or substance that is foreign to the host.
incidence The number of instances of illness commencing, or of persons 
falling ill, during a given period in a specified population.
incidence rate The rate at which new events occur in a population. The 
numerator is the number of new events that occur in a defined period 
and the denominator is the population at risk of experiencing these 
events during this period, sometimes expressed as person-time.
indicator A measure that shows whether a standard has been reached. It is 
used to assess and communicate the results of programmes as well as the 
process or methods used. Indicators can be qualitative or quantitative.
infection, mixed Malaria infection with more than one species of Plasmo-
dium.
informed consent Voluntary consent given by a subject (i.e. person or a 
responsible proxy such as a parent) for participation in a study, immu-
nization programme, treatment regimen, etc., after being informed of 
the purpose, methods, procedures, benefits and risks, and, when rele-
vant, the degree of uncertainty about outcomes. The essential criteria of 
informed consent are that the subject has both knowledge and compre-
hension, that consent is freely given without duress or undue influence, 
and that the right of withdrawal at any time is clearly communicated to 
the subject.
inpatient facility A health care institution that provides lodging, nursing 
and continuous medical care for patients within a facility and with an 
organized professional staff.
K
knowledge, attitudes, practice (KAP) survey A formal survey, using face- 
to-face interviews, in which people are asked standardized pre-tested 
questions dealing with their knowledge, attitudes and practice concern-
ing a given health or health-related problem.
knockdown Rapid immobilization of an insect by an insecticide, without 
necessarily causing early death.
L
larva The pre-adult or immature stage hatching from a mosquito egg.
loading dose An initial higher dose of a drug, given with the objective of 
rapidly providing an effective drug concentration.
GLOSSARY
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logistics The procurement, maintenance and transport of material, person-
nel and facilities; management of the details of an undertaking.
M
merozoite A stage in the life cycle of the malaria parasite. Product of seg-
mentation of a tissue schizont, or of an erythrocytic schizont before 
entering a new host cell. Merozoites are found either separated from or 
contained in the original schizont.
mesoendemicity A pattern of malaria transmission typically found among 
small rural communities in subtropical zones, with varying intensity of 
transmission depending on local circumstances.
mobile clinic See outreach clinic.
monitoring Episodic measurement of the effect of an intervention on the 
health status of a population or environment; not to be confused with 
surveillance, although surveillance techniques may be used in mon-
itoring. The process of collecting and analysing information about the 
implementation of a programme for the purpose of identifying prob-
lems, such as non-compliance, and taking corrective action. In manage-
ment: the episodic review of the implementation of an activity, seeking 
to ensure that inputs, deliveries, work schedules, targeted outputs and 
other required actions are proceeding according to plan.
morbidity Any departure, subjective or objective, from a state of physio-
logical or psychological well-being. Sickness, illness, and morbid condition 
are similarly defined and synonymous. Morbidity can be measured as: 
(a) persons who are ill; (b) the illnesses experienced by these persons; 
and (c) the duration of these illnesses.
mortality rate An estimate of the proportion of a population dying during 
a specified period. The numerator is the number of persons dying during 
the period and the denominator is the total number of the population, 
usually estimated as the mid-year population.
myalgia Pain in the muscles.
N
needs assessment A systematic procedure for determining the nature 
and extent of problems that directly or indirectly affect the health of a 
specified population. Needs assessment makes use of epidemiological, 
socio-demographic and qualitative methods to describe health problems 
and their environmental, social, economic and behavioural determi-
nants. The aim is to identify unmet health care needs and make recom-
mendations about ways to address these needs.
xxi
O
oedema Swelling caused by an excess of fluid in the tissues.
oliguria The production of an abnormally small amount of urine over a 
period of time.
outpatient clinic A facility for diagnosis, treatment and care of ambulatory 
patients.
outreach (clinic, team) The extending of services or assistance beyond 
fixed facilities.
P
pallor Paleness.
palmar Relating to the palms of the hands.
parasitaemia Condition in which malaria parasites are present in the 
blood. If this condition in the human subject is not accompanied by fever 
or other symptoms of malaria except for a possible enlargement of the 
spleen, it is known as asymptomatic parasitaemia, and the person exhib-
iting the condition is known as an asymptomatic parasite carrier.
parenteral Relates to drug administration by any route other than oral, 
e.g. by injection.
paroxysms Cyclic manifestation of acute illness in malaria characterized 
by a rise in temperature with accompanying symptoms; usually caused 
by invasion of the blood by a brood of erythrocytic parasites.
Plasmodium Genus of parasites causing human malaria (Plasmodium falci-
parum, P. vivax, P. ovale, P. malariae).
population structure Composition of the population, usually by age and 
sex.
preparedness Readiness to prevent, mitigate, respond to and cope with 
the effects of a disaster or epidemic.
prevalence The number of instances of a given disease or other condition 
in a given population at a designated time, with no distinction between 
new and old cases. Prevalence may be recorded at a specific moment 
(point prevalence) or over a given period of time (period prevalence).
prevalence rate The total number of all individuals who have a disease or 
condition at a particular time (or during a particular period) divided by 
the population at risk of having the attribute or disease at that point in 
time or midway through that period.
prevention Actions aimed at eradicating, eliminating or minimizing the 
impact of disease and disability or, if none of these is feasible, retard-
ing the progress of disease and disability. The concept of prevention is 
best defined in the context of levels, called primary, secondary, and ter-
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tiary prevention. In epidemiological terms, primary prevention aims to 
reduce the incidence of disease; secondary prevention aims to reduce the 
prevalence of disease by shortening its duration; and tertiary prevention 
aims to reduce the number and/or impact of complications.
proportion See under ratio.
pulmonary Relating to, associated with or affecting the lungs.
R
random sample A sample that is arrived at by selecting sample units in such 
a way that each possible unit has a fixed and determinate probability of 
selection. Random allocation follows a predetermined plan that is usual-
ly devised with the aid of a table of random numbers. Random sampling 
should not be confused with haphazard assignment.
rate A measure of the frequency of occurrence of a phenomenon. In epi-
demiology, demography and vital statistics, a rate is an expression of the 
frequency with which an event occurs in a defined population in a spec-
ified period of time. The use of rates rather than raw numbers is essential 
for comparison of experience between populations at different times, 
different places, or among different groups of persons. The components 
of a rate are the numerator, the denominator, the specified time in which 
events occur, and usually a multiplier, a power of 10, that converts the 
rate from an awkward fraction or decimal to a whole number. E.g. num-
ber of events in specified period divided by average population during 
the period
ratio The value obtained by dividing one quantity by another; a general 
term of which rate, proportion, percentage, etc. are sub-sets. The impor-
tant difference between a proportion and a ratio is that the numerator of 
a proportion is included in the population defined by the denominator, 
whereas this is not necessarily so for a ratio. A ratio is an expression of the 
relationship between a numerator and a denominator where the two are 
usually separate and distinct quantities, neither being included in the 
other.
recrudescence Repeated manifestation of an infection after a period of 
latency following the primary attack. It is used particularly in the con-
text of treatment failure of Plasmodium falciparum, and is often the result 
of non-adherence to the treatment regimen, especially with short-acting 
drugs such as quinine and the artemisinins, and can signify antimalarial 
drug resistance.
relapse Renewed manifestation (of clinical symptoms and/or parasitaemia) 
of malaria infection separated from previous manifestations of the same 
xxiii
infection by an interval greater than that related to the normal periodic-
ity of the paroxysms. The term is used mainly for renewed manifestation 
due to survival of exo-erythrocytic forms of Plasmodium vivax or P. ovale.
reservoir (of infection) Any person, animal, arthropod, plant, soil or sub-
stance, or a combination of these, in which an infectious agent normal-
ly lives and multiplies, on which it depends primarily for survival, and 
where it reproduces itself in such a manner that it can be transmitted to a 
susceptible host. The natural habitat of the infectious agent.
resistance Ability of a parasite strain to multiply or to survive in the pres-
ence of concentrations of a drug that normally destroy parasites of the 
same species or prevent their multiplication. Ability in a population of 
insects to tolerate doses of an insecticide that would prove lethal to the 
majority of individuals in a normal population of the same species; devel-
oped as a result of selection pressure by the insecticide.
retention (in ITN programme) An indicator used to establish whether 
nets remain with the individuals to whom they were originally distrib-
uted. Retention alone is not an indicator of the correct use of the nets.
risk The probability that an event will occur, e.g. that an individual will 
become ill or die within a stated period of time or by a certain age. Also a 
non-technical term encompassing a variety of measures of the probabili-
ty of a (generally) unfavourable outcome.
S
sample A selected sub-set of a population. A sample may be random or 
non-random and may be representative or non-representative.
sampling The process of selecting a number of subjects from all subjects in 
a particular group, or “universe”. Conclusions based on sample results 
may be attributed only to the population from which the sample was tak-
en. Any extrapolation to a larger or different population is a judgement 
or a guess and is not part of statistical inference.
schizont Intracellular asexual form of the malaria parasite, developing 
either in tissue or in blood cells.
sensitivity (of a screening test) The proportion of truly diseased persons in 
the screened population who are identified as diseased by the screening 
test. Sensitivity is a measure of the probability of correctly diagnosing a 
case, or the probability that any given case will be identified by the test. 
See also specificity.
species Group of organisms capable of exchanging genetic material with 
one another and incapable, by reason of their genetic constitution, of 
exchanging such material with any other group of organisms.
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specificity (of a screening test) The proportion of truly non-diseased per-
sons who are so identified by the screening test. Specificity is a measure 
of the probability of correctly identifying a non-diseased person with a 
screening test.
spleen rate A term used in malaria epidemiology to define the frequency 
of enlarged spleens detected on survey of a population in which malaria 
is prevalent.
splenomegaly Enlargement of the spleen.
sporozoite The infective form of the malaria parasite occurring in a mature 
oocyst before its rupture and in the salivary glands of the mosquito.
surveillance The process of systematic collection, orderly consolidation 
and evaluation of pertinent data with prompt dissemination of the 
results to those who need to know, particularly those who are in a posi-
tion to take action.
survey An investigation in which information is systematically collected; 
usually carried out in a sample of a defined population group, within 
a defined time period. Unlike surveillance a survey is not continuous; 
however, if repeated regularly, surveys can form the basis of a surveil-
lance system.
systematic sampling The procedure of selecting according to some simple, 
systematic rule, such as all persons whose names begin with specified 
alphabetical letters, who are born on certain dates, or who are located at 
specified points on a master list. A systematic sample may lead to errors 
that invalidate generalizations. For example, people’s names more often 
begin with certain letters of the alphabet than with other letters. A sys-
tematic alphabetical sample is therefore likely to be biased.
T
target population The group of people for whom an intervention is intend-
ed.
transmission Any mechanism by which an infectious agent is spread from 
a source or reservoir to another person.
transmission, perennial Transmission occurring throughout the year 
without great variation of intensity.
transmission, seasonal Natural transmission that occurs only during some 
months and is totally interrupted during other months.
trend A long-term movement in an ordered series, e.g. a time series. An 
essential feature is movement consistently in the same direction over the 
long term.
xxv
triage The process of selecting for care or treatment those of highest prior-
ity or, when resources are limited, those thought most likely to benefit.
trophozoite Strictly, any asexual and growing parasite with an undivided 
nucleus. In malaria terminology, generally used to indicate intracellular 
erythrocytic forms in their early stages of development. Trophozoites 
may be in either a ring stage or an early amoeboid or solid stage, but 
always have the nucleus still undivided.
V
vector Any insect or living carrier that transports an infectious agent from 
an infected individual or his/her waste to a susceptible individual or his/
her food or immediate surroundings. The organism may or may not pass 
through a developmental cycle within the vector.
vector control Measures of any kind directed against a vector of disease 
and intended to limit its ability to transmit the disease.
verbal autopsy A procedure for gathering systematic information that ena-
bles the cause of death to be determined in situations where the deceased 
has not been medically attended. It is based on the assumption that most 
common and important causes of death have distinct symptom complex-
es that can be recognized, remembered and reported by lay respondents.
vulnerability Defencelessness, insecurity, exposure to risks, shock, and 
stress, and having difficulty coping with them. The potential that when 
something destructive happens or goes wrong, people will not be able 
to handle the consequences by themselves and the ability to sustain life 
is endangered.
Z
zoophilic Descriptive of mosquitoes showing a relative preference for non-
human blood even when human hosts are readily available.
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Introduction
This chapter:
■■ defines humanitarian emergencies, including different types and 
phases
■■ describes malaria, including parasites and transmission
■■ identifies the importance of malaria in humanitarian emergencies and 
main populations at risk 
Humanitarian emergencies 
Definitions
A humanitarian emergency, as used in this handbook, is equivalent to a 
major disaster – i.e. a calamitous situation in which the functioning of a 
community or society is severely disrupted, causing human suffering and 
material loss that exceeds the affected population’s ability to cope using its 
own resources (UNISDR 2004). This includes natural disasters (e.g. earth-
quakes) and man-made disasters (e.g. industrial accidents, violent armed 
conflicts). A complex emergency, as described by the United Nations 
Inter-Agency Standing Committee (IASC) and the Active Learning Net-
work for Accountability and Performance (ALNAP), is a humanitarian 
emergency with complex social, political and economic origins, break-
down of governmental authority and structures, and often human rights 
abuses and armed conflict (IASC 1994 and ALNAP 2003).
This second edition will address malaria control in humanitarian emer-
gencies generally. 
Types of humanitarian emergencies
Both natural disasters and man-made disasters can lead to population 
displacements, food scarcity, and health systems disruption, causing 
excess mortality and morbidity in affected populations. As the differences 
between these two types of emergencies seldom affect basic malaria con-
trol, this handbook will not generally distinguish between them. 
MALARIA CONTROL IN HUMANITARIAN EMERGENCIES
2
Rapid-onset emergencies describe a suddenly deteriorating situation, 
such as the Haiti earthquake of 2011. Slow-onset emergencies involve a grad-
ually deteriorating situation, such as the Pakistan floods of 2010. Chronic 
or protracted emergencies involve consistently high levels of humanitari-
an need, and often lower levels of aid, as the root causes of the emergency 
are not being resolved (e.g. Somalia, Afghanistan). These distinctions can 
sometimes affect malaria control and will be mentioned where likely to be 
relevant.
An increasing number of humanitarian emergencies involve open set-
tings, in which internally displaced populations (IDPs) or refugees settle 
in host communities and urban settings. Humanitarian assistance is more 
complicated in open than in traditional closed settings (i.e. refugee camps), 
usually requiring at least an expansion of assistance into host communities 
to address host community health needs as well as those of refugees or IDPs. 
These different types of settings can affect malaria control options and will 
be addressed in this handbook whenever they are likely to be relevant.
Phases of humanitarian emergencies
Humanitarian emergencies often evolve rapidly and unpredictably. Divid-
ing the emergencies into phases can help guide how humanitarian aid 
should be implemented. These phases generally consist of acute, post-acute, 
early recovery, and reconstruction phases. Table 1.1 summarizes different 
phases of a humanitarian emergency. 
Table 1.1 Phases of humanitarian emergencies 
Sudden-onset crisis Slow-onset crisis Chronic crisis
Phase 1 First 24–72 hours First 1–2 weeks Ongoing (often low-
level conflict with 
ad-hoc flares)Phase 2 First 4–10 days First month
Phase 3
4 to 6 weeks for a disaster
Up to 3 months for conflict
2 –3 months Indefinite (low-
level continuation 
response) Phase 4 Continuation response and progressive recovery
Source: adapted from WHO, 2009.
In a humanitarian emergency, key characteristics of the acute phase (i.e. 
phases 1–2 in the table above) include:
■• elevated mortality rates (e.g. crude mortality rate over 1/10 000 popu-
lation per day, and under-5 mortality rate over 2/10 000 per day) or a 
doubling of the baseline rate;
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■• poor access to effective health care for the affected population (e.g. 
health infrastructure may be overwhelmed, inadequate or non-existent); 
■• an appropriate response that is beyond local or national capacity;
■• the possible breakdown of normal coordination mechanisms.
Malaria
Overview 
Malaria is a common and life-threatening disease in many tropical and 
subtropical areas and it is currently endemic in 99 countries. In 2010, 
there were an estimated 219 million malaria episodes (uncertainty range 
154–289 million), of which approximately 81% were in Africa, and an esti-
mated 660  000 malaria deaths (uncertainty range 490 000 to 836 000), of 
which 91% were in Africa. Approximately 86% of malaria deaths globally 
are among children under five years old and an estimated 10 000 pregnant 
women and 200 000 newborn babies die annually due to malaria during 
pregnancy. Estimated malaria incidence has been reduced by 17% and 
malaria-specific mortality rates by 26% globally since 2000. These rates of 
decline are lower than the 50% target reductions agreed internationally for 
2010, but nonetheless represent a major achievement (WHO, 2012). 
Parasites
Malaria is caused by the protozoan parasite Plasmodium. Human malaria is 
caused by four different species of Plasmodium: P. falciparum, P. malariae, 
P. ovale and P. vivax. Humans occasionally become infected with Plasmodi-
um species that normally infect animals, such as P. knowlesi. As previously 
mentioned, over 80% of malaria cases and 90% of malaria deaths occur in 
tropical sub-Saharan Africa where P. falciparum predominates. The current 
distribution of malaria in the world is shown in Figure 1.1.
Malaria is an acute febrile illness with an incubation period of seven days 
or longer. The most severe form is caused by P. falciparum; variable clini-
cal features include fever, chills, headache, muscular aching and weakness, 
vomiting, cough, diarrhoea and abdominal pain. Other symptoms relat-
ed to organ failure may supervene, such as acute renal failure, pulmonary 
oedema, generalized convulsions, and circulatory collapse, followed by 
coma and death. The initial symptoms, which can be mild, may not be easy 
to recognize as being due to malaria. Children, pregnant women, and those 
with compromised immune systems, such as people living with HIV/AIDS, 
are especially vulnerable to malaria. Malaria, particularly P. falciparum, in 
non-immune pregnant women increases the risk of maternal death, miscar-
riage, stillbirth and neonatal death. 
MALARIA CONTROL IN HUMANITARIAN EMERGENCIES
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5The forms of human malaria caused by P. vivax, P. malariae and P. ovale 
cause significant morbidity but not the high mortality rates seen with fal-
ciparum malaria. Vivax malaria is frequently associated with high fevers, 
anaemia and splenomegaly. Cases of severe P. vivax malaria have been 
reported among populations living in (sub)tropical countries or areas at 
risk. 
Plasmodium vivax and P. ovale can remain dormant in the liver. Relapses 
caused by these persistent liver forms (“hypnozoites”) may appear months, 
and rarely several years, after exposure. Latent blood infection with 
P. malariae may be present for many years, but it is very rarely life threat-
ening. Human malaria due to P. knowlesi, which may be severe, is mainly 
a public health problem among populations living or working in forested 
areas in South-East Asia. 
Human malaria species are not evenly distributed across the malaria- 
affected areas of the world; and their relative importance varies between 
and within different regions. The risk of contracting malaria is therefore 
highly variable from country to country and even between areas within a 
country. It is important to know which species are present in any particular 
area and their relative proportion, because this will affect the appropriate 
diagnostic modalities and treatment. In Afghanistan, for example, 85% of 
malaria is caused by P. vivax and up to 15% by P. falciparum; in DRC, 95% of 
malaria is due to P. falciparum, with P. malariae and P. ovale accounting for 
the remaining 5%; in Timor-Leste, 60% is caused by P. falciparum and 40% 
by P. vivax.
A global distribution map is available at: http://gamapserver.who.int/
mapLibrary/Files/Maps/Global_Malaria_ITHRiskMap.JPG.
A description of malaria risk by country is available at: World Malaria 
Reports (www.who.int/malaria) and http://www.who.int/entity/ith/
chapters/ith2012en_countrylist.pdf. 
Vectors 
Malaria parasites are transmitted by female Anopheles mosquitoes, which 
bite mainly between sunset and sunrise. There are approximately 400 dif-
ferent species of Anopheles mosquitoes throughout the world, but only 
about 60 of these are natural malaria vectors and only 30 are vectors of 
major importance. Each species behaves differently and knowledge of rele-
vant behaviour patterns is important for planning malaria prevention meas-
ures (see Chapter 7). 
CHAPTER 1. INTRODUCTION
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Epidemiology and population risk 
Knowledge of malaria epidemiology in areas affected by humanitarian 
emergencies is essential for appropriate prevention and case-management. 
Endemicity refers to the malaria burden in an area, measured as the preva-
lence of peripheral blood stage infections in a population. Epidemic malaria 
signifies a periodic sharp increase in incidence. WHO classifies endemicity 
as hypoendemic (child parasite rates below 10%), mesoendemic, hyperen-
demic, or holoendemic (child parasite rates above 75%). Transmission can 
be categorized as stable, with minimal fluctuations over the years (though 
seasonal fluctuations may occur), or unstable, in which transmission fluctu-
ates from year to year.
Malaria epidemiology varies by region, determining levels of immunity 
and risk of severe disease. For example, in rural lowland areas of Africa, 
malaria transmission may be high and stable, whether perennial or sea-
sonal. People in areas of moderate or high transmission gradually develop 
partial immunity after childhood. Thus, young children are at greatest risk 
from severe malaria. Malaria in pregnancy can cause maternal anaemia, 
spontaneous abortions, stillbirths and low birth-weight (particularly in 
first and second pregnancies and among HIV-infected women of all gravid-
ities). In such settings, incidence of symptomatic disease generally remains 
relatively constant throughout the year and people may carry malaria par-
asites in their blood without showing clinical symptoms of disease. Thus, 
with a high proportion of the population parasite-positive at any time, the 
presence of parasites in a patient’s blood is not a clear indicator that malar-
ia is causing the presenting illness. However, Plasmodium infection, once 
identified, should always be treated, regardless of whether or not it is the 
cause of the acute illness.
Seasonal or epidemic peaks of malaria occur in parts of Asia and the 
Americas where transmission is low to moderate. Transmission can be 
high in forested and forest-fringe areas of South-East Asia, while popula-
tion immunity remains low. Anecdotal data indicates that severe disease 
occurs most frequently in adults staying overnight in forests (e.g. loggers). 
In high-altitude and desert-fringe areas and city centres, malaria endemicity 
is usually low, with less than 10% of the population infected, although there 
may be more intense transmission in certain African and south Asian cities. 
In areas of unstable malaria transmission, such as highland areas in sub- 
Saharan Africa and the semi-arid and desert fringes of countries in the Horn 
of Africa and the Sahel, populations may have low to no immunity and out-
breaks of malaria may affect all age and population groups. In these areas, 
7presence of parasites in a patient’s blood indicates that malaria is highly like-
ly to be the cause of the presenting illness.
Environmental and political changes can contribute to the emergence 
or re-emergence of malaria in areas where it was previously non-existent 
or well controlled. For example, population displacement from malaria- 
endemic areas of Afghanistan contributed to the re-emergence of P. falcipar-
um malaria in Tajikistan. Climate change may be changing the distribution 
of malaria vectors, and therefore malaria transmission patterns and malaria 
burden globally. Warmer winter temperatures and prolonged amplification 
cycles may allow the establishment of imported mosquito-borne diseases in 
countries from which they have previously been absent. Increased rains and 
extreme precipitation events can lead to increased mosquito breeding sites, 
and therefore increased transmission risk.
Importance of malaria in humanitarian emergencies
Falciparum malaria can be rapidly fatal and is a priority during the acute 
phase of an emergency. Effective malaria control programmes prevent 
malaria transmission by promoting personal protection and effective vector 
control, and providing appropriate case management with early diagnostic 
testing of suspected malaria and effective treatment for those with confirmed 
infection. However, malaria control in humanitarian emergencies is often 
complicated by the breakdown of existing health services and programmes, 
displacement of health workers and field staff with malaria expertise, move-
ment of non-immune people to endemic areas, and concentrations of peo-
ple, often already in poor health, in high-risk, high-exposure settings. 
Regions whose populations are most affected by humanitarian emergen-
cies are often those with the greatest malaria burden. Consequently, malar-
ia is a significant cause of death and illness in many emergencies.
Vulnerability and constraints
Many factors contribute to increased malaria burden in populations affect-
ed by humanitarian emergencies, including:
 — the collapse of health services;
 — ongoing conflict limiting access to effective treatment;
 — resistance of malaria parasites to commonly available drugs and vec-
tor resistance to insecticides;
 — lack of immunity to malaria due to population displacement from 
non-malarious or low-transmission areas to/through an area of high 
transmission (Table 1.2);
CHAPTER 1. INTRODUCTION
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 — weakened immunity because of multiple infections and malnutrition;
 — increased exposure to Anopheles mosquitoes due to poor or absent 
housing;
 — environmental deterioration resulting in increased vector breeding.
Women and young children often make up the largest proportion of malar-
ia-affected populations. Additionally, some groups are particularly vulner-
able, especially in the acute phase of an emergency, because they are given 
lower priority in the distribution of limited resources, are marginalized 
socially or politically, or have greater difficulty in accessing treatment and 
care. This often includes infants and lone children, pregnant women, older 
people, people with disabilities, minority ethnicities, and geographically 
isolated groups. 
Table 1.2 Population displacement and risk of malaria in resettlement areas
Population movement
Risk
FROM  
area with: 
TO area with (or 
through area with):
No or little 
transmission 
High transmission
All age group displaced persons at risk 
(expected malaria outbreak) 
No or little 
transmission 
Not at increased risk
High 
transmission
High transmission
Children and pregnant women at greatest 
risk. Also risk may be increased by stress of 
displacement, or by increased exposure to 
vectors.
No or little 
transmission
Possible explosive outbreaks in the non-
immune host population depending on the 
malaria receptivity status (possibility of 
transmission in area)
Returnees from
settlement 
area with low 
transmission
Area of origin with 
high transmission 
If return after a period of one year, assume that 
returnees have lost most of their semi-immune 
status. Children born outside their area of origin 
will be especially at risk.
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Effective humanitarian response
An effective humanitarian response relies on many factors. Six principles for 
effective emergency response are listed below. Each is described more fully 
in relation to malaria control in the relevant chapters of this publication:
■• coordination of responses, advocacy, and resource mobilization (Chap-
ter 2)
■• accurate and timely assessments of the situation and those affected 
(Chapter 3)
■• operational planning of the response (Chapter 3)
■• implementation of the response and specific interventions (Chapters 
4–8)
■• operational research to improve intervention delivery (Chapter 9)
■• monitoring and evaluation to support coordination and planning 
(Chapters 4–5).
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CHAPTER 2
Coordination
This chapter:
■■ outlines key coordination mechanisms for preparation and response in 
humanitarian emergencies
■■ summarizes advocacy and resource mobilization considerations for 
malaria control in humanitarian emergencies 
■■ describes principles, priorities, and constraints during preparation and 
response
Coordination mechanisms
The cluster approach
Since 2005, the cluster approach has been used, both globally and at coun-
try level, to plan and organize the international response to humanitarian 
emergencies. This approach aims to improve the predictability, effective-
ness, and accountability of humanitarian responses by grouping human-
itarian actors (e.g. UN agencies, national and international NGOs, the 
International Red Cross and Red Crescent Movement, and civil society) 
into sectoral groups called clusters. Each cluster is headed by a cluster lead 
agency whose role is to facilitate a coordinated response and to support 
national capacity as much as possible. Refugee settings are an exception, as 
the cluster approach is not activated, and UNHCR is the lead agency. For 
new humanitarian emergencies the cluster activation procedure entails the 
following:
■• The UN humanitarian coordinator (HC) or resident coordinator (RC) 
consults relevant partners;
■• S/he proposes leads for each major area and sends a proposal to the 
Emergency Response Coordinator (ERC);
■• ERC shares the proposal with Global Cluster Leads;
■• ERC ensures agreement at global level and communicates agreement to 
HC/RC and partners within 24 hours;
■• HC/RC informs the host government and all partners.
11
CHAPTER 2. COORDINATION
There are currently eleven clusters; malaria control falls under the Health 
Cluster, which is led by the World Health Organization (WHO). Addition-
ally, the Inter-Agency Standing Committee (IASC), established in 1992, 
is the primary mechanism for inter-agency coordination of humanitarian 
assistance.
Coordination among partners
Effective malaria coordination is multisectoral, both globally and at coun-
try level. Malaria control will include clusters and key sectors such as pub-
lic health, water and sanitation, shelter, and social protection/community 
services. Operational partnerships are essential among a range of organi-
zations. It is critical to work with national and local government agencies 
when planning and implementing an emergency malaria control response. 
Existing health facilities and national staff play an important role in any 
response and, with international support, are often best placed to deliver 
emergency health care. 
Local NGOs, faith-based organizations, and community groups are 
important partners in an emergency response, particularly after the acute 
phase. Local and refugee communities have important skills, influence and 
cultural understanding, which may be lacking in the international human-
itarian community, and it is important to identify existing capacity as soon 
as possible and work together with affected communities.
Advocacy and resource mobilization 
Global and local advocacy considerations
Universal access to services for malaria control is a declared international 
goal, promoted by WHO, the Roll Back Malaria (RBM) Partnership and 
others. For example, Millennium Development Goal 6 includes reducing 
malaria incidence among its targets. Inclusion of conflict-affected and dis-
placed populations is necessary if the world is to achieve this global target. 
Access to malaria control programmes is an important public health 
priority for populations in malarious areas affected by humanitarian emer-
gencies. Integration of these populations into national malaria control 
programmes and strategies provides important benefits, both for affect-
ed populations and for global and national malaria reduction targets. To 
ensure this inclusion, strong and concerted advocacy at global, regional, 
and country levels is necessary. Improved coordination among govern-
ments, the UN system and civil society during the planning and revision of 
national strategic plans is needed. 
MALARIA CONTROL IN HUMANITARIAN EMERGENCIES
12
In addition to ensuring emergency planning in national malaria control 
strategies, malaria control should be included in humanitarian emergen-
cy preparedness and contingency planning at country level. This inclusion 
will not only allow an improved coordinated response, but will provide the 
flexibility to prioritize and rapidly transfer the necessary malaria control 
funds from routine to humanitarian programming.
Resource mobilization
There are four key ways of obtaining funds for malaria control needs in 
humanitarian emergencies:
1. The inclusion of malaria control in humanitarian planning and appeals, such as 
flash and consolidated appeals
A flash appeal is launched five to seven days after the onset of an emergen-
cy in order to fundraise for the first three to six months. Malaria control 
activities during the acute phase of the emergency should be included in 
this appeal. 
A consolidated appeal is a multisectoral document developed among 
agencies. The appeal is not only a fundraising document, but also serves 
as an important tool for the planning, coordination, implementation and 
monitoring of humanitarian activities.
 Malaria control programmes should be included under the health sec-
tion of the common humanitarian action plan (CHAP) with a coherent set 
of activities that correspond to agreed priorities and strategies. 
2. The inclusion of malaria control in proposals for grants from the UN Central 
Emergency Response Fund (CERF) 
The Central Emergency Response Fund (CERF) is a stand-by fund estab-
lished by the UN to enable timely and reliable humanitarian assistance to 
victims of natural and human-induced disasters. Malaria control activities 
can usually be included in both the Health in Emergencies submission, for 
activities that have an immediate impact on the health of emergency-affect-
ed populations, and as part of the water, sanitation and hygiene (WASH) 
submission, when emphasising vector control. 
3. Global Fund to Fight AIDS, Malaria and Tuberculosis 
The primary source of funding for national malaria control programmes for 
many countries is the Global Fund to Fight AIDS, Tuberculosis and Malar-
ia (Global Fund). Ten percent of allocated funds can be reprogrammed at 
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country level and this should be explored if an emergency occurs in areas 
where funding has been designated. A good example of this was during the 
major floods in Pakistan in 2010.
The importance of including provisions for populations affected by 
humanitarian emergencies in strategic planning documents has been rec-
ognized in the recent decision by the board of the Global Fund to move 
towards funding national malaria strategic plans in its new funding model. 
4. Assessing funds from other sources 
A number of other potential funding sources exist. For example, funds can 
be sought from the World Bank, the Office of U.S. Foreign Disaster Assis-
tance (OFDA), Multi-Donor Trust Funds, and through the United Nations 
Development Assistance Framework (UNDAF). 
Priorities and constraints
The priority in a humanitarian emergency is to reduce excess mortality and 
morbidity due to malaria as quickly as possible. Unsustainable approach-
es (e.g. augmenting existing infrastructure with temporary expatriate staff 
and/or parallel facilities) can be justified during the acute phase. However, 
a number of general constraints are encountered in humanitarian emergen-
cies, some of which are listed in Table 2.1.
Finding out more
■• CERF Life Saving Criteria and Sectoral Activities http://www.who.int/
hac/network/interagency/news/cerf/en
■• Inter-Agency Standing Committee (IASC). (2006). Guidance note on using 
the cluster approach to strengthen humanitarian response. Geneva, IASC. 
■• Inter-Agency Standing Committee (IASC), WHO (2009). Health Clus-
ter Guide. A practical guide for country-level implementation of the Health 
Cluster. Geneva, World Health Organization.
■• Spiegel et al. (2010). Conflict-affected displaced persons need to benefit 
more from HIV and malaria national strategic plans and Global Fund 
grants. Conflict and Health 2010, 4:2. 
■• The Global Fund. http://www.theglobalfund.org/en/
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Table 2.1 Constraints in humanitarian emergencies
Health infrastructure
Local health facilities in humanitarian emergencies are often in poor condition, as 
affected areas have frequently experienced many years of social and economic decline 
before the onset of conflict or political strife. Infrastructure may be destroyed during 
the emergency. Modern intensive care facilities and equipment, and even relatively 
basic inpatient equipment and supplies such as X-ray and oxygen, are rarely available 
or, if available, cannot be maintained in emergency conditions.
Human resource capacity
During the acute phase of many emergencies, national capacity may be weakened 
and civil structures, including health and other services, are often unable to cope with 
the scale of response required. Shortages of skilled staff are the norm. Skilled national 
professionals, who have the means to relocate from the affected area, are often the 
first to leave in conflict situations, further weakening national capacity. There is often 
a lack of the specific technical skills required to ensure health care delivery in difficult 
and challenging situations. Capacity may remain weak for many years.
Local transmission data
During the acute phase of emergencies, there is often confusion or lack of information 
about the presence and types of vectors and about the potential for local transmission 
in temporary settlements. This has implications for prioritization of preventive services 
in addition to diagnostic and curative services.
Logistics
Supply, storage and distribution problems are often exacerbated by poor road 
infrastructure, looting of stores, and breakdown of procurement systems and supply 
management.
Security
Poor security complicates logistics and service provision, restricts the access of 
vulnerable populations to health care, and places emergency teams under great stress, 
resulting in high staff turnover.
Funding
Delayed funding decisions, insufficient funding, and a rapid decline in funding 
availability are key problems. Resources for training field teams in malaria control 
methods may also be severely limited.
Coordination
Lack of transparency, complementarity, and information sharing among partners can 
hinder effective response.
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CHAPTER 3
Assessment and  
operational planning
This chapter:
■■ outlines essential and desirable information for analysing malaria 
burden and risk in humanitarian emergencies
■■ describes appropriate data collection activities if such data is not 
already available
■■ explains operational planning for an effective malaria response 
Assessment and information needs
Assessment in a humanitarian emergency context is used primarily to deter-
mine the level of malaria risk and the capacity to respond. The following 
guiding principles can be used for the assessment, planning and selection 
of malaria control activities:
■• maximize the use of existing information at international, national, dis-
trict and community levels;
■• carry out rapid surveys if existing information is inadequate or inacces-
sible;
■• link malaria control interventions to current effective national policies;
■• use available local expertise to assist with the selection of malaria control 
options;
■• involve affected populations in decision-making and action.
Essential and desirable information 
In an emergency, information about the demographics of affected popu-
lations, local malaria parasites, vectors, malaria endemicity, transmission, 
and response capacity, is critical in planning and implementing control 
measures. General information is needed to:
■• identify current health priorities and potential health threats;
■• assess the capacity and resources available to respond;
■• collect baseline information for monitoring and evaluating the effective-
ness of planned interventions.
MALARIA CONTROL IN HUMANITARIAN EMERGENCIES
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Malaria-specific information is needed to:
■• determine whether malaria is a major health problem (e.g. actual malaria 
disease and death burden in host and displaced populations); 
■• determine if there is local transmission and whether the area and context 
increase the likelihood of malaria outbreaks (e.g. immune status of pop-
ulations, geographical and climatic conditions, environmental changes, 
local malaria parasite species, local vector species and their behaviour, 
population knowledge and behaviours);
■• determine which population groups are most at risk of malaria infection, 
illness and death (e.g. ages, gender, and socioeconomic groups most 
affected) so that service delivery can be prioritized;
■• identify any constraints to implementing an effective response (e.g. inad-
equate health policies, weak health system structures and capacity, lim-
ited access to health services, and inability to mobilize international and 
national partner support);
■• ensure pesticide regulatory issues are addressed: LLINs, and insecticides 
for IRS and for larviciding, where appropriate, should be WHOPES- 
recommended and may need to be registered by the national regulatory 
agency before use; insecticide-treated materials, such as tarpaulins and 
blankets, may require agreement by national authorities prior to in-coun-
try usage; and some relief agencies will need to obtain an environmental 
assessment or waiver before using vector control products that are not 
formally recommended by WHO. WHO will consider vector control 
products for policy recommendation on an individual basis as data for 
those products become available.
Sources of information
Assessments should be conducted jointly with national authorities and key 
partners, and results shared with international and national partners so 
they can contribute to overall assessment of the health situation and wider 
humanitarian needs. The initial situation assessment should take less than 
a week, although this will depend on security, transport, and communica-
tion.
Basic information on malaria in the country can often be found in nation-
al malaria strategic plans, reports of recent malaria programme reviews, the 
WHO annual World Malaria Reports, Roll Back Malaria Partnership Coun-
try Facts, country-specific Malaria Operational Plans of the President’s 
Malaria Initiative (PMI), Global Fund country grant portfolios, contin-
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gency information and vector ecology profiles from the US Armed Forces 
Pest Management Board (http://www.afpmb.org/), and in information 
on national registration status and vector-borne disease data from major 
WHOPES-approved pesticide manufacturers.
Where malaria information relevant to the emergency zone is limited or 
outdated, particularly where government structures and services have been 
severely disrupted, it may be necessary to carry out rapid surveys to assess 
the situation and the relative importance of malaria. Surveys can include 
clinic-based fever surveys or cross-sectional prevalence surveys (see the 
Rapid epidemiological surveys section below and Annex III). 
Data collection
Information on context and demographics 
Use the general checklists below to ensure relevant information is gathered. 
Data collection should include information on:
■• the background to the emergency situation;
■• transport, roads and infrastructure, including access to airports;
■• security;
■• communications;
■• environments and climate;
■• international and national partner locations and activities; 
■• coordination mechanisms. 
Data collection on the demographics of affected populations should include:
■• estimated total population size and breakdown by age and gender (see 
Chapter 4);
■• estimated mortality per 10 000 per day (see Chapter 4);
■• origins of displaced or refugee populations;
■• other known or measurable health indicators (e.g. prevalence of malnu-
trition, previous exposure to malaria); 
■• distribution and settlement patterns;
■• ongoing movement or mobility;
■• type and location of dwellings;
■• main professions;
■• gender roles; 
■• main languages spoken.
MALARIA CONTROL IN HUMANITARIAN EMERGENCIES
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Information on malaria transmission
Data collection should include:
■• previous exposure of displaced and local populations to malaria (see 
Figure 3.1) – this will help in determining which populations may be 
most at risk;
■• where possible, information on elevation, potential breeding sites, and 
seasonality of risk (e.g. climate, season, rainfall, temperature).
Information on malaria morbidity 
Data collection should include information concerning the malaria burden 
in affected populations and on which population groups are most affected. 
Figure 3.1 Assessing malaria risk
Source: WHO. (2005). Malaria control in complex emergencies: An inter-agency field handbook  
(First Edition). Geneva.
Resettlement area
All age groups are at risk
(expected malaria outbreak)
Children and pregnant women
are at risk of (severe) malaria
Coming from non-endemic region
 (little or no immunity)
Coming from endemic areas
Immune status of refugees
Endemic region Non-endemic region
People not at risk of malaria. 
Region could be prone 
to malaria outbreaks
Quick epidemiological
investigation needed
NOYES
Local malaria situation is clearly defined
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As a minimum, both clinical symptoms (e.g. actual or reported fever) and 
the presence of malaria parasites in those with fever should be measured 
(by RDT or microsocopy). This information can often be obtained from 
provincial, national, district and local levels through:
■• a review of past and present medical records from health facilities in 
affected locations (e.g. number of fever or suspected malaria cases and 
confirmed malaria cases stratified by age group [usually ≤5 years and >5 
years of age], and severe anaemia data [usually haemoglobin <77 g/dl] if 
available). Malaria disease trends can be assessed from a review of sur-
veillance data over time;
■• a rapid parasite prevalence survey at a health facility or mobile clinic, 
preferably one that sees patients from all affected groups (i.e. host, ref-
ugee, and internally displaced). This will indicate the actual proportion 
of confirmed malaria cases among all people presenting with fever (see 
Rapid epidemiological surveys section below and Annex III).
Information on malaria mortality
Specific mortality data are often unavailable or inaccurate. Data collection 
should include: 
■• malaria admissions and deaths, disaggregated by age and sex (both in 
absolute numbers and as a proportion of all admissions and deaths). 
Data should be obtained from referral hospitals or facilities that admit 
patients with severe disease, with the caveat that such data usually represent 
only a fraction of overall malaria mortality at community level. 
Data on malaria parasite species present in the area, and the relative 
importance of each, will affect the choice of diagnostic test, antimalarials 
procured for treatment, and possibly the choice of control measures. This 
information can be obtained from laboratory records or, for greater accura-
cy, from a cross-sectional parasitological survey, when time, resources, and 
operational realities allow.
Data on vector susceptibility to insecticides is paramount. Data on local 
vectors, their behaviours, and location of major breeding sites is also useful 
for understanding transmission patterns and choosing the most cost-effec-
tive vector control options (see Chapter 7). This information is particularly 
useful to avoid placing settlements in high-risk areas and to select potential 
additional prevention measures. The following information should be col-
lected in relation to vectors:
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■• Species
■• Susceptibility to insecticides
■• Preferred breeding sites
■• Feeding habits (e.g. time, location, host preference – usually inferred 
from species identification)
■• Resting habits (e.g. inside, outside)
■• Seasonal density changes
■• Time and location that people come into contact with vectors.
Information on local vectors is often difficult to obtain but can frequent-
ly be gathered from ministry of health and national malaria control pro-
gramme records or staff, records from previous entomological surveys (e.g. 
agency reports or “grey” literature maintained on websites such as WHO 
and the Armed Forces Pest Management Board [AFPMB]), and published 
literature.
Rapid epidemiological surveys
Rapid surveys may be used when the local malaria situation is not clearly 
defined (see Figure 3.1). They are used to assess whether malaria is, or may 
become, a significant problem, and to monitor trends. Rapid malaria sur-
veys can:
■• identify population groups most at risk of malaria (as this will not always 
be pregnant women and children under the age of five);
■• estimate the proportion of the population, both symptomatic and 
asymptomatic, infected with P. falciparum and other malaria species; and
■• help determine priorities for action, including the most appropriate case 
management and vector control measures.
Rapid surveys assess basic clinical signs and symptoms in a patient and para-
site presence using microscopy or RDTs. Two types of rapid malaria surveys 
are:
■• clinic-based among patients attending a health facility or mobile clinic;
■• cross-sectional prevalence survey across the affected population.
Details on conducting these surveys are provided in Annex III. Conduct-
ing malaria surveys at the same time as other rapid surveys (e.g. population 
nutritional status, vaccination coverage) could save time and money.
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Information on malaria outbreaks and control efforts
Data collection should include:
■• presence of known risk factors for malaria outbreaks and whether the 
area has experienced earlier outbreaks;
■• risk factors including large influxes of non-immune people into an area 
of high transmission, rainfall after an unusual period of drought, recent 
environmental changes that have increased suitable breeding sites, out-
dated treatment protocols, or drug and/or insecticide resistance;
■• if there have been earlier outbreaks, a review of the number of cases and 
deaths and the causes of the outbreak;
■• a review of past and present malaria control efforts in the area.
Information on population knowledge and practices
Data collection should include:
■• knowledge, attitudes and beliefs among different ethnic groups about 
malaria and its causes, prevention and treatment;
■• current usage of protective measures such as insecticide-treated materi-
als, types of shelter and, where possible, family sleeping arrangements;
■• treatment-seeking behaviour and health care provision by traditional 
healers and private practitioners; 
■• other practices (e.g. night-time behaviours) that could increase exposure 
to vectors.
Assessing capacity to respond
Response capacity in an emergency will depend on existing national pol-
icies, health system and services, population knowledge and practices, 
and the capacities of international and national stakeholders. Assessing 
response capacity in a humanitarian emergency requires information on 
existing health policy and services, infrastructure, relevant programmes, 
drugs and insecticides, and service usage.
Information on health policy, planning, and services
Data collection should include:
■• current health policy (e.g. health sector reforms);
■• financial mechanisms (e.g. user fees);
■• responsibilities for planning and implementation at national, regional, 
provincial and district levels.
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Information on health infrastructure and personnel
The actual condition of public and private health facilities and other infra-
structure should be assessed, as should the availability of personnel, par-
ticularly those who have worked in malaria control. Assessment should 
include:
■• types of health facilities, including those set up by NGOs and mobile 
structures;
■• numbers of health workers and their level of training;
■• staff turnover, especially for international staff;
■• clinical algorithms for diagnosis, including Integrated Management of 
Childhood Illness (IMCI) strategy usage;
■• treatments protocols for uncomplicated and severe malaria;
■• availability of diagnostic testing (e.g. microscopy, RDTs);
■• referral services;
■• drugs and equipment, including blood transfusion facilities;
■• health service logistics (e.g. transport facilities for patient transfer, effec-
tiveness of communication between different levels of the system);
■• surveillance, monitoring, and information management systems;
■• supervision mechanisms.
Information on the National Malaria Control Programme
Data collection should include:
■• programme goals, objectives, strategies, targets and action plans; 
■• programme structure, management and staff; 
■• protocols and guidelines, including those on dealing with malaria in 
emergencies and during epidemics.
Information on other priority health programmes and activities
Data collection should include: 
■• the national essential drugs list; 
■• drug stocks, supply and distribution systems; 
■• environmental health activities (e.g. vector control, insecticide stocks 
and supply lines); 
■• mother and child health initiatives, such as Making Pregnancy Safer 
(MPS), and IMCI. 
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Information on drugs and insecticides
National policies and regulations govern the use of drugs and insecticides 
in all countries, so it is important to collect information on:
■• malaria diagnostic testing policy and practices;
■• antimalarial drugs currently recommended by the ministry of health for 
treatment of uncomplicated malaria, management of severe malaria, and 
other drugs used locally (see Chapter 6);
■• potential emergency drug options that are registered or whether these 
will need to be negotiated and introduced;
■• which insecticides are recommended and used (see Chapter 7);
■• available evidence on the efficacy of drugs and insecticides being used 
under national protocols;
■• capacity for quality control of drugs and insecticides imported for the 
emergency;
■• regulatory policies, including import and customs regulations and excis-
es. 
Information on accessibility and use of health services
Information should be collected on:
■• host and displaced populations’ access to, and use of, existing health care 
services, and the extent to which these services could be strengthened;
■• factors likely to reduce access and treatment-seeking behaviour signifi-
cantly in emergencies (e.g. poor security, culturally inappropriate servic-
es, preferences for alternative sources of health care, full or partial cost 
recovery mechanisms for consultation, diagnosis and treatment). Plan-
ning should include working with private treatment providers (if these 
are commonly used by the population that will be served).
Operational planning
Multisectoral planning
The capacity to respond to a humanitarian emergency will often depend 
on international and national partners. It is therefore important once the 
presence and activities of other agencies has been assessed, to determine 
mechanisms and scope for coordination and joint planning. As malaria con-
trol goes beyond the health sector, it is vital that multisectoral planning is 
undertaken based on the malaria risk and response capacity assessments.
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Site planning
In the initial phase of humanitarian emergencies, refugees and internally 
displaced people move quickly to the nearest safe place outside the conflict 
area. Subsequently, international organizations and the host government 
may resettle refugee or internally displaced populations in more permanent 
sites. Whether or not this happens depends on the local situation. For exam-
ple, some local authorities may be reluctant to encourage the establishment 
of long-term settlements.
If displaced populations are to be resettled, criteria for site selection 
include the availability of water and land, means of transport, access to 
fuel, and security (and possibly distance from borders). However, areas that 
meet these criteria are usually already occupied by resident populations, so 
displaced populations are instead often resettled in less desirable sites. If 
there is a choice when selecting a site, it is helpful to consider specific crite-
ria that may affect the risk of malaria:
■• assess the epidemiological characteristics of the area;
■• investigate potential vector breeding sites, making use of local expertise 
and knowledge of important vectors;
■• avoid sites close to major breeding locations of local vectors. In Africa, 
such sites often include marshy areas and flat, low-lying land at risk of 
flooding. If possible, sloping, well-drained sites with tree cover and shel-
tered from strong winds, should be chosen. In South-East Asia, thick for-
est should be avoided, as such areas are frequently a suitable habitat for 
efficient malaria vectors.
Selecting vector control activities
If malaria transmission is very high, rapid prescriptive standardized 
approaches to vector control may be necessary, such as long-lasting insecti-
cidal nets (LLINs), indoor residual spraying (IRS), or provision of blankets 
or other materials that have been treated with insecticide (see Chapter 7). 
However, costly and logistically intensive activities such as IRS require a 
clear understanding of vector behaviour and the susceptibility of local vec-
tors to available insecticides. In addition, understanding population knowl-
edge and practice is critical in selecting appropriate vector control activities 
(see Chapter 8).
Selecting effective first-line antimalarial treatment
Since early testing of suspected malaria cases and prompt effective treat-
ment of these are the first priority in malaria control, it is essential to select 
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and use a first-line antimalarial drug that is efficacious and safe, with limited 
contraindications and side-effects (see Chapter 6).
Managing supplies of diagnostics, antimalarials, and other  
essential medicines
After diagnostic tests and antimalarial medicines have been selected, impor-
tant steps in establishing systems to manage supplies include:
■• establishment of a working group or interagency committee, involving 
local and international agencies and organizations, to manage the emer-
gency;
■• establishment of a working group subcommittee to manage supplies of 
diagnostic tests and essential medicines, including antimalarials. The 
agency with the most experience and expertise in supply management 
of essential medical commodities should take the lead, with responsi-
bility for receiving, storing and distributing goods and monitoring the 
supply system. It is important to involve the relevant health authorities 
in the host country;
■• careful attention to quality of diagnostics and medicines and sources of 
supply. It is important to check product specifications, including diag-
nostic performance, expiry dates, and in the case of medicines, dosage 
form and strengths;
■• development of a stock management system that is as simple as possi-
ble and within the scope of the host country (e.g. storage conditions for 
medicines and diagnostic supplies in relatively cool and non-humid con-
ditions is important to prevent deterioration);
■• development of a clear policy for free distribution of diagnostic testing 
and medicines, ensuring that all agencies and communities are aware of 
this policy;
■• ensuring that all staff who provide health care are trained in rational use 
of medicines, including the use of diagnostic testing and adherence to 
recommended antimalarials. Training should be arranged if necessary;
■• seeking advice from the national health authorities if donated supplies 
of medicines are not approved or aligned with national treatment pro-
tocols. If there is no other option, health workers should be trained in 
the rational use of these medicines as a temporary measure to save lives, 
while the procurement of approved medicines is started as soon as pos-
sible;
■• ensuring patient counselling to improve adherence to treatment and 
advise on how to recognize symptoms that would require a return to the 
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clinic. This may not be feasible in the acute phase of an emergency where 
there is a heavy case load, but should be possible once the displaced or 
refugee population is living in stable settlements and during the chronic 
phase; 
■• an early decision, with health authorities, on whether or not the resident 
population will also have access to health care services delivered as part 
of humanitarian assistance. If so, estimates of requirements for the resi-
dent population must be included when diagnostic test and drug supply 
requirements are calculated.
Procurement and supply chain management
Procurement and supply chain management (PSM) are crucial to ensuring 
that interventions reach affected populations. Providing supplies quickly 
and cost-effectively is often a great challenge. It is important to be aware 
that:
■• countries need to have prepositioned emergency stocks;
■• the main procurement bodies for malaria intervention commodities are 
governments, United Nations agencies and international organizations. 
Different partners support countries with product procurement;
■• PSM for malaria is usually integrated with other diseases. Interagency 
Emergency Health Kits (IEHK) are standardized to provide for the basic 
health needs of 10 000 people for three months while health services are 
disrupted. There is a specific malaria module for emergencies occurring 
in malaria endemic areas, which includes RDTs, artemether-lumefan-
trine, and injectable artesunate to treat falciparum malaria;
■• supply storage and distribution can be challenging due to damage to 
buildings and road infrastructure, to shortage of vehicles, and to looting 
of warehouses or lack of storage space. A number of malaria interven-
tions, such as IRS and LLINs, require significant storage space. 
Community outreach 
Community participation and effective health education are essential to the 
success of malaria control interventions in humanitarian emergencies and 
attention must be paid to understanding community perspectives and the 
sociocultural factors that influence community behaviours (see Chapter 8). 
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Finding out more
■• IASC (2006). Guidance note on using the cluster approach to strengthen human-
itarian response. Geneva, Inter-Agency Standing Committee
■• Inter-Agency Standing Committee (IASC), WHO (2009). Health Cluster 
Guide: A practical guide for country-level implementation of the Health Cluster. 
Geneva, World Health Organization.
■• Spiegel et al. (2010). Conflict-affected displaced persons need to benefit 
more from HIV and malaria national strategic plans and Global Fund 
grants. Conflict and Health, 4:2
■• WHO. Information note on recommended selection criteria for procure-
ment of malaria rapid diagnostic tests (RDTs). Available at http://www.
who.int/malaria/publications/atoz/9789241501125/en/index.html
■• Test.Treat.Track Initiative. See details at http://www.who.int/malaria/
areas/test_treat_track/en/index.html
■• Guidelines on procurement of public health pesticides. See http://www.
who.int/malaria/publications/atoz/9789241503426_pesticides/en/
index.html
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CHAPTER 4
Surveillance
This chapter:
■■ defines surveillance for health outcomes, including malaria, in 
humanitarian emergencies
■■ outlines the basic information needed to plan and implement malaria 
surveillance in humanitarian emergencies, including what data to collect, 
how to collect data, and how to use data
■■ describes the use of surveillance for monitoring and evaluation in 
humanitarian emergencies
Health surveillance in humanitarian emergencies
Definition
Surveillance for health outcomes in humanitarian emergencies, as in other 
settings, refers to the systematic collection, consolidation, and evaluation of 
relevant health data, as well as the prompt dissemination of results to those 
who need them. For example, malaria surveillance may be used to: identify 
malaria as a health problem; monitor trends in its occurrence; give early 
warning of potential malaria outbreaks; and monitor the effectiveness of 
control interventions. Surveillance for health outcomes, including malaria, 
is essential for planning, implementing and evaluating health interventions. 
In a humanitarian emergency, a surveillance system is a priority that must 
be established quickly. A well-functioning surveillance system can help 
determine which conditions, including malaria, are operational priorities. 
Malaria surveillance should itself be integrated into an overall surveillance 
system that collects data on all potentially significant causes of morbidity 
and mortality.
Surveillance approaches 
In humanitarian emergencies, surveillance is most often based on data col-
lected by health care providers and reported at regular intervals through 
health facilities (e.g. clinics, hospitals). Where necessary this data can be 
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complemented by active surveillance or periodic surveys. Active surveil-
lance includes an ongoing collection of information that is obtained either 
by periodically contacting health care providers who are not participat-
ing in routine surveillance, or via regular home visits. Periodic surveys are 
time-limited exercises that are usually conducted at the community level 
and are often carried out early in a crisis when routine surveillance systems 
are not yet established or are functioning poorly. Surveys can be repeated 
at intervals, ideally using the same methodology each time, to allow for the 
comparison of results as the situation progresses. 
If no surveillance system is in place or the existing system is inadequate, it 
is essential to establish a functional system. This must, however, be carried 
out in a coordinated and integrated manner (see Box 4.1). Challenges to 
establishing an effective surveillance system in a humanitarian emergency 
may include:
■• inadequate understanding at field level of what a surveillance system is 
and why it is needed, resulting in poor recording, reporting and use of 
information;
■• poor motivation of health workers;
■• insufficient diagnostic capacity to confirm clinical diagnoses, resulting in 
inaccurate and unreliable data;
■• unknown representativeness of health facility-based data because only 
a small percentage of the population use health services (e.g. security 
Box 4.1 Surveillance challenges after the Haiti earthquake, 2010
Following the 2010 Haiti earthquake, over one million people were left 
homeless, with the majority of the displaced population living outdoors or in 
temporary shelters, putting them at increased risk of malaria. Throughout much 
of the earthquake-affected zone there was extensive destruction of health 
care facilities and of public health infrastructure, as well as the displacement 
and loss of many health care providers. After the earthquake, the chaotic 
and changing environment was a major challenge to efforts to set up malaria 
surveillance. Lack of coordination, logistical challenges, mobile populations, 
and a constantly changing network of health care facilities, made accurate 
and timely surveillance difficult. In this context, initial rapid active surveillance 
was conducted by mobile teams, who used RDTs for case confirmation and 
who provided locally effective treatment. The teams also relayed information 
back to the Haitian Government and its partners. As the situation became less 
chaotic, a more formal surveillance system was employed relying on a mixture 
of active and passive methods.
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problems or cost can limit access for a proportion of the affected popu-
lation);
■• lack of coordination among agencies;
■• restricted access to the population by health care workers and agencies 
(e.g. due to security issues).
Planning malaria surveillance during humanitarian emergencies 
Collecting basic information
Before any surveillance system is implemented in a humanitarian emergen-
cy, it is necessary to have basic information about the size and structure of 
the population in question. In this chapter it is assumed that much of this 
basic information, such as estimated population size and demographics, 
has been collected by emergency response agencies and is available for use 
and incorporation into the health surveillance system. 
In cases where basic information about the affected population has not 
yet been collected or is inaccessible, it can be collected following the meth-
ods described in Annex I. If such basic data is lacking, it is advisable to 
strengthen coordination between partners to ensure that as much informa-
tion as possible is gathered as quickly as possible. 
Population size and structure
Data on population size and structure is important for planning the scale 
and size of an emergency response as well as for allocating resources. It is 
also helpful for calculating health indicators, such as mortality and disease 
burden. Population size and structure can be determined using the meth-
ods summarized below and described in Annex I:
■• counting households and the average number of people per household;
■• mapping the site area and measuring average population density;
■• conducting a census or reviewing records (e.g. of population, camp reg-
istration, food distribution);
■• using information from programme activities (e.g. vaccine coverage).
Basic information on the number of deaths that have occurred (retrospec-
tive mortality) and data from verbal autopsies can also be of use and may 
already have been collected (see Annex I). 
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Surveillance priorities in humanitarian emergencies
In an emergency:
■• collect only the information that is absolutely necessary;
■• keep data collection as simple as possible;
■• decide who will collect data, from where, and what training will be giv-
en;
■• decide how often to collect data;
■• budget for the costs of surveillance (see Box 4.2);
■• analyse what the data reveals about trends and give feedback in relevant 
coordination forums and to data providers (e.g. clinics).
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Box 4.2 Budgeting for surveillance
Surveillance should be seen as an activity in its own right and should, therefore, 
be specifically included in budgets for malaria control. Dedicated surveillance 
staff and activities should be developed.
Human resources
Usually a combination of local and health ministry resources (e.g. vector control 
teams from the national malaria control programme), possibly reinforced 
by external assistance and/or partners. Personnel required may include a 
surveillance coordinator or manager, an epidemiologist, and a laboratory 
technician. Outreach teams may also be needed for active surveillance.
 
Laboratory
Cost is dependent on the chosen diagnostic strategy (e.g. RDT, microscopy). 
Other laboratory equipment and associated consumables need to be included, 
as well as costs for quality control of laboratories and supervision of data 
collection (see Chapter 6).
Transport and logistics
Requirements and costs will depend on the terrain and on the accessibility of 
different areas, but adequate resourcing is crucial.
Training
Costs of training health workers and outreach teams should be included, and 
refresher training should be considered in most circumstances.
Other costs
Costs could include: the forms, equipment or materials required for analysing 
data; communication equipment; training and administration.
MALARIA CONTROL IN HUMANITARIAN EMERGENCIES
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Data collection
In complex humanitarian emergencies, it is essential to prioritize surveil-
lance of all-cause mortality, cause-specific mortality, syndrome-based mor-
bidity, and disease-specific morbidity, including malaria. Where possible, 
this should be done in an integrated and standardized way through exist-
ing systems rather than in parallel to existing systems. Possible sources of 
data include:
■• local community health workers and the community;
■• health personnel working in hospitals (e.g. outpatient and inpatient 
departments), health centres, and mobile outreach teams; 
■• special teams trained to conduct surveys.
Mortality surveillance
Monitoring mortality is an essential component of a health surveillance sys-
tem and overall mortality is important, even in a malaria-focused surveil-
lance system. Death rates may be high in the acute phase of an emergency 
and the immediate priority is to reduce mortality as quickly as possible. 
Mortality should be assessed across standard age groups and should 
distinguish deaths that occur among pregnant women. Indicators used for 
mortality surveillance include:
■• number of deaths per 10 000 persons per day (crude mortality rate);
■• number of deaths in children under five per 10 000 persons under five 
per day (under-5 crude death rate);
■• disease and cause-specific mortality rates (e.g. malaria, measles, acute 
respiratory infections, diarrhoea, war-related violence or injuries);
■• proportion of mortality attributable to specific diseases (see section 
below).
Ideally, crude death rate estimates would already be collected by emergen-
cy response agencies early in a humanitarian response and would be avail-
able for programmes aiming to control malaria. However, if a system has 
not been established, an active mortality surveillance system using home 
visits should be established and home visitors trained to record daily total 
deaths and deaths in children under 5 years of age. Daily data should be 
compiled and analysed at the end of each week (Figure 4.1). Surveillance for 
deaths that occur at facilities should be part of facility-based health surveil-
lance. Community data from the active mortality surveillance system can 
be combined with health facilities mortality data, to ensure that all available 
data are included, but should be verified to avoid double-counting deaths 
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registered at the clinic and recorded in the community. Recording where a 
reported death occurred can help with verification. 
Cause-specific mortality
In the mortality surveillance, information can be recorded about the cause 
of death (Figure 4.2). Possible data sources include health facility regis-
ters, home visits, and interviews with heads of households. However, data 
should be verified to avoid double-counting deaths registered at the clinic 
and recorded in the community. 
Causes of morbidity
A standard case definition should be used for each disease, and morbidity 
should be assessed across standard age groups and among pregnant wom-
en. Indicators used for morbidity surveillance include:
■• incidence rate (the number of new cases per week, expressed as a popu-
lation percentage or per 1000, 10 000 or 100 000 persons); 
CHAPTER 4. SURVEILLANCE
Figure 4.1 Example: mortality surveillance reporting form
Place: .......................................................  Reported by: .......................................
From:....../......./......... (day/month/year) To: ....../......./......... (day/month/year)
Populationa
Population End of  New Departures End of  Average 
 previous  arrivals  this week   population 
 week (A)   (B)  (A+B)/2
<5 years old
≥5 years old
Pregnant women
a Information about the population is needed to calculate mortality rate.
Mortality rate
 Number of deaths Rate (deaths/10 000 per day)
 Male Female Total Male Female Total
<5 years old
≥5 years old
Pregnant women
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■• incidence rate by age-group or categories (e.g. the number of new cases 
in a specified time-period in under-fives, or in pregnant women).
In humanitarian emergencies, these data are often collected from dai-
ly records of fixed health facilities or mobile clinics providing outpatient 
and inpatient services to the population (Figure 4.3). Daily data should be 
recorded at the facility and collected and analysed at the end of each week 
by the central coordinating agency for surveillance. These data can also 
be collected actively using cross-sectional surveys. Care should be taken 
to avoid double-counting of patients who report illness and have been to 
a clinic. If active data collection is repeated it is important to maintain a 
standard data collection method to evaluate trends.
Figure 4.2 Example: cause-specific mortality reporting form
Place: .......................................................  Reported by: .......................................
From:....../......./......... (day/month/year) To: ....../......./......... (day/month/year)
Deaths due to <5 years of age ≥5 years of age Total Percentage
 M F Total M F Total M F Total
Non-bloody diarrhoea
Bloody diarrhoea
Severe respiratory infections
Suspected malariaa
Confirmed malariab
Presumed malariac
Measles
Malnutrition
Suspected meningitis
Injury
Others
Total
a Suspected malaria (i.e. confirmed malaria + confirmed non-malaria + plus presumed malaria); 
b Confirmed malaria is based on parasite-based diagnosis (e.g. RDT or microscopy); 
c Presumed malaria is suspected malaria (as determined by clinical signs and symptoms only) that has been 
treated without testing. 
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Figure 4.3 Example: cause-specific morbidity reporting form
Place: .......................................................  Reported by: .......................................
From:....../......./......... (day/month/year) To: ....../......./......... (day/month/year)
Diseases <5 years of age ≥5 years of age Total Percentage
M F Total M F Total M F Total
Non-bloody diarrhoea
Bloody diarrhoea
Respiratory infections
Suspected malariaa
Suspected malaria 
testedb
Confirmed 
uncomplicated malariac
Presumed uncomplicated 
malariad
Suspected severe 
malaria
Suspected severe 
malaria tested
Confirmed severe 
malaria
Presumed severe malaria
Malnutrition
Suspected meningitis
Injury
Others
Total
a  Suspected malaria (i.e. confirmed malaria + confirmed non-malaria + plus presumed malaria) is useful for 
calculating test positivity rate (see Table 4.1); 
b  Tracking the number of suspected malaria cases tested can be used to calculate test positivity rates; 
c  Confirmed malaria is based on parasite-based diagnosis (e.g. RDT or microscopy); 
d  Presumed malaria is suspected malaria (as determined by clinical signs and symptoms only) that has been 
treated without testing. 
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Malaria-specific surveillance needs
The purpose of malaria-specific surveillance is to:
■• Monitor trends, e.g.:
 — Are malaria cases or malaria deaths occurring and are they increasing 
or decreasing?
 — Is the number of malaria patients as a proportion of the total number 
of patients rising?
 — Is an increase due to new arrivals or to an increase in the transmission 
of malaria?
■• Provide early warning of an outbreak, e.g.: 
 — Is malaria incidence increasing?
 — Is the proportion of confirmed malaria cases (e.g. RDT positivity 
rate, slide positivity rate) increasing?
 — Is the proportion of adults with malaria increasing?
■• Monitor effectiveness of malaria control interventions and, if necessary, redefine 
priorities, e.g.:
 — Do sick people access health care structures?
 — What is the coverage and use of bednets?
 — How effective is the detection and treatment of malaria cases?
■• Map cases, e.g.:
 — Is there a clustering of cases that could indicate a focus of local trans-
mission or higher-risk activities? 
Malaria surveillance should include the indicators summarized in Table 4.1.
Data collected should be based on the standard WHO case definitions 
(see Table 4.2). Use of standard case definitions and confirmation of cas-
es are essential to ensure high quality surveillance with which to make 
informed judgements about progress in malaria control. Relying only on 
clinical diagnosis will provide inadequate data about malaria cases in all but 
the highest transmission areas and, as such, it is important to use a suitable 
confirmatory tool, such as RDTs or microscopy (see Chapter 6). Quality 
surveillance also depends on reliable and complete data reporting from 
health facilities and laboratories to a central data point; on adequate and 
timely analysis of data collected; and on appropriate dissemination to part-
ners and stakeholders.
Information specific to malaria can be collected from health centre labo-
ratories to provide information additional to the formal health surveillance 
system, including the number of tests (smear/RDT) performed and the 
number of positive tests (smear/RDT) – to estimate test positivity rates.
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Where there is more than one species of malaria of concern (e.g. P. falci-
parum and P. vivax) it is advisable to note the species for each case if possible. 
Recommended treatments for these two species often differ. P. falciparum 
malaria is also associated with higher mortality than P. vivax, so the ratio of 
cases caused by each species is important for resource allocation. 
Malaria incidence rates should be used to guide prioritization. Test pos-
itivity rates (e.g. RDT/microscopy) may be useful if health seeking, testing 
or reporting rates cannot be accounted for to assess changes in malaria inci-
dence. These can be collected through an appropriate passive surveillance 
system from health facilities and other providers (e.g. CHWs). Surveillance 
data should therefore be used for prioritization and targeting of interven-
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Table 4.1 Useful indicators for malaria surveillance
Rates Calculation Interpretation
Crude mortality rate 
(CMR)
Number of deaths/10 000 
population per day
>1/10 000 indicates an emergency 
(a doubling of baseline mortality 
rate)
Malaria-specific 
mortality rate
Number of malaria 
deaths/10 000 population 
per day
Is malaria a health priority? Is 
malaria a significant proportion of 
overall CMR?
Proportion of mortality 
caused by malaria
Number of malaria 
deaths/total number of 
deaths
Is malaria contributing significantly 
to overall CMR
Malaria incidence rate Number of new malaria 
cases/1000 population 
per week 
Is malaria increasing? What action 
should be taken?
Case-fatality rate in all 
malaria cases
Number of confirmed 
malaria deaths/1000 
confirmed malaria cases
Are cases being managed 
effectively?
Case-fatality rate in 
severe malaria cases
Number of severe 
malaria deaths/Total 
number of severe malaria 
cases
How effective is the referral 
service? How well are severe 
cases managed at community, 
clinic or hospital level?
Malaria test positivity 
rate
Number of positive RDTs 
or slides/Total RDTs or 
slides examined
What proportion of suspected 
malaria is actually malaria? An 
increasing rate may indicate the 
beginning of a malaria epidemic or 
a seasonal peak (see chapter 4).
Proportion of 
population (or target 
group) covered by the 
intervention
Number of intervention 
units (e.g. LLINs)/
Population of interest 
Can intervention coverage 
be improved? Are targeted 
populations being adequately 
reached?
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Table 4.2 Standardized malaria case definitions
Suspected malaria
Patient illness suspected by a health worker to be due to malaria. Criteria for 
suspected malaria usually include fever, but the precise criteria vary according to 
local circumstances. All patients with suspected malaria should be tested by either 
microscopy or a rapid diagnostic test (RDT).
Presumed (not tested) malaria
A suspected case in which the patient did not undergo a diagnostic test but was never-
theless treated for malaria. Such cases have been sometimes referred to as probable 
cases; however, in most settings, the chance that a suspected case will be confirmed is 
<50% and therefore the term probable is inappropriate and should not be used. 
Confirmed malaria
A suspected case of malaria in which malaria parasites have been demonstrated, 
generally by microscopy or RDT. In some suspected cases with a positive test, 
particularly in populations that have acquired immunity to malaria, febrile illness may 
be due to other causes. Nevertheless, a diagnosis of confirmed malaria is still given. If 
concurrent disease is suspected, it should be further investigated and treated.
Confirmed severe malaria
A patient with laboratory confirmed acute malaria with signs of severity and/or 
evidence of vital organ dysfunction.
Note: Uncomplicated and severe malaria categories are intended to be mutually 
exclusive. For example, a patient who initially presents with uncomplicated malaria but 
then develops signs or symptoms of severe disease should be classified only as having 
severe malaria, and not counted twice. This also applies to situations where health 
services record cases as suspected malaria until diagnosis is confirmed by microscopy 
or RDT, after which the cases become confirmed malaria, or the patient is treated for 
malaria without testing, after which the case becomes presumed malaria. Presumed and 
confirmed malaria cases should be reported separately. Though confirmed and presumed 
cases are subsets of suspected malaria, it can be useful to track suspected malaria cases 
and the number of cases tested for malaria as well, in order to understand changes in 
confirmed and presumed malaria.
Presumed malaria death
Death of a patient who has been diagnosed with presumed severe malaria, i.e. treated 
for malaria without laboratory testing being performed.
Confirmed malaria death
Death of a patient who has been diagnosed with severe malaria, with laboratory 
confirmation of parasitaemia.
Source: WHO (2012) Disease Surveillance for Malaria Control.
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tions. For example, during the Afghan refugee crisis in Pakistan, only those 
camps where incidence exceeded a certain threshold were targeted for vec-
tor control. Using this system, preventive interventions targeted the most 
endemic camps, making the interventions more efficient.
Establishing passive disease surveillance requires microscopy quality 
control. Technicians from a central reference laboratory can provide this 
service. These technicians can regularly monitor the technical accuracy of 
microscopists working in field laboratories and clinics. Malaria rapid diag-
nostic tests can also be used for routine diagnosis. Both RDTs and micros-
copy should be connected to a quality assurance system (see Chapter 6). 
Monitoring and evaluation
Surveillance is an important programme component of a comprehensive 
monitoring and evaluation (M&E) plan. Monitoring, as distinguished from 
surveillance of health outcomes, is systematic collection and regular analy-
sis of programme data (e.g. number of LLINs distributed per day or week), 
to determine day-to-day programme functioning and changes over time. It 
can be used for a variety of functions (e.g. directing resources, identifying 
bottlenecks, reporting to donors).
Evaluation is usually conducted at set points in the programme cycle to 
assess whether the programme has achieved its aims by measuring progress 
against specific indicators. Normally, multiple indicators are used. These 
can include input indicators (e.g. items procured on time), process indica-
tors (e.g. number of health workers trained), output indicators (e.g. number 
of items distributed), or outcome indicators (e.g. proportion of population 
protected by intervention) and impact indicators (e.g. reductions in malaria 
incidence or malaria deaths). 
Indicators are often agreed upon with donors before implementation 
and thus should be used as far as possible in M&E. Indicators should be 
designed using SMART or SMARTER criteria (e.g. Specific, Measurable, 
Agreed, Relevant, Time-bound, Ethical, Realistic). 
Programme effectiveness indicators
Information on programme effectiveness should be collected and analysed 
every week to assess how well different components are functioning. Infor-
mation that can be useful in monitoring programme functioning include:
■• How many home visitors are working and where?
■• How many patients are diagnosed and treated for malaria and where?
■• How many health personnel are involved in programme activities?
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■• What kind of antimalarial drugs are available, and in which dosage 
strengths?
■• How long is the delay between ordering drugs and receiving them at 
health facilities?
■• Are there shortages of drugs? If so, how frequent are the shortages and 
how long do they last?
■• Are rapid diagnostic tests available? Are there shortages of diagnostic 
supplies? If so, how frequent are the shortages and how long do they last?
■• What percentage of febrile patients are tested using blood smears or 
RDTs in outreach activities or health facilities, and what is the delay 
(both average and extreme) before test results are known?
Monitoring case management helps demonstrate how effectively cases are 
being diagnosed and treated. An indicator that can be used to monitor case 
management is the case-fatality rate.
Monitoring coverage helps ensure that vulnerable groups are being 
reached or have access to services. Indicators that can be used to assess cov-
erage include:
■• proportion of sick patients with access to a health centre;
■• proportion of affected geographical areas covered by the programme;
■• proportion of pregnant women and children under five years of age cov-
ered by the programme;
■• ownership/use of LLINs.
Other considerations when assessing indicators for surveillance
Trends in malaria cases and deaths may be influenced by changes in health 
care seeking behaviour, diagnostic effort at points of care, and complete-
ness of reporting throughout the system. The following are some suggested 
indicators that can be used to monitor or evaluate the surveillance compo-
nents of the malaria control programme:
■• number of persons or proportion of the population seeking care through 
available points of care;
■• number and proportion of suspected cases tested for malaria;
■• proportion of facilities providing timely reporting of their weekly data;
■• proportion of community workers providing timely reporting of their 
weekly data;
■• proportion of community workers providing complete reporting of their 
weekly data;
■• number of weekly or monthly analysis reports disseminated (and used in 
decision making);
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■• timely reporting at project or agency level;
■• timely reporting towards broader platforms, for example, the lead coor-
dinating agency, MoH, or other stakeholder meetings.
Surveillance for other aspects of malaria control 
Surveillance for other aspects of malaria control, outside the purview of 
normal health programming in emergency situations, can also be conduct-
ed. The primary focus of malaria control in humanitarian emergencies is to 
save lives and prevent morbidity. As such, routine disease surveillance is 
a priority. Therefore, only if resources allow are the following malaria-fo-
cused surveillance activities worth considering:
Drug efficacy surveillance
If possible, and the drug-efficacy status of the area is unknown, it can be 
useful to identify at least one health facility site in which to conduct in- 
vivo antimalarial drug efficacy surveillance (see Chapter 8). However, 
unless changes in efficacy are expected to be extreme, sentinel surveillance 
for drug efficacy should not interfere with other priorities. 
The WHO protocol for in-vivo efficacy surveillance recommends that 
clinical and parasitological parameters be monitored on days 0, 2, 3, 7, 14 
and 28 (see Box 4.3). Efficacy surveillance allows the efficacy and safety of 
first-line treatment to be monitored and confirmed. Monitoring of drug 
resistance can also be done using in vitro tests that identify genetic markers 
of resistance (e.g. PCR). This technique is increasingly applied, though sup-
port of an expert laboratory is required. 
It may also be important to monitor drug quality if poor effectiveness or 
efficacy has been detected or if locally manufactured drugs are applied and 
the quality is questionable. Such monitoring can be done more accurately 
by a specialist laboratory than by using off-the-shelf kits.
Vector surveillance 
Knowledge of malaria vector composition and density is operationally use-
ful. Differing vector habitats and behaviours may have an impact on which 
control measures are implemented. If no data on local vector composition 
is available (e.g. from the national malaria control programme, published 
papers, local universities), and local transmission has been determined 
epidemiologically, then vector surveillance is particularly important to 
determine: (i) what and where vectors are, and (ii) susceptibility status 
to insecticides. Vector surveillance and insecticide resistance monitoring 
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requires specialist equipment (e.g. light traps) and laboratory infrastructure 
and should be conducted under the guidance of an experienced entomol-
ogist (see Chapter 7).
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Finding out more
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Box 4.3 Classification of malaria treatment responses
Early treatment failure (ETF)
• danger signs or severe malaria on day 1, 2 or 3, in the presence of 
parasitaemia;
• parasitaemia on day 2 higher than on day 0, irrespective of axillary 
temperature;
• parasitaemia on day 3 with axillary temperature ≥ 37.5 °C; and parasitaemia 
on day 3 ≥ 25% °C count on day 0
Late clinical failure (LCF)
• danger signs or severe malaria in the presence of parasitaemia on any day 
between day 4 and 28 (day 42) in patients who did not previously meet any 
of the criteria of early treatment failure; and
• presence of parasitaemia on any day between day 4 and day 28 (day 42) 
with axillary temperature ≥ 37.5 °C in patients who did not previously meet 
any of the criteria of early treatment failure.
Late parasitological failure (LPF)
• presence of parasitaemia on any day between day 7 and day 28 (day 42) 
with axillary temperature ≥ 37.5 °C in patients who did not previously meet 
any of the criteria of early treatment failure of late clinical failure.
Adequate clinical and parasitological response (ACPR)
• absence of parasitaemia on day 28 (day 42) irrespective of axillary 
temperature, in patients who did not previously meet any of the criteria of 
early treatment failure, late clinical failure or late parasitological failure.
Source: http://whqlibdoc.who.int/publications/2009/9789241597531_eng.pdf
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CHAPTER 5
Outbreaks
This chapter:
■■ outlines malaria outbreak preparedness for humanitarian emergencies
■■ provides guidelines for investigating a malaria outbreak
■■ describes malaria outbreak response and follow-up 
Outbreak preparedness
Epidemic malaria may occur in areas of normally low or seasonal malaria 
transmission where people have little immunity to the disease. It may occur 
in non-immune populations that have moved through or into endemic 
areas. It may also occur in areas that were previously malarious, but where 
control has reduced the case load over recent years while the area remains 
receptive to malaria transmission. In these cases, severe disease and deaths 
can occur in all age groups, with young children, pregnant women, mal-
nourished individuals, and people with concurrent infections (e.g. HIV) 
the most vulnerable. Even when malaria transmission is not excessive com-
pared with previous years, local epidemics with high mortality may occur 
among vulnerable displaced populations because of the concentration 
of people, lack of adequate housing for preventive measures resulting in 
increased exposure to mosquito bites, concurrent infections and malnutri-
tion, and reduced access to effective treatment. 
Determining epidemic risk
Outbreak preparedness and response is thus an important component of 
malaria control in humanitarian emergencies. However, in emergency set-
tings, clearly defined malaria outbreak thresholds (e.g. mortality or mor-
bidity rates) are rare and detection of outbreaks is not straightforward. 
Unusual or sudden increases in malaria mortality, proportional mortality 
or incidence rates, when compared with previous weeks or months, may 
suggest an outbreak. It is important to be aware that:
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■• malaria outbreaks may continue longer than other disease outbreaks 
during emergencies, lasting 3-4 months or even longer depending on cli-
matic conditions;
■• malaria outbreaks often have multiple underlying causes.
In stable situations, an epidemic threshold can be calculated using five or 
more years of historical data. On this basis, WHO has developed an epi-
demic threshold calculator based on historical data. However, in an emer-
gency, it is unlikely that sufficient historical data will be available – unless 
the camp or settlement area has been established for several years and 
accurate malaria data has been collected, at least monthly and consistently, 
allowing comparisons with deviations from the mean or median.
In the absence of historical data but where recent weekly patient data 
are available, epidemic malaria should be suspected if there is an unexpect-
ed rise in the number of malaria cases, a rising malaria test positivity rate 
(i.e. increasing proportion of patients with fever who have confirmed Plas-
modium infection) and/or a rise in the case-fatality rate – as non-immune 
people can die of malaria in a matter of hours, even in well-equipped facil-
ities. Where no comparative data are available, a cluster of severe cases and 
deaths due to febrile disease warrants investigation.
Preparedness action plans
Measures for epidemic prevention and control can be implemented effec-
tively only if they are supported by inter-agency coordination, an infra-
structure of well-trained personnel, adequate supplies and equipment, 
supervision and evaluation. In areas and populations prone to epidemic 
malaria, it is important that partners agree and implement a preparedness 
action plan, at national and/or local-level, covering the following:
■• Supplies – a sufficient stock of quality-assured essential laboratory diagno-
sis and treatment supplies for uncomplicated and severe malaria, includ-
ing RDTs (see Chapter 6); bednets (LLINs); and equipment, materials, 
protective clothing and insecticide for emergency prevention activities 
(see Chapter 7). 
■• Laboratory facilities – an identified laboratory that can provide quality 
control, determine parasite species and density, and ensure safe blood 
transfusions. 
■• Staff and transport – staff and transport for mobile teams; capacity to 
expand inpatient and outpatient care facilities, including the number of 
skilled medical and technical staff needed to adequately respond to an 
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increased malaria case load; and capacity to improve transport and logis-
tics for referral of severe cases to inpatient facilities.
■• Educational messages – messages to encourage population uptake of pre-
ventive measures and early treatment-seeking, and materials and equip-
ment to transmit these messages to the public.
■• Training and refresher training of staff – on malaria diagnostic testing, anti-
malarial treatment, management of non-malarial febrile illnesses, vector 
control, weekly disease surveillance and survey methods.
■• Budget – for all of the above.
Outbreak investigation
A suspected malaria outbreak should be investigated immediately as early 
intervention is critical. The purpose of an investigation is to confirm the 
need to scale-up malaria control interventions beyond normal implemen-
tation (e.g. extending clinic opening hours, intensifying vector control) 
and to differentiate between a genuine epidemic and normal seasonal var-
iation. It is important to describe the outbreak using the person-place-time 
framework (e.g. patient characteristics, local context, changes in frequency 
over time). Formally declaring “an epidemic” may be of secondary concern 
given a sudden and unexpected rise in malaria burden. This is particularly 
true when no confirmatory historical data is available, as is often the case in 
humanitarian emergencies.
Confirming the outbreak
To confirm an outbreak, the first step is to visit the area, if it is accessible, 
and collect information from local health staff and community leaders. Ask 
if the number of malaria cases is unusual for the season. Have there been 
recent population movements that could account for the rise in case num-
bers? Have there been changes in mortality or in-patient admissions for 
malaria? This is also an opportunity to conduct a rapid needs assessment for 
diagnostic testing and treatment and to check if clinics are able to cope with 
a rise in suspected and/or confirmed malaria cases.
Assessment should determine whether there is evidence of increased 
morbidity and mortality, including among vulnerable groups, and look for 
evidence of increased transmission intensity and/or movement of non-im-
mune people into a transmission area. Increased transmission intensity can 
result from increased vector breeding; the local area should be examined 
to identify potential new breeding sites (Box 5.1). One or more rapid prev-
alence surveys, such as test positivity rate among fever cases, should be 
included as part of this assessment (see Chapter 3).
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Box 5.1 Pakistan malaria outbreak
In 2003, several thousand refugees crossed the border from Afghanistan 
into the tribal areas of Pakistan. They constructed mud-brick shelters, 
unintentionally creating vector breeding sites in the borrow pits from which 
they dug the mud. This resulted in high-intensity transmission of P. falciparum 
(Figure 5.1) in a relatively arid desert area and earlier in the season than would 
be expected. Note in Figure 5.1 that transmission took place earlier in the 
epidemic year and resulted in rapid rises in incidence over the course of only a 
few weeks.
Figure 5.1 Epidemic malaria in Northwest Frontier Province Pakistan 
in 2003, showing incidence of P. falciparum in a population of 
approximately 4000 Afghan refugees. Black lines indicate the refugee 
camp where the epidemic occurred, red lines indicate nearby camps 
and grey lines indicate the remaining six camps that had been 
established in the 1980s.
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It is worth noting that malaria data can be misleading, and give rise to 
false alarms concerning potential outbreaks, particularly in the context of a 
changing health system. For example, an increase in case numbers resulting 
from improved malaria surveillance or removal of user-fees would result in 
increased numbers of detected and reported cases. This increase in cases, 
while real, is attributable to improved case detection rather than intensified 
malaria transmission. It is therefore important to collect as much informa-
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tion about local context as possible when investigating potential outbreaks, 
and to examine alternatives to the hypothesis that it is a true malaria epi-
demic.
Describing the outbreak
Planning an effective outbreak response requires a description of the out-
break. This should identify the timing and location of the outbreak to allow 
a focussed and measured response. In all settings it is important to rely on 
accurate malaria diagnostic testing (either RDTs or microscopy), and to 
gather data on confirmed malaria cases. Data on presumed malaria (i.e. 
clinically diagnosed malaria) may also be useful in the absence of other 
sources. The following outbreak description procedure is suggested: 
■• Discussion with local partners and those with knowledge of malaria 
transmission and local context;
■• Analysis of information from rapid prevalence survey or surveys;
■• Analysis of data collected through the surveillance system, including: 
 — retrospective data from registers (if any);
 — prospective data collected using a malaria outbreak form (see Annex 
XI); the data should be stratified by population structure (age group, 
pregnant women) and geographical area (village, district, camp) so 
that the attack rate can be calculated for different groups and areas, 
and so that interventions can target the most vulnerable groups;
 — an epidemic curve, which shows graphically the number of new cases 
per week and the evolution of the outbreak. When regularly updated, 
the curve can show the transmission season, whether the epidemic 
has reached its peak, and whether preventive interventions are lead-
ing to a reduction in new cases (although variations in access to treat-
ment may make interpretation difficult). 
Outbreak response and follow-up 
Coordinate planning and implementation
If an outbreak is confirmed, all health partners (e.g. government depart-
ments, UN agencies, humanitarian health organizations, and NGOs) need 
to:
■• Decide together how to tackle the outbreak – Even if individual health actors 
will be limited to certain areas or population groups or focus only on cer-
tain methods (e.g. surveillance, disease management, vector control), it 
is essential that actions be coordinated to maximize the impact of inter-
ventions. Coordination is especially important if the response involves 
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multiple layers of interventions (e.g. expanding inpatient capacity at 
referral facilities as well as improving access to first line care).
■• Choose agency focal-persons – There should be a clearly defined focal-person 
for each organization and a lead-agency for central coordination if neces-
sary (e.g. this is often WHO within the cluster approach).
■• Follow good planning principles – Prioritizing services for those geograph-
ical areas and population groups that were identified as most-affected 
during the investigation phase.
Choose a strategy
The priority in a malaria epidemic is prompt and effective diagnostic test-
ing and treatment with (in case of falciparum malaria) artemisinin-based 
combination therapy (ACT) in line with the national antimalarial drug 
policy. The operational strategy for disease management (e.g. whether to 
use mobile teams, additional or existing fixed units, or focus initially on 
improvement of inpatient or outpatient care) will depend on:
 — the population affected and risk groups (during an outbreak, all age 
groups may be affected);
 — the malaria proportional mortality rate;
 — the case-fatality rate;
 — the prevalence in different areas;
 — access to existing health facilities 
 — distance to health facilities from affected areas.
Preventive measures and vector control should also be implemented if the 
situation warrants it (see Chapter 7). The provision of life-saving treatment 
for all malaria cases should be prioritized over vector control interventions 
if resources for the epidemic response are constrained. Annex V provides a 
checklist for effective malaria epidemic response. 
Operational strategy components include ensuring treatment access, 
effective diagnosis, treatment, prevention of new cases, and response 
review.
Access to treatment
It is critical to ensure: that there are sufficient treatment points for the pop-
ulation to access treatment easily; that these are providing prompt and 
accurate diagnosis and effective case management with quality-assured 
ACT; and that vulnerable groups have access to treatment (see Chapter 6). 
Barriers to health services access (e.g. user-fees, poor organization of the 
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patient circuit, early closing times) should be removed to ensure that as 
many patients as possible have equitable and prompt access (see Box 5.2). 
Preventive treatment should be considered for pregnant women depending 
on the setting (see Chapter 7). 
Active case detection can be conducted if resources are available. This 
involves parasite-based screening of fever cases at household level and treat-
ment of all identified cases. If adequate diagnostic testing is not available, 
active case detection may, in rare instances, be based on fever screening 
only; in such circumstances, agreement and training on clinical case defini-
tions is important in order to avoid inappropriate treatment of non-malarial 
illnesses. A potential approach for treating malaria infections that escape 
diagnosis is mass drug administration (MDA), the practice of treating a 
whole population within a given geographical area, irrespective of symp-
toms or diagnosis. Because of operational hurdles and safety concerns, and 
because its impact on transmission is generally short-lived, MDA should be 
considered only after careful consultation with malaria experts. The likeli-
hood of increasing selection for drug-resistant genotypes through the use of 
MDA must also be considered. 
Diagnostic testing
In all settings, including outbreaks, everyone with a positive malaria test 
result should be treated immediately, regardless of his or her symptoms. 
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Box 5.2 Outbreak response using mobile clinics in Burundi, 2009
A rapid increase in malaria cases was identified in Burundi’s northern provinces 
of Kayanza and Ngozi at the end of 2009. A field assessment, conducted by 
a team of Ministry of Health and Médecins Sans Frontières staff, identified 
overwhelmed clinics. Visits to villages showed that a significant proportion 
of people with fever had not consulted a health centre. The team decided to 
reinforce capacity in the hospitals and health centres, launch mobile clinics in 
villages and village clusters where high numbers of cases were reported, and 
target LLIN distribution. Fifteen mobile teams were deployed, with one team 
going three times a week to each site. Each team comprised four nurses, one 
driver, one person for registration and recording temperature, and one person 
to administer the first dose and explain treatment to the patient or parents. 
One nurse was responsible for triage, one conducted RDT diagnoses, and two 
took patient histories, conducted clinical examinations and dispensed drugs. 
Over five months, the mobile clinics contributed to covering a population of 
537 000. The mobile clinics themselves identified 72 000 confirmed malaria 
cases and treated them with ACTs.
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In epidemic situations, where patient numbers are very high, RDTs can 
enable a team of two people to accurately screen up to 200 patients per 
day. Where this is not possible, because of shortages of either staff or RDTs, 
clinical diagnosis may be the only option. In such settings, once malaria has 
been established as the cause of the epidemic (e.g. through prevalence sur-
veys) and agreement reached on a clinical case definition for malaria (also to 
avoid inappropriate treatment of non-malarial illnesses), presumptive treat-
ment of fever cases with ACT is an appropriate strategy for reducing mor-
tality, though only if systematic testing would overwhelm health facilities. 
In a confirmed malaria epidemic, the proportion of fever cases present-
ing to health facilities is usually high and use of clinical diagnosis may be 
appropriate given personnel and/or supply limitations. If this approach is 
adopted, RDTs or microscopy should be performed on a proportion of clin-
ically-diagnosed cases to track test positivity rate and the evolution of the 
epidemic. To ascertain whether the epidemic is continuing and to avoid 
over-treating, it is useful to carry out RDT surveys among patients in health 
centre waiting rooms at weekly intervals, or to make daily RDT checks of a 
percentage of consecutive fever patients. As the epidemic wanes, over-treat-
ment will increase significantly if confirmatory diagnostic capacity is not 
established and as such, re-establishing parasite-based diagnosis becomes 
a priority.
Treatment 
During an outbreak, pre-referral treatment with artesunate suppositories 
should be provided to severe cases identified in peripheral locations to cov-
er the period of transport to a hospital. Severe cases should be treated with 
IV artesunate, or if not available, IM artemether. IV Quinine can be used, 
though its complex administration and need for monitoring (e.g. glycae-
mia) mean it is not usually a first choice. All severe malaria treatment cours-
es should be followed by a full course of oral ACT (see Chapter 6).
Prevention
■• Though treatment is prioritized during malaria outbreaks, preventing 
new cases is also important (see Chapter 7). The principal interventions 
to reduce infection risk during emergencies are indoor residual spraying 
(IRS) where sprayable surfaces are available, and long-lasting insecticid-
al nets (LLINs). Other insecticide-treated materials, such as insecticide 
treated plastic sheeting (ITPS), insecticide-treated blankets etc., can be 
used where LLINs and IRS are not operationally feasible as long as there 
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is local evidence for additional benefit, noting the absence of a general 
recommendation from WHO.
Vector control – if well planned, targeted and timely – can contribute sig-
nificantly to reducing infection risk and saving lives. Vector control is most 
cost-effective when implemented to prevent an epidemic starting or to 
introduce control in the very early stages of an epidemic. Vector control 
is logistically demanding and time-consuming. If delayed or mistimed, its 
effect can be suboptimal (see Annex V).
The most cost-effective interventions for malaria vector control are IRS 
and LLINs, if used just prior to, or at the start of, an epidemic (i.e. applied 
well before the epidemic peak and its subsequent natural decline). Pro-
grammes must achieve high coverage to affect transmission. IRS requires 
coverage of at least 80% of dwellings to be fully effective. The peak in 
malaria cases usually occurs some weeks after vectorial capacity has already 
peaked and transmission potential has already dropped off. As it usually 
takes some time to mobilize equipment and spray teams, IRS may not nec-
essarily be the best response in an outbreak. LLINs can provide communi-
ty vector control in some settings with high population coverage. At lower 
coverage rates on the other hand, LLINs provide protection only for those 
sleeping under them and will have limited or no effect in reducing transmis-
sion (Magesa et al.; 1991).
Response review
An epidemic response review involves monitoring the evolution of the 
outbreak and assessing the effectiveness of the response – in terms of how 
well activities are being carried out, the timing of activities and the level of 
coverage achieved. Monitoring the roll-out of interventions is an important 
aspect of outbreak follow-up. The evolution of malaria morbidity and mor-
tality over time can be expressed in terms of proportional incidence and 
case-fatality rates (see Chapter 4).
If facility-based incidence data is not available, repeat prevalence surveys 
may be needed whenever there are major changes in the composition of 
the population (e.g. the arrival of large numbers of non-immune people to 
endemic areas) and to verify whether the outbreak has been controlled.
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CHAPTER 6
Case management
This chapter:
■■ Describes clinical assessment, including emergency triage for rapid 
identification and treatment of patients at greatest risk of dying
■■ discusses confirmatory parasitic diagnosis of malaria using microscopy 
and rapid diagnostic tests (RDTs)
■■ describes malaria treatment, including determining treatment choice 
and management of uncomplicated malaria, treatment failures, and 
severe malaria with associated complications
■■ Discusses special groups (e.g. pregnant women, malnourished 
patients, displaced persons/returnees)
Initial assessment 
During humanitarian emergencies in malaria-endemic countries, malaria 
is a leading cause of mortality among febrile patients, particularly children. 
If patients with P. falciparum malaria do not receive appropriate treatment 
with an effective antimalarial drug, they may deteriorate and develop severe 
malaria within a few hours or days. However, it is important to remember 
that the clinical presentation of both uncomplicated and severe malaria 
is variable and nonspecific (see Table 6.3), so the differential diagnosis of 
malaria from other febrile illnesses is very difficult without confirmation 
of diagnosis by microscopy or rapid diagnostic test (RDT). Additionally, 
patients often have more than one underlying disease with overlapping 
clinical presentations (e.g. malaria and pneumonia).
Efforts must be made to improve diagnostic capacity for febrile illnesses 
by confirmation of the presence of parasites. Reliable RDTs for malaria are 
now readily available, making diagnostic testing for malaria possible even 
in emergency settings. If diagnostic testing is not feasible, particularly dur-
ing the acute stages of an emergency, the most practical approach is to treat 
febrile patients as suspected malaria cases, with the inevitable consequenc-
es of over-treatment of malaria and potentially poor management of other 
MALARIA CONTROL IN HUMANITARIAN EMERGENCIES
54
diseases. Knowledge of local disease epidemiology helps in determining 
the likelihood that any serious febrile illness is due to P. falciparum.
Operational aspects of case management
Delivery of care is determined by patient numbers, resources, and access 
to health services. It is best to use diagnostic tools and medicines that are 
effective, safe and simple to administer. The essential elements of case man-
agement are:
■• Triage
■• History and physical examination
■• Parasitological confirmation of diagnosis
■• Antimalarial treatment, with first dose given under observation
■• Advise patient or caregiver regarding treatment adherence and when to 
return
■• Management of treatment failures
Emergency triage
Emergency triage is essential. The priority should be to save lives, with the 
sickest patients treated first. The key is rapid identification, assessment and 
treatment of emergency danger signs. 
Severe malaria is a medical emergency, and patients need immediate 
referral to a health facility for parenteral treatment and good-quality nurs-
ing care. The priority is to identify and strengthen a clinical site capable of 
managing severe malaria. The risk of developing severe malaria depends on 
the age and immunity of the patient (see Table 6.1).
Table 6.1 Groups at high risk of severe malaria and mortality in all  
 transmission areas
• Non-immune pregnant women
• Young children
• Severely malnourished children and non-immune adults 
• HIV-infected persons
Many deaths during the acute phase of emergencies can be avoided with 
prompt identification and effective treatment of all patients who are severe-
ly ill, because of malaria or another condition. However, this is not easy in 
situations with few skilled staff, limited health care services, and excessive 
case loads. It is therefore essential to adopt an emergency triage procedure 
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that can effectively identify high-risk patients, and that is simple and quick 
to perform. The procedures described in the Integrated Management of 
Childhood Illness (IMCI) guidelines for febrile patients (e.g. Table 6.2) can 
rapidly identify children who need immediate assessment and treatment 
(WHO, 2005). 
According to the WHO guidelines for the Integrated Management of 
Adolescent and Adults Acute Care (2009), all patients should receive an 
initial Quick Check for Emergency Signs. Any patients who present one or 
more of the following conditions require rapid referral after initial emer-
gency treatment:
■• Airway and breathing: Appears obstructed or central cyanosis (blue 
mucosa) or severe respiratory distress;
■• Circulation: Weak and fast pulse or capillary refill longer than 2 seconds;
■• Unconscious/repeated convulsing: Convulsing (now or recently), or 
unconscious; 
■• Chest pain, severe abdominal pain, neck pain or severe headache; 
■• Any fever with one or more of the following: 
 — confusion, agitation, lethargy 
 — stiff neck 
 — very weak (not able to stand or to walk unaided)
 — not able to drink 
 — severe abdominal pain
 — fast and deep breathing or severe respiratory distress. 
Table 6.3 lists clinical features associated with malaria. Although none of 
the clinical signs listed is unique to malaria, those related to severe malaria 
are a clear indication that a patient needs immediate investigation and treat-
ment (see Table 6.4 and Managing severe P. falciparum malaria below).
Confirmatory malaria diagnosis
Purpose of confirmatory diagnosis
Diagnosing malaria on the basis of clinical features alone can be highly 
inaccurate and is likely to result in significant over-treatment. It is therefore 
important to establish, at the start of any emergency intervention, capacity 
for confirmatory diagnostic testing. Effective confirmatory diagnostic test-
ing can help to:
 — identify patients who need antimalarial treatment;
 — reduce unnecessary use of antimalarial drugs for patients without 
malaria;
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 — identify patients who need management for other illnesses;
 — improve malaria case detection and reporting;
 — provide confirmation of treatment failures.
Parasitological confirmation of suspected malaria before treatment is now 
recommended for all patients. There are currently two widely available 
options for confirmatory diagnostic testing of malaria:
 — light microscopy
 — rapid diagnostic tests (RDTs).
The characteristics and potential uses of these two methods are outlined 
below.
An interactive guide, allowing users to identify RDTs that have been eval-
uated by the WHO Product Testing Programme based on different diag-
nostic performance parameters, is available online from the Foundation for 
Innovative New Diagnostics (FIND) at: http://www.finddiagnostics.org/
programs/malaria/find_activities/rdt_quality_control/product_testing/
malaria-rdt-product-testing/index.jsp. 
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Table 6.3 Clinical features of uncomplicated and severe malaria
Uncomplicated malaria Severe malaria
Clinical features may include:
• Fever
• Headache
• Vomiting
• Diarrhoea
• Cough
• Influenza-like symptoms  
(e.g. chills, muscle pains)
• Febrile convulsions (in 
children)
Clinical features may include:
• Prostration (i.e. generalized weakness so the 
patient is unable to sit or to walk)
• Impaired consciousness or unarousable coma, 
not attributable to another cause 
• Multiple convulsions (>2 in last 24 hours)
• Severe normocytic anaemia
• Hypoglycaemia
• Metabolic acidosis
• Deep breathing, respiratory distress
• Acute renal injury
• Acute pulmonary oedema and adult respiratory 
distress syndrome (ARDS)
• Circulatory collapse or shock, 
• Abnormal bleeding (e.g. bruising, bleeding gums, 
haemoglobinuria) 
• Jaundice plus evidence of vital organ dysfunction
• Hyperlactataemia
Important: These severe manifestations can occur singly or, more commonly, in 
combination in the same patient.
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Table 6.4 Comparison of microscopy and RDTs
Microscopy RDTs
Requirements
Equipment Microscope None
Electricity Preferred, not necessary None
Supplies Lancets, slides, alcohol 
swabs, staining reagents 
and supplies, water
Lancets, blood collecting 
devices, alcohol swabs 
(included in some kits)
Transport/storage conditions Reagents stored out of 
direct sunlight
Avoid exposure to high 
temperature (4–30 °C 
recommended)
Quality assurance Periodic re-reading of 
percentage of slides 
by expert microscopist 
and supervision of 
microscopists
Lot testing of kits, 
monitoring of storage 
temperature, supervision 
of health workers 
Performance
Test duration Usual minimum 60 
minutes
15–20 minutes
Labour-intensiveness High Low
Dependence on individual 
competence 
High Low
Direct costs
Cost per test US$0.12–0.40 US$0.60–1.00
Technical specifications
Detection threshold 5–10 parasites/µL 40–100 parasites/µL
Detection of all 4 species Yes Some RDTs
Quantification Possible Not possible
Differentiation between Pv, 
Po, and Pm
Possible Few can differentiate Pv 
from others
Differentiation between 
sexual and asexual stages 
Possible Not possible
Detection of Pf sequestered 
parasites
No Possible
Antigen persistence No Yes (kits detecting HRP2 
antigen)
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Table 6.4 Continued
Light microscopy
Microscopy has long been considered the “gold standard” for malaria diag-
nosis. When performed by a skilled technician, microscopy is more sensi-
tive than RDTs for the detection of low levels of P. falciparum parasitaemia 
(<100 parasites/µl) and can differentiate between the various malaria spe-
cies. However, when poorly performed, microscopy produces unreliable 
results with lower sensitivity and specificity than RDTs. Effective microsco-
py for malaria parasites requires: (i) good-quality equipment and reagents; 
(ii) skilled technicians who can prepare and stain films, identify parasites, 
and differentiate between Plasmodium species; and (iii) rigorous technical 
supervision and quality control. However, since these may not be availa-
ble in emergencies, it is often necessary for emergency partners to establish 
capacity themselves (see WHO 2011b). 
Rapid diagnostic tests
In the acute emergency phase, limited time and resources make RDTs pref-
erable to microscopy for confirmation of clinical diagnosis in low-transmis-
sion areas, and for confirming malaria in severely ill patients in moderate 
to high-transmission areas. Malaria RDT selection should be based on the 
prevalence of malaria species in the country (WHO 2011). Three geograph-
ical zones have been defined:
Advantages and disadvantages of microscopy or RDTs in special situations
Routine diagnosis and patient 
management
Determination of parasite 
density for management 
of severe malaria
More easily implemented 
in emergency situations
Investigating suspected 
treatment failure
Recommended Not recommended, as 
some HRP2 kits can 
remain positive several 
weeks after parasite 
clearance
Drug efficacy studies Recommended Not recommended
High case loads 1 skilled microscopist 
can prepare/read 40–60 
slides in a day
1 trained health worker 
can process up to 100 
RDTs in a day
Community surveys or rapid 
assessments
May be time consuming 
and labour intensive
Suitable for screening 
large numbers of people in 
the field
Source: Updated and adapted from WHO (2011b)
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■• Zone 1, in which P. falciparum is predominant and the majority of non- 
falciparum species cause mixed infection with P. falciparum (e.g. most 
areas of sub-Saharan Africa and lowland Papua New Guinea);
■• Zone 2, where P. falciparum and non-falciparum infections occur com-
monly as single-species infections (e.g. most endemic areas of Asia and 
the Americas and isolated areas in the Horn of Africa); and
■• Zone 3, where only non-falciparum infections occur (e.g. mainly 
P. vivax-only areas of East Asia, central Asia, South America, and some 
highland areas elsewhere).
In Zone 1, RDTs that detect only P. falciparum are generally preferable. 
In Zone 2, RDTs that detect all species and distinguish P. falciparum from 
non-falciparum infections are necessary. In Zone 3, RDTs that detect non- 
falciparum species alone are appropriate (i.e. pan-specific or P. vivax- 
specific RDTs).
The type of antigen targeted depends on the species to be detected (see 
Table 6.5). To detect P. falciparum, tests targeting HRP2 are generally pref-
erable, as they are more sensitive than those that detect pLDH. To detect 
non-falciparum species, tests targeting Aldolase, pLDH specific to non-fal-
ciparum species, or pLDH common to all species, are recommended. 
Ideally, commercially available RDTs should be selected in accordance 
with national malaria control programme recommendations and, selection 
should be based on the results of the WHO product testing programme 
(WHO 2012). 
Table 6.5 Antigen targets of rapid diagnostic tests (RDTs)
Plasmodium 
species HRP2
pLDH
pLDH–Pf pLDH–pan pLDH–Pvom pLDH–Pv Aldolase
P. falciparum x x x x
P. vivax x x x x
P. malariae x x x
P. ovale x x x
NB: HRP2 – histidine rich protein 2; pLDH – Plasmodium lactate dehydrogenase; Pf – P. falciparum; pan – all 
Plasmodium species; Pvom – P. vivax, P. ovale, and P. malariae; Pv – P. vivax
Source: WHO (2011)
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Malaria treatment 
Wherever possible, a confirmatory parasitological diagnosis of suspected 
malaria cases should be conducted before initiating malaria treatment. 
The signs and symptoms of malaria are varied. Virtually all non-immune 
individuals will experience fever. Other frequent symptoms include chills, 
sweating, headache, anorexia, myalgia, fatigue, nausea, abdominal pain, 
vomiting, and diarrhoea. Anaemia, thrombocytopenia, splenomegaly, 
hepatomegaly, and jaundice can develop. Case definitions for malaria can 
be found in Table 4.2: 
■• Suspected malaria – a patient with a fever, or history of fever in the last 48 
hours, who is currently residing in or has come from a malaria-endemic 
area; 
■• Uncomplicated malaria – a patient with a fever, or history of fever in the 
last 48 hours, with a positive confirmatory parasitological test and no 
signs of severity or evidence of vital organ dysfunction;
■• Severe malaria – a patient with a positive confirmatory parasitological test 
and one or more symptoms of severe disease (see Table 6.3).
Choosing antimalarial drugs
Wherever possible, national policy and malaria treatment guidelines should 
be followed. In emergencies, limited access to health care and poor security 
may mean that a health worker sees a patient only once. Since patient adher-
ence to multi-day therapies may be poor and can lead to treatment failure, it 
is vital that treatment regimens are as simple and convenient as possible and 
clearly and accurately explained to each patient. The choice of drugs used in 
malaria treatment depends on: 
■• local parasite species; 
■• antimalarial susceptibility of local parasite strains;
■• drug therapeutic efficacy; 
■• drug safety (i.e. few side effects);
■• safety for special groups such as young children and pregnant women;
■• acceptability to both providers and consumers (e.g. packaging, taste, 
specific child-friendly formulations); 
■• simplicity of dosage regimes to encourage treatment adherence;
■• availability on the market with a minimal lead time;
■• authorization for use by national health authorities;
■• affordability for consumers (in cases where medicines are not being pro-
vided free-of-charge).
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During humanitarian emergencies, populations are more vulnerable to 
malaria, and the first-line treatment for falciparum malaria should be of the 
highest possible efficacy. Artemisinin-based combination therapies (ACTs) 
are currently the best choice for treating uncomplicated falciparum malar-
ia. The efficacy of an individual ACT depends on resistance to the arte-
misinin partner drug. Any ACT chosen for deployment in a humanitarian 
emergency should have an efficacy of at least 95%. ACT options currently 
recommended by WHO, in alphabetical order, are: 
■• Artemether + Lumefantrine (AM/LM) 
■• Artesunate + Amodiaquine (AS+AQ ) 
■• Artesunate + Mefloquine (MAS)
■• Artesunate + Sulfadoxine/Pyrimethamine (AS+SP)
■• Dihydroartemisinin + Piperaquine (DP)
Fixed-dose/coformulated drug combinations should be used where pos-
sible, particularly in humanitarian emergencies, since their use improves 
patient compliance as compared to co-blistered combinations. The most 
up-to-date list of recommended ACTs can be found in the WHO Guidelines 
for the Treatment of Malaria posted on the Global Malaria Programme. 
WHO has established a system for pre-qualification of antimalarial med-
icines including ACTs, and provides guidelines for pharmacovigilance. 
Medicines with the highest efficacy and safety record should always be 
deployed, especially in situations where the population is stressed, suffers 
from malnutrition, and may have low levels of immunity. WHO treatment 
guidelines list recommended pharmaceutical products selected on the basis 
of clinical efficacy, safety, and suitability for large-scale use; medicines for 
use during humanitarian emergencies should always be chosen from this 
list.
Correct transport and storage of drugs, particularly ACTs, is extremely 
important, as is abiding by expiry dates to avoid degradation of active phar-
maceutical ingredients,. 
If no information on local drug efficacy is available, an ACT should be 
chosen from those that have the highest cure rates (i.e. over 95% efficacious 
in most settings). In chronic emergencies, every other year therapeutic 
efficacy testing of the chosen ACT should be conducted in sentinel sites to 
determine that it remains above 95% efficacious. Information on antimalar-
ial drug resistance and testing protocol is available at http://www.who.int/
malaria/diagnosis_treatment/resistance/en/index.html.
A coordinated approach to procurement and distribution is essential if 
adequate supplies of good-quality antimalarial drugs are to be provided 
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regularly. Standardized purchase and supply of recommended, good-qual-
ity antimalarial drugs are the responsibility of all emergency partners. 
Managing uncomplicated falciparum malaria 
In high transmission zones, all cases of fever suspected as malaria should 
have a confirmatory parasitological diagnostic test before treatment is pre-
scribed. Test results should always be considered accurate, and if negative, 
another cause of fever should be urgently sought in order that correct treat-
ment can be administered. It is important to remember that malaria may be 
accompanied by other serious conditions (e.g. pneumonia) and a positive 
malaria test does not exclude bacterial infections that may also require anti-
biotic treatment. If the patient does not have severe illness, the test is nega-
tive, and no other cause can be found, the patient should be asked to return 
within two days – or sooner if their condition deteriorates. 
In low and moderate transmission zones, a careful examination of the 
patient should be conducted to exclude other causes of fever before para-
sitological testing is initiated. In areas with both P. falciparum and P. vivax, 
microscopy or combination RDTs should be used to ensure that the correct 
treatment is given. 
ACTs are the treatment of choice for uncomplicated P. falciparum malar-
ia and patients with mixed infections. ACTs are indicated for treatment of 
uncomplicated falciparum malaria during the first trimester of pregnancy 
if this is the only treatment immediately available, or if there is uncertainty 
about compliance with a 7-day treatment (e.g. quinine plus clindamycin). 
Treatment of uncomplicated falciparum malaria during the second and 
third trimesters of pregnancy should be with one of the following:
■• ACTs known to be effective in the country/region;
■• artesunate plus clindamycin for seven days; or
■• quinine plus clindamycin for seven days.
See Annex VI for treatment regimens. 
Artemisinin derivatives are contraindicated in cases of a proven allergy. Oral 
monotherapies (e.g. chloroquine, amodiaquine, sulfadoxine/pyrimeth-
amine, quinine, and especially artemisinin or its derivatives) should nev-
er be used to treat uncomplicated falciparum malaria or mixed falciparum 
infections. 
Supportive and ancillary care for uncomplicated malaria
When an antimalarial drug is given to a young child, the chance of the child 
vomiting the medication will be lower if fever (i.e. axillary temperature 
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above 37.5 °C) is first treated with an antipyretic and tepid sponging. An 
antipyretic such as paracetamol should be used. Aspirin is not recommend-
ed for use in children because of the increased risk of Reye’s syndrome. 
Mothers should be instructed on how to administer medication successful-
ly, especially to young infants. 
Children should remain at the clinic for an hour after the first dose of 
antimalarial drug is administered (see Annex IV for information concern-
ing the safety of antimalarial drugs in young children). If it is not possible 
for a child to wait at the clinic, the parent or carer should be told to return if 
the child vomits within the first hour after taking the medication. If a child 
vomits within 30 minutes of taking the first dose, administer a full replace-
ment dose. If vomiting occurs between 30 minutes and 1 hour, give a half 
dose. A child who vomits the drug more than once should be managed as 
a severely ill patient, as “vomiting everything” is a danger sign. It is impor-
tant to watch for signs of dehydration and hypoglycaemia, especially in very 
young or malnourished children and pregnant women, and to give appro-
priate treatment if necessary. Caregivers should be told that it is important 
for infants to breastfeed frequently, and for older children to drink plenty 
of fluids, to prevent dehydration.
Carers and/or patients should be instructed to return to the health facil-
ity for immediate care if danger signs appear (see Table 6.2) or symptoms 
worsen. Carers and/or patients should also be instructed to return to the 
health facility if symptoms have not resolved after completion of treatment.
Managing treatment failures 
Recurrence of P. falciparum malaria can result from either re-infection or 
recrudescence/failure. Treatment failure is defined as the failure to effec-
tively clear malaria parasites from the blood or resolve clinical symptoms 
despite administration of an antimalarial medicine. Treatment failure may 
result from a number of causes.
■• Vomiting or poor absorption – the patient or carer may have been confused 
about what to do when treatment was vomited.
■• Poor prescribing practice – prescription or sale of an incomplete course of 
antimalarial treatment increases the risk of treatment failure. 
■• Poor adherence – this may be caused by several factors, including:
 — information on the correct regimen may have been unclear to the 
patient or carer;
 — patients may choose to stop taking the treatment once initial symp-
toms have resolved (particularly problematic with drugs that pro-
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duce very rapid symptoms clearance), or to share the remaining 
treatment with family/friends;
 — in areas with cost-recovery systems, many patients cannot afford to 
buy a complete course of treatment;
 — where drugs are not co-formulated, patients may discard one of the 
medicines of the combination that is associated with side effects. 
■• Drug quality – the use of antimalarial drugs that do not contain the rec-
ommended amount of active ingredient is a particular risk if patients are 
receiving treatment from the informal private sector. ACT quality should 
be ensured by: (i) sourcing from reputable pharmaceutical companies 
and procurement agencies; (ii) proper storage at all levels of the distribu-
tion system to avoid degradation due to exposure to high temperatures; 
and (iii) not administering drugs beyond their expiry dates.
■• Drug resistance – is the ability of a parasite to survive and/or multiply 
despite the administration and absorption of a drug given in doses equal 
to or higher than those usually recommended, but within the tolerance 
of the subject. 
Treatment failure within 14 days of receiving an ACT is very unusu-
al. A careful history and examination is necessary to ascertain any non- 
malarious causes of symptoms. For example, was the complete course of 
ACT taken, accompanied by food where appropriate, and with no vom-
iting in the first hour following any dose? All treatment failures should be 
confirmed parasitologically, preferably by blood slide examination. It is 
important to keep a record of all true treatment failures and inform health 
authorities, as these failures need to be confirmed by drug efficacy studies 
that may lead to changes in first-line antimalarial treatment.
■• Treatment failures after 14 days of initial treatment, should be considered 
re-infections in the absence of PCR genotyping and another dose of ACT 
can be given (avoid reuse of mefloquine within 60 days, due to increased 
risk of neuropsychiatric reactions: in case AS+MQ was the initial treat-
ment an alternative ACT not containing mefloquine should be given). 
■• Treatment failures within 14 days of initial treatment should be treated 
with a second-line antimalarial, in order of preference: 
 — an alternative ACT known to be effective in the region;
 — artesunate plus tetracycline or doxycycline or clindamycin (for a total 
of 7 days);
 — quinine plus tetracycline or doxycycline or clindamycin (for a total 
of 7 days).
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Doxycycline and tetracycline, but not clindamycin, are contraindicated for 
pregnant women and children under 8 years old. Drug choice will depend 
on the antimalarial drug already taken, availability of alternatives, con-
traindications, and operational feasibility. Adherence to the full course of 
re-treatment is vital, and is improved if detailed instructions are given to 
patients, carers and health personnel.
Managing severe falciparum malaria
The main treatment objective for severe malaria is to prevent the patient 
from dying. Secondary objectives are prevention of disabilities and recru-
descence. In humanitarian emergencies, where patient numbers are high 
and there are many late presentations, effective triage with immediate 
resuscitation and treatment are essential (Table 6.6). The clinical features of 
severe falciparum malaria are provided in Table 6.3.
Table 6.6 Supportive treatment for patients with severe malaria
• Clear the airway and check that the patient is breathing; 
• Establish intravenous (IV) access;
• Treat convulsions lasting 5 minutes or more, (see below);
• Take blood for malaria parasites, blood glucose and haemoglobin (urea and 
electrolytes, blood gas and blood culture are extremely useful, but unlikely to be 
feasible in most humanitarian emergencies);
• Treat hypoglycaemiaa (blood glucose <2.2 mmol/l), (see Table 6.7); 
• Rapidly assess circulation, hydration and nutritional status, and resuscitate as 
necessary with normal (0.9%) saline, (see below);
• In children, if haemoglobin is <4 g/dl, transfuse blood;
• In children, if haemoglobin is 4–6 g/dl, transfuse blood if the patient also has 
respiratory distress, impaired consciousness, hyperparasitaemia (>20% parasitized 
RBCs), shock, or heart failure;
• In children in low transmission settings and in adults, if haemoglobin is <7 g/dl, 
transfuse blood; 
• For unconscious patients, insert a nasogastric tube and aspirate stomach contents 
to prevent aspiration pneumonia; 
• Place the patient in the lateral or semi-prone position, and perform a lumbar 
puncture to exclude meningitis;
• Start antimalarial drug treatment, (see below);
• Start antibiotic therapy, (see below).
a Threshold for correction of hypoglycaemia in children is blood glucose < 3 mmol/l.
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Pre-referral treatment – For emergency pre-referral treatment of severe 
malaria, or of a patient who cannot tolerate oral medication, artesunate 
can be administered rectally before transport to a facility where parenteral 
treatment of severe malaria can be provided. Once the patient is able to 
tolerate oral medication, treatment must be completed with a full course 
of ACT.
Antimalarial drug treatment – Parenteral artesunate is the treatment of 
choice for severe malaria, given either by the intravenous or intramuscu-
lar route. Artemether and quinine are acceptable alternatives if injectable 
artesunate is not readily available. Parenteral treatment should be giv-
en for at least 24 hours, or until the patient can tolerate oral medications, 
and should always be followed by a full course of ACT (see Annex VI for 
detailed drug regimens).
Adjunctive treatment of complications associated with severe malaria
Coma, convulsions, hypoglycaemia (blood glucose <2.2 mmol/l), severe anae-
mia, shock, pulmonary oedema, and acute renal failure are common complica-
tions of severe malaria that require immediate management (Table 6.7).
Blood transfusion – It is essential to ensure a safe supply of blood for trans-
fusion. Blood should be cross-matched and screened for HIV, malaria and 
hepatitis B. Local laboratory facilities must therefore be able to perform 
compatibility testing (i.e. cross-matching) and screening for HIV, malaria 
and, if possible, hepatitis B. If a safe supply cannot be assured, transfusion 
should be restricted to patients with severe anaemia and signs of acute fail-
ure (shock, respiratory distress). If suitable donors without malaria infec-
tion cannot be found, blood should be administered with an antimalarial 
treatment.
Concomitant antibiotics – There is considerable clinical overlap between 
septicaemia, pneumonia and severe malaria and these conditions may 
coexist. In children with suspected severe malaria with associated alterations 
in the level of consciousness, broad spectrum antibiotic treatment should 
therefore be started immediately along with antimalarial treatment, and 
should be completed unless a bacterial infection is excluded. In adults with 
severe malaria, antibiotics are recommended if there is evidence suggestive 
of bacterial co-infection (e.g. shock, pneumonia). All patients with clinical 
evidence of bacterial infection (e.g. pneumonia, dysentery) should receive 
antibiotic therapy according to local treatment protocols.
Fluid management – Fluid requirements should be assessed carefully 
and individually to avoid over and under-hydration. In adults, both dehy-
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dration and rehydration should be managed cautiously as relatively small 
changes in fluid levels can mean the difference between over-hydration 
and increased pulmonary oedema risk, and under-hydration, contributing 
to shock, worsening acidosis and renal impairment. Careful and frequent 
evaluations of jugular venous pressure, peripheral perfusion, venous filling, 
skin turgor and urine output should be made.
Table 6.7 Managing complications of severe malaria
Manifestation/complication Immediate managementa
Coma (cerebral malaria) Maintain airway, place patient on his side or her 
side, exclude other treatable causes of coma (e.g. 
hypoglycaemia, bacterial meningitis); avoid harmful 
ancillary treatment, such as corticosteroids, heparin and 
adrenaline; intubate if necessary. 
Hyperpyrexia Administer tepid sponging, fanning, a cooling blanket 
and antipyretic drugs. Paracetamol is preferred over 
more nephrotoxic drugs (e.g. NSAIDsb).
Convulsions Maintain airways; treat promptly with intravenous or 
rectal diazepam or intramuscular paraldehyde. Check 
blood glucose.
Hypoglycaemia Check blood glucose, correct hypoglycaemia and 
maintain with glucose–containing infusion.
Severe anaemia Transfuse with screened fresh whole blood.
Acute pulmonary oedemac Prop patient up an an angle of 45°, give oxygen, give 
diuretic, stop intravenous fluids, intubate and add 
positive end–expiratory pressure/continuous positive 
airway pressure in life threatening hypoxaemia.
Acute renal failure Exclude pre–renal causes, check fluid balance and 
urinary sodium; if in established renal failure add 
haemofiltration or haemodialysis , or if unavailable, 
peritoneal dialysis.
Spontaneous bleeding and 
coagulopathy
Transfuse with screened fresh whole blood 
(cryoprecipitate, fresh frozen plasma and platelets, if 
available); give vitamin K injection.
Metabolic acidosis Exclude or treat hypoglycaemia, hypovolaemia 
and septicaemia. If severe add haemofiltration or 
haemodialysis
Shock Suspect septicaemia, take blood for cultures; give 
parenteral broad–spectrum antimicrobials, correct 
haemodynamic disturbances.
a It is assumed that appropriate antimalarial treatment will have been started in all cases
b Non–steroidal anti–inflammatory drugs
c Prevent by avoiding excess hydration
Source: WHO (2010)
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Use IV fluids containing 0.9% (normal) saline and 5–10 % dextrose, 
changing to 10% dextrose if the patient becomes hypoglycaemic. In most 
humanitarian emergencies, with large numbers of patients and limited 
numbers of nursing staff, close observation of patients may be impossible 
and it is safest to give maintenance fluids by nasogastric tube. The carer can 
help to administer 4-hourly nasogastric feeds of milk or diluted porridge, 
making it possible to provide calories in addition to fluid – an advantage 
as many patients are likely to be malnourished. However, inhalation pneu-
monia must be prevented. Rapid fluid boluses are contraindicated in severe 
malaria resuscitation. 
Anaemia – Anaemia is commonly associated with malaria and is particu-
larly serious for young children and pregnant women. To assess patients of 
all ages, check for palmar and conjunctival pallor. Time constraints are like-
ly to necessitate starting oral treatment on the basis of clinical signs alone. 
Where possible, measure blood haemoglobin (Hb) level – HemoCue® can 
be used in most settings. Hb <5 g/dl indicates severe anaemia, requiring 
urgent referral to an inpatient facility for further assessment and possible 
blood transfusion. Hb of 5–10 g/dl requires oral treatment.
Treating anaemia
Anaemia is a condition in which haemoglobin production or the number of 
red blood cells is diminished in relation to the age, gender, residential ele-
vation above sea level, smoking behaviour, and stage of pregnancy. WHO 
recommends that anaemia be diagnosed by measuring haemoglobin con-
centrations and monitored until it disappears. Clinical symptoms such as 
weakness and pallor of the eyelids, tongue, nail beds, or palms appear in 
severe cases. It is acknowledged that between 50 and 60% of anaemia cases 
are due to iron deficiency. To overcome other nutritional causes of anae-
mia, vitamins and minerals may be added to iron and folic acid supplements 
without exceeding the daily recommended intake dose (WHO, 2004). 
The doses below are recommended by WHO for the treatment of anae-
mia. However, intermittent iron supplementation is recognized as a public 
health intervention that can be used to prevent anaemia in children, men-
struating women, and non-anaemic pregnant women (WHO, 2011). In 
malaria-endemic areas, the provision of iron supplements should be imple-
mented in conjunction with adequate measures to prevent, diagnose and 
treat malaria.
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In children
■• Give 3 mg elemental iron/kg/day in the form of drops, chewable tab-
lets or powders to infants and younger children (approximately 30 mg/
day at 24 months of age). For children 60 months of age and older give 
60 mg elemental iron day in the form of tablets, pills or powders. 1 mg 
of elemental iron equals 3 mg of ferrous fumarate, 5 mg of ferrous sulfate 
heptahydrate or 8.4 mg of ferrous gluconate.
■• Give 250 µg (0.25 mg) of folic acid to children 60 months of age and 
older.
■• Treat all children over 2 years of age presumptively for intestinal worms 
with a single 500-mg dose of mebendazole or 400-mg dose of albenda-
zole (unless either of these has been given in the previous 6 months); 
Advise caregivers about good feeding practices. Meat, poultry, fish or 
eggs should be eaten daily, or as often as possible, because they are rich 
sources of many key nutrients such as iron and zinc. Diets that do not 
contain animal source foods (meat, poultry, fish or eggs, plus milk prod-
ucts) cannot meet all nutrient needs at this age unless fortified products 
or nutrient supplements or powders are used. During humanitarian 
emergencies, fortified products or nutrient/powder supplements may be 
more practical than providing animal source foods.
In non-pregnant adults 
■• Give 60 mg elemental iron twice a day in two separate doses (i.e morning 
and evening, for a total dose of 120 mg elemental iron). 60 mg of elemen-
tal iron equals 300 mg of ferrous sulfate heptahydrate, 180 mg of ferrous 
fumarate or 500 mg of ferrous gluconate;
■• Give 400 µg (0.4 mg) folic acid per day;
■• Treat presumptively for intestinal worms with a single 500mg dose of 
mebendazole or 400 mg dose of albendazole. Diagnosis should be con-
firmed by microscopy, if time and facilities allow.
In pregnant women
■• Give 120 mg elemental iron daily in two separate doses of 60 mg (i.e 
morning and evening). When anaemia is no longer present reduce the 
dose to 60 mg elemental iron per day. 60 mg of elemental iron equals 
300 mg of ferrous sulfate heptahydrate, 180 mg of ferrous fumarate or 
500 mg of ferrous gluconate.
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Supportive and ancillary care for patients with severe malaria
Regular observation of patients with severe malaria is critical, because the 
clinical situation may change quickly. The most important observations are 
pulse, respiratory rate and pattern, blood pressure, temperature, and level 
of consciousness. If there is any deterioration in consciousness, it is essen-
tial to check for hypoglycaemia and for a significant fall in haemoglobin, 
because these are amenable to treatment.
In all patients:
■• Check Hb and parasitaemia daily for the first 3 days and before discharge 
from hospital.
In unconscious patients:
■• Ensure the airway is clear;
■• Nurse the patient in the lateral or semi-prone position to avoid aspiration 
of fluid;
■• Insert a nasogastric tube and aspirate the stomach contents into a syringe 
every 4 hours, to reduce the risk of aspiration pneumonia;
■• Monitor temperature, pulse, respiration, blood pressure, blood glucose, 
and level of consciousness at least every 4 hours until the patient is out 
of danger;
■• Suspect raised intracranial pressure in patients with irregular respira-
tion, abnormal posturing, worsening coma, unequal or dilated pupils, 
elevated blood pressure and falling heart rate, or papilloedema. In all 
such cases, nurse the patient in a supine posture with the head of the bed 
raised;
■• Check blood glucose and Hb if the level of consciousness deteriorates;
■• Assess fluid balance daily if possible (daily weight gives a rough indica-
tion of overall fluid balance);
■• Report immediately any deterioration in level of consciousness, occur-
rence of convulsions or changes in behaviour;
■• Turn unconscious patients every 2 hours to prevent pressure sores;
■• If rectal temperature rises above 39 °C, remove patient’s clothes, give 
oral or rectal paracetamol, and use tepid sponging and fanning to reduce 
temperature; 
■• Note appearance of red or black urine (haemoglobinuria), and assess 
haematocrit, as severe anaemia may develop rapidly.
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Managing mixed Plasmodium infections
Mixed malaria infections should be treated with an appropriate ACT. The 
addition of 14 days of primaquine is indicated in the case of P. vivax or 
P. ovale mixed infections (see Managing relapsing malaria infections below). 
Managing non-falciparum malaria 
Chloroquine remains the treatment of choice for non-falciparum malaria 
in most settings. With the exception of AS+SP, which is not highly effective 
against P. vivax, ACTs cure all types of malaria. However, chloroquine is 
still effective and considerably cheaper for treating most cases of P. vivax, 
P. malariae and P. ovale. In chloroquine-sensitive areas, a 3-day course of 
treatment kills most stages of all non-falciparum species. In specific geo-
graphical areas (particularly on the island of Borneo) the monkey parasite 
P. knowlesi can cause malaria in humans. Chloroquine is fully effective, but 
treatment should be started immediately, as uncomplicated P. knowlesi cases 
can rapidly lead to severe disease with a high case fatality rate.
Evidence of chloroquine efficacy in managing vivax malaria should be 
sought for the specific area of deployment. Chloroquine-resistant P. vivax 
has been confirmed in Brazil, Bolivia, Ethiopia, Indonesia, Malaysia (Bor-
neo), Myanmar, Papua New Guinea, Peru, the Solomon Islands, and Thai-
land. Chloroquine-resistant P. malariae has been reported in Indonesia. 
Managing relapsing malaria infections
Both chloroquine and ACTs only kill parasites in red blood cells, and not 
pre-erythrocyte forms and the hypnozoites of P. vivax and P. ovale in the 
liver that are responsible for relapses. At present, primaquine is the only 
drug available to eliminate hypnozoites and prevent relapses of non-falci-
parum malaria. Radical treatment of relapsing malaria (i.e. P. vivax, P. ovale) 
requires 14 days of primaquine treatment. Primaquine may be given con-
currently with an active blood schizonticide, such as chloroquine, from the 
first day of treatment. 
Anti-relapse treatment is unnecessary for patients living in endemic 
areas with sustained high transmission. In such cases, relapses cannot be 
distinguished from reinfections and such patients should be treated with an 
effective blood schizonticide for each symptomatic recurrence of malaria. 
Primaquine anti-relapse treatment is usually not feasible during the acute 
emergency phase, but may be appropriate in chronic emergencies or during 
resettlement and repatriation. Adherence to the required 14-day treatment 
course may prove challenging but shorter anti-relapse treatment courses 
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(e.g. the 5-day course adopted in some Asian countries) are ineffective and 
are not recommended.
Primaquine is contraindicated for pregnant women, children under 12 
months old, or patients with glucose-6-phosphate dehydrogenase (G6PD) 
deficiency. Daily administration of primaquine for a 14-day radical cure of 
vivax malaria should not be given to any patient with G6PD deficiency, 
because of the risk of intravascular haemolysis. Fetuses are G6PD deficient 
and prevalence of G6PD deficiency is also high in Asia and some parts of 
Africa. Patients should be tested for G6PD deficiency before treatment with 
primaquine. Current G6PD testing kits are relatively inexpensive and simple 
to use, but are laboratory based. G6PD field tests are under development. 
Managing malaria in special groups 
Pregnant women, children under 5 years of age, severely malnourished peo-
ple, people living with HIV (PLHIV) and displaced populations generally 
require additional attention.
Pregnant women
Plasmodium falciparum malaria is a major cause of maternal, perinatal and 
newborn morbidity and mortality. The clinical effects of falciparum malaria 
depend on the immune status of women, which is determined by previous 
exposure to malaria and parity. P. vivax infection can cause negative health 
outcomes for both mother and fetus, particularly maternal anaemia and 
low birth-weight. To address malaria risk during pregnancy, WHO recom-
mends LLINs, intermittent preventive treatment in pregnancy (IPTp – in 
areas of sub-Saharan Africa with moderate-to-high transmission of malar-
ia), and effective case management of clinical malaria.
In low falciparum transmission settings, pregnant women have little 
pre-existing immunity and malaria usually presents as an acute illness with 
detectable peripheral parasitaemia. Uncomplicated malaria can progress 
quickly to severe malaria, with high case fatality rates and risk of death for 
the fetus (i.e. abortion or stillbirth). Pregnant women without immunity 
to P. falciparum are 2–3 times more likely to develop severe disease, and 
approximately three times more likely to die than non-pregnant women. In 
these settings, management of malaria risk in pregnancy should be based 
on prompt diagnostic testing and effective treatment. 
In settings with moderate-to-high transmission of P. falciparum, pregnant 
women have a degree of pre-existing immunity and may develop malaria- 
related anaemia with no microscopically-detectable parasites in the periph-
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eral blood, although the placenta may be heavily infected. The main effect 
of placental infection on the fetus is low birth-weight and increased risk 
of neonatal mortality. These effects are observed frequently in HIV- 
negative women in their first and second pregnancies. Among pregnant 
PLHIV, malaria infections increase maternal anaemia risk and low birth-
weight risk in all pregnancies. In these settings, management of malaria 
risk in pregnancy should be based on prevention using LLINs and prompt 
diagnosis and treatment of anaemia and uncomplicated malaria. Saving the 
mother should take priority when treating severe malaria during pregnancy 
in all settings.
Managing anaemia in pregnancy – Anaemia is a common, and potentially 
dangerous, complication of malaria in pregnancy. Anaemia prevention and 
management should be a priority when working with pregnant women in 
malaria-endemic areas during humanitarian emergencies. 
■• For prevention, 1 tablet containing ferrous sulfate, 200 mg (equivalent 
to 60 mg elemental iron), plus folic acid, 400 µg, should be given daily 
throughout pregnancy;
■• In areas of moderate-to-high malaria transmission in sub-Saharan Africa, 
where there is a high risk of asymptomatic malaria infection in pregnan-
cy, pregnant women should receive intermittent preventive treatment 
with sulfadoxine-pyrimethamine (see Intermittent preventive treatment 
in pregnancy [IPTp] below);
■• Presumptive treatment for intestinal worms (using a single 500 mg dose 
of mebendazole or 400 mg dose of albendazole) can be given once dur-
ing the second or third trimester of pregnancy, but these drugs must not 
be given in the first trimester. 
Intermittent preventive treatment in pregnancy (IPTp) – In areas of moder-
ate-to-high falciparum transmission in sub-Saharan Africa, IPTp with sul-
fadoxine-pyrimethamine (provided to pregnant women through ANC 
services) can reduce the incidence of placental infection, anaemia, and low 
birth-weight. It is not feasible to implement this during the acute phase of 
an emergency unless ANC services already exist.
Currently, the only drug for which there is documented evidence of 
safety and effectiveness when used as IPTp is sulfadoxine-pyrimethamine 
(SP). SP given at each scheduled antenatal care visit after the first trimester 
or quickening (first fetal movement perceived by the mother) has proven 
effective in reducing placental infection and material parasitaemia, prevent-
ing maternal anaemia, and improving birth-weight. 
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Key points on IPTp of semi-immune pregnant women in areas of high 
malaria endemicity are listed in Table 6.8.
Non-falciparum malaria in pregnancy is treated the same way as for 
non-pregnant patients, with the exception of radical cure of P. vivax and 
P. ovale, for which primaquine is contraindicated in pregnancy (see Manag-
ing non-falciparum malaria).
Uncomplicated falciparum malaria in pregnancy – All pregnant women with 
confirmed malaria should receive urgent treatment with effective antima-
larials. Symptoms in partially-immune pregnant women can be mild. ACTs 
should be used in the 2nd and 3rd trimesters. Quinine plus clindamycin can 
be used safely for treatment in any trimester. An ACT is indicated in the first 
trimester if this is the only treatment immediately available, if treatment 
with 7-day quinine plus clindamycin fails, or if there is uncertainty of com-
pliance with a 7-day treatment. Primaquine, tetracyclines and doxycycline 
are contraindicated in pregnancy (see Annex VI). 
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Table 6.8 IPTp in areas of high malaria endemicity
Key points
• Give IPT with SP (3 tablets) for all pregnant women at each scheduled antenatal 
care visit after the first trimester. WHO recommends a schedule of four antenatal 
care visits. 
— The first IPTp-SP dose should be administered as early as possible during the 
2nd trimestera of gestation.
— The last dose of IPTp with SP can be administered up to the time of delivery, 
without safety concerns.
— IPTp should ideally be administered as directly observed therapy (DOT).
— SP can be given on an empty stomach or with food.
• IPTp should be given under direct observation at the time of the ANC visit.
Precautions
• Do not give IPT with SP more frequently than once a month. If a woman develops 
malaria after receiving SP for IPTp she should be treated with an antimalarial that 
does not contain SP.
• Do not give SP to women who have a history of allergy to sulfa drugs. If an allergic 
reaction is suspected after the first IPT dose, do not give further doses.
• Do not give IPT with SP to PLHIV who already receive cotrimoxazole prophylaxis.
• Advise women to return for the next dose of IPT after a clearly defined time interval 
(e.g. 4 weeks).
• Explain to women that they can still get clinical malaria, despite IPT, and that they 
should return immediately to the clinic if they develop a fever or anaemia.
a IPTp administration should be avoided during the 1st trimester of gestation but should start as soon as 
possible in the 2nd trimester. The fact that a woman has entered the second trimester can be determined 
by the onset of quickening or by measurement of fundal height by ANC health personnel.
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Severe malaria in pregnancy – Pregnant women with severe malaria should 
receive urgent medical care, because of the high risk of maternal and fetal 
mortality. Parenteral artesunate is the treatment of choice for severe malar-
ia; if this is not available artemether is preferable to quinine in late preg-
nancy as quinine is associated with 50% risk of hypoglycaemia. Parenteral 
treatment should be given for at least 24 hours, or until the woman can tol-
erate oral medication, and should always be followed by a full course of 
ACTs. See Annex VI for indications and dosages.
Hypoglycaemia, acute pulmonary oedema, hyperpyrexia, postpartum 
haemorrhage, premature delivery and perinatal death are particular risks. 
Presentation and treatment of these complications include:
■• Hypoglycaemia is a significant risk for all pregnant women with malaria. 
The risk is greatest in the 2nd and 3rd trimesters, may be present on admis-
sion, and can be a complication of quinine treatment. The increased risk 
of hypoglycaemia persists into the post-partum period and blood glu-
cose should be monitored every 4 hours. In women with cerebral malar-
ia, hypoglycaemia may be asymptomatic or may cause deterioration in 
the level of consciousness, extensor posturing, or convulsions. Differen-
tial diagnoses include sepsis, meningitis and eclampsia. Hypoglycaemia 
may recur after correction with IV glucose, and blood glucose should be 
monitored frequently.
■• Convulsions in pregnant women can be caused by hypoglycaemia, cere-
bral malaria, or eclampsia. An appropriate evaluation should be done to 
determine the cause.
■• Acute pulmonary oedema is particularly common during labour and imme-
diately after delivery. Severe anaemia and the increase in blood volume 
and peripheral resistance that follows placental separation may precipi-
tate acute pulmonary oedema and heart failure. This is a medical emer-
gency that requires immediate treatment:
 — Check for increased respiratory rate, chest signs (crackles on auscul-
tation), and hepatomegaly;
 — If pulmonary oedema is suspected, position the patient upright, give 
high concentration oxygen, and IV furosemide, 0.6 v/kg (adult dose 
40 mg); 
 — If pulmonary oedema is associated with overhydration, stop all intra-
venous fluids and give furosemide (same dose as above).
■• Severe anaemia. Blood transfusion is indicated in women with erythro-
cyte volume fraction (EVF = haematocrit) lower than 20% or a haemo-
globin concentration less than 7 g/dl: 
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 — Give screened packed red blood cells by slow transfusion over 6 
hours and furosemide (frusemide) 20 mg intravenously; 
 — Folic acid and iron supplements may be required during recovery. 
Malnourished persons
Malnutrition is a significant cause of morbidity and mortality in humanitar-
ian emergencies, and often coexists with malaria. There are different ways of 
classifying malnutrition. The most common include differentiating between 
overnutrition and undernutrition, distinguishing chronic from acute forms, 
and within acute forms, distinguishing moderate from severe forms. Over-
nutrition remains a lesser issue in humanitarian contexts. Undernutrition 
can result in acute malnutrition (i.e. wasting or low weight-for-height, nutri-
tional oedema), chronic malnutrition (i.e. stunting or low height-for-age), 
micronutrient malnutrition, and inter-uterine growth restriction. 
The focus in humanitarian emergencies is usually acute malnutrition and 
micronutrient deficiencies, as they manifest most rapidly and visibly. Under-
weight (i.e. low weight-for-age), a composite measure of acute and chronic 
malnutrition, is an important marker in emergency contexts. Chronic mal-
nutrition and underweight reflect underlying nutritional vulnerability, and 
emergency-prone populations are more likely to be chronically malnour-
ished. Acute malnutrition is further divided into severe (SAM) and mod-
erate (MAM) forms, with global acute malnutrition (GAM) encompassing 
both. 
Diagnosis – Patients with SAM may have an asymptomatic malaria infec-
tion and should therefore be screened for malaria (using microscopy or 
RDT) on admission to a therapeutic feeding programme and weekly there-
after until discharge. 
Treatment – Once a patient has tested positive for malaria, an ACT should 
be given for treatment. There are limited data on the effect of malnutrition 
on chloroquine, doxycycline, quinine, sulfadoxine-pyrimethamine and 
tetracycline, and insufficient evidence to suggest that dosages (in mg/kg 
body-weight) of any antimalarial should be changed in patients with mal-
nutrition. 
Severe malaria – Patients with severe malaria and SAM are at very high 
risk of death and require intensive medical and nursing care. They should 
be hospitalized in a therapeutic feeding centre and treated with an effective 
parenteral artemisinin derivative.
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People living with HIV
There is considerable geographic overlap between malaria and HIV, indi-
cating the potential for substantial numbers of co-infected individuals in 
many humanitarian emergencies. Worsening HIV-related immunosuppres-
sion may lead to more severe manifestations of malaria. In HIV-infected 
pregnant women, adverse effects of placental malaria on birth-weight are 
increased. HIV-infected individuals may suffer more frequent and higher 
density infections or an increased risk of severe malaria and malaria-related 
death, depending on transmission intensity and level of malaria immunity. 
Treatment – Information is still limited on how HIV infection modi-
fies therapeutic responses to ACTs or on interactions between antimalar-
ial drugs and antiretrovirals. Thus, PLHIV who develop malaria should 
receive the appropriate antimalarial regimen for their setting, though 
sulfadoxine-pyrimethamine should be avoided by those taking cotrimox-
azole prophylaxis and amodiaquine should be avoided by PLHIV taking 
zidovudine or efavirenz. Given the potential risks of treatment interactions, 
particular focus for PLHIV should be on malaria prevention (e.g. usage of 
LLINs) where feasible. 
Displaced and returnee populations
Generally, mass population movements in geographical areas of mixed 
endemicity can increase the risk of severe malaria epidemics, especially 
when people living in an area with little or no malaria transmission move 
to an endemic area (e.g. displacement from highland to lowland areas). 
The lack of protective immunity, the concentration of people in exposed 
settings, the breakdown in public health and preventive activities, togeth-
er with difficulties in accessing effective treatment and with concomitant 
infections and malnutrition, all render populations vulnerable to epidem-
ic malaria. Such circumstances are also ideal for the development of par-
asite resistance to antimalarials. For these reasons, particular efforts must 
be made to deliver, free-of-charge, prompt diagnostic testing and effective 
antimalarial treatment to populations at risk.
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CHAPTER 7
Prevention
This chapter
■■ discusses available methods for malaria prevention in humanitarian 
emergencies
■■ outlines how to choose prevention interventions and organize activities
■■ describes operational aspects of mosquito biology and behaviour
Malaria prevention in humanitarian emergencies
While the first priorities in the acute phase of an emergency are prompt and 
effective diagnosis and treatment of people with malaria, prevention can 
make an important contribution to reducing the risk of infection and saving 
lives. This chapter addresses prevention related to humanitarian emergen-
cies, including vector control, personal protection against mosquito bites, 
intermittent preventive treatment (IPT), and the prospects for a malaria 
vaccine. Chapter 5 addresses prevention specific to malaria outbreaks.
The same prevention methods are usually appropriate for both human-in-
duced and natural disasters and the same constraints often apply. In emer-
gencies with a risk of malaria, the most important initial questions related 
to prevention are:
■• Is malaria prevention likely to be useful (e.g. how great is the malaria 
burden? Where is transmission occurring? What is the risk and does it 
necessitate pro-active rather than reactive response?)?
■• Which malaria prevention methods are most feasible (e.g. depending 
on local vector species, access, security, population mobility, human 
resources, funding, and logistics)?
A situation assessment (see Chapter 3), particularly regarding malaria con-
trol strategies in both the host country and the country of origin for refugee 
populations, should answer some of these questions. However, the nature 
of humanitarian emergencies presents both opportunities and constraints 
that may justify different prevention approaches (see Table 7.1).
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Table 7.1 Factors that may affect prevention approaches  
 in humanitarian emergencies
Opportunities
• Readily available trained workforce and adequate supervision.
• Concentrated population, potentially facilitating access, health education and 
logistics.
• Additional humanitarian funding provided by international donors.
Constraints
• Access to affected populations may be limited by conflict or geography.
• Priority for curative care and food security may limit funding and human resources 
available for vector control.
• Baseline information on vector presence and insecticide susceptibility may be missing.
• Most malaria transmission may occur outside resettlement sites.
• Language barriers may make it difficult to provide information.
• Temporary shelters may differ from local housing and make IRS and use of LLINs 
more problematic.
• Unstable and unpredictable situations make longer-term planning difficult.
• Evaluation of prevention strategies can be difficult.
• Problems in securing orders and importing commodities (e.g. insecticide, pumps, 
LLINs) quickly enough.
The evidence base for effective vector control in humanitarian emergen-
cies has expanded and field experience confirms the feasibility of timely 
vector control interventions. New tools for vector control and personal pro-
tection have the potential to significantly improve delivery of timely inter-
ventions and make a difference in humanitarian emergencies in a variety 
of contexts (see Chapter 9). When planning vector control, it is important 
to consider how malaria prevention approaches will need to change as the 
humanitarian emergency moves from acute to post-acute phase or consoli-
dates into a chronic emergency.
■• Acute-phase priorities are prompt and effective diagnosis and treatment 
of all clinical malaria episodes to limit avoidable malaria deaths. Where 
feasible, this should be supplemented with barrier methods of mosqui-
to-bite prevention – most commonly LLINs – aimed first at priority vul-
nerable groups with the highest risk of developing severe malaria but 
aiming to cover all at risk (i.e. universal coverage). Alternatively, IRS may 
be used in some contexts. IRS requires substantial planning, logistics 
and human and material resources, but has been shown to protect peo-
ple in well-organized settings such as transit camps. IRS is not suitable 
for protecting individual households scattered over large distances or 
where shelters are very temporary (i.e. less than about three months) and 
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without surfaces that can be readily sprayed (e.g. very open structures of 
sticks with a tarpaulin roof). IRS is best suited for protecting larger pop-
ulations in more compact settings, where shelters are more permanent 
and solid.
■• Post-acute phase priorities broaden as the situation stabilizes. It may be 
possible to prevent new infections by adding high-coverage community 
vector control measures i.e. covering a high percentage of the population 
with insecticide-treated nets (LLINs) or spraying a high percentage of 
dwellings with residual insecticide to achieve an impact on transmission.
During the acute phase, decisions on vector control and prevention will 
depend on:
 — malaria infection risk;
 — behaviour of the human population (e.g. mobility, where they are 
sleeping or being exposed to vector mosquitoes);
 — behaviour of the local vector population (e.g. indoor resting, indoor 
biting, early evening or night biting);
 — the type of shelter available (e.g. ad-hoc refuse materials, plastic 
sheeting, tents, more permanent housing).
New vector control and personal protection tools have been specifically 
designed for acute-phase emergencies. For example, in new settlements 
where shelter is very basic, insecticide-treated plastic sheeting may be more 
appropriate, acceptable and feasible than LLINs or IRS. Insecticide-pyre-
throid-treated plastic sheeting should not be used in areas where the local 
malaria vectors are resistant to pyrethroids. There are not currently suffi-
cient data on the efficacy and safety of insecticide-treated plastic sheeting 
for a formal WHO recommendation. However, operational realities may 
necessitate such approaches when neither IRS nor LLINs are operationally 
feasible. It is for these reasons that they are included in this handbook. Oth-
er methods, including permethrin-treated blankets and topical and spatial 
repellents, may sometimes be useful as adjunct control measures. 
As the situation stabilizes, longer-term approaches can be introduced. 
Prevention methods may change as the population becomes less mobile 
and temporary shelters are replaced by more permanent structures. There 
may be greater opportunities for providing LLINs. LLINs are widely used 
for malaria prevention and most communities in endemic areas will have 
some exposure to them. IPT (see Chapter 6) may be useful during post-
acute or chronic emergencies in appropriate settings in sub-Saharan Africa 
as it requires relatively few resources compared to LLINs or IRS. 
MALARIA CONTROL IN HUMANITARIAN EMERGENCIES
84
Long-lasting insecticidal nets (LLINs)
Whenever possible, LLINs should be provided in sufficient numbers to cov-
er everyone exposed to transmission in target communities. Normally, a 
combination of campaign (catch-up) and routine (keep-up) distribution sys-
tems are needed to sustain coverage. When supplies are constrained, LLINs 
can still provide personal protection to risk groups (e.g. young children 
and pregnant women) in high transmission areas. LLINs may be distrib-
uted through specialized delivery channels (e.g. emergency mass distribu-
tions) or integrated strategies (e.g. through antenatal care, vaccination). 
Only WHOPES-approved LLINs should be used. While the insecticide on 
an LLIN should last for at least three years, the physical lifespan of an LLIN 
is highly variable, thus requiring continuous distribution and monitoring in 
harsh emergency settings. Recent data from control programmes (not oper-
ating under emergency circumstances), suggest that the life span of many 
LLINs may be less than 24 months. 
LLINs are highly effective in the control of malaria in most settings 
and are accepted by malaria-affected communities worldwide. Sleeping 
under an untreated mosquito net provides a physical barrier against mos-
quitoes; however, mosquitoes can still bite through any tears or holes or 
if any part of the body is touching an untreated net. Nets treated with a 
pyrethroid insecticide provide a significantly increased level of protection. 
Untreated nets that require insecticide treatment are not practical in emer-
gencies, and it is preferable to deploy WHO Pesticide Evaluation Scheme 
(WHOPES)-approved LLINs. These are factory-treated mosquito nets that 
retain their biological activity for a minimum period of time and number 
of washes, currently at least 20 standardized WHO washes and 2–3 years of 
recommended use under normal field conditions. 
Pyrethroids are the only class of chemical currently approved for use on 
mosquito nets. They are very safe for humans, but toxic in low doses for 
mosquitoes – killing or repelling mosquitoes before they can enter the net 
or bite those sleeping under it. Pyrethroid treatment of nets provides per-
sonal protection for those who sleep under them even when coverage is 
low. High coverage of LLINs may also provide a mass impact (i.e. provide 
some protection for those not sleeping under LLINs) through reduction of 
mosquito populations and reduced longevity of adult mosquitoes. Insec-
ticide-treated nets have a killing or disabling effect on other biting vectors 
(e.g. lice, fleas, ticks, sandflies). Bedbugs, however, often exhibit a higher 
degree of tolerance to insecticides and may not be killed (e.g. some IRS pro-
grammes noted that bedbugs are simply agitated by insecticides and appear 
during the day, upsetting house owners). 
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WHOPES-approved LLINs are made of polyester, polyethylene or poly-
propylene mesh and meet the criteria for “long-lasting” labelling of contain-
ing insecticide that is wash-resistant and can remain efficacious even when 
the net has been washed 20 times. The physical durability of netting materi-
al is an important quality that varies with the denier, or weight of the fibre, 
and other net characteristics. Nets with a denier value less than 100 are not 
recommended due to relative ease of tearing. The contexts in which LLINs 
are used may also determine their physical durability (e.g. if they are subject 
to physical abrasion, tearing by reed sleeping mats, chewing by rodents, or 
fire damage). 
WHO has produced protocols for assessing the longevity of LLINs under 
field conditions that are available on WHO Global Malaria Programme and 
WHOPES websites. Table 7.2 provides a list of WHO recommended LLINs 
as of October 2012. The WHOPES website should be consulted for the latest 
update at http://www.who.int/whopes/en/.
General preconditions for successful LLIN distribution during emergencies – People 
must be under their LLINs at the time of night that most vector mosquitoes 
bite. Most people are willing to use LLINs, and behaviour-change commu-
nications (see Chapter 8) can improve population usage. It is important to 
organize and implement an effective community promotion campaign pri-
or to distribution. 
LLINs can be used indoors or outdoors, wherever the population nor-
mally sleeps, but appropriate installation and support mechanisms should 
be supplied and explained (Figure 7.1). Rigid or durable dwellings (e.g. 
mud huts) are suitable for hanging LLINs. Tent structures present a chal-
lenge, as some may not be of sufficient size or construction to be suitable 
for hanging LLINs; some tents can be sprayed with a residual insecticide 
instead, but duration of effect depends on the compound used and the type 
of tent material. Consultation with an experienced field entomologist or 
vector control expert is advised in such circumstances.
Good logistics are crucial. Ensure the delivery system is adequate and 
that information on population size and location of houses and population 
can be acquired. Timely procurement, factoring in shipping needs, storage 
capacity, and local transport will enable LLINs to be made available when 
and where needed in sufficient numbers and without gaps in the supply 
chain. Where possible, LLINs should be ordered well in advance of planned 
distribution, to ensure timely delivery and standard transportation costs. 
LLINs of standard specifications (e.g. double, family-size) are faster to pro-
cure, as manufacturers tend to maintain stocks. In chronic emergency situ-
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Table 7.2 WHO recommended LLINs
Product name Product type
Status  
of WHO  
recommendation
Status of  
publication of 
WHO specification
DawaPlus® 2.0
Deltamethrin coated on 
polyester
Interim Published
Duranet®
Alpha-cypermethrin 
incorporated into 
polyethylene
 Interim Published
Interceptor®
Alpha-cypermethrin coated 
on polyester
Full Published
Lifenet®
Deltamethrin incorporated 
into polypropylene
Interim Published
MAGnet™
Alpha-cypermethrin 
incorporated into 
polyethylene
Interim Published
Netroprotect®
Deltamethrin incorporated 
into polyethylene
Interim Published
Olyset®
Permethrin incorporated into 
polyethylene
Full Published
Olyset® Plus
Permethrin and PBO 
incorporated into 
polyethylene
Interim Pending
Permanet® 2.0
Deltamethrin coated on 
polyester
Full Published
Permanet® 2.5
Deltamethrin coated on 
polyester with strengthened 
border
Interim Published
Permanet® 3.0
Combination of deltamethrin 
coated on polyester with 
strengthened border (side 
panels) and deltamethrin 
and PBO incorporated into 
polyethylene (roof)
Interim Published
Royal Sentry®
Alpha-cypermethrin 
incorporated into 
polyethylene
Interim Published
Yorkool® LN
Deltamethrin coated on 
polyester
Full Published
Notes:
1. Reports of the WHOPES Working Group Meetings should be consulted for detailed guidance on use and 
recommendations. These reports are available at http://www.who.int/whopes/recommendations/wgm/
en/); and
2. WHO recommendations on the use of pesticides in public health are valid ONLY if linked to WHO specifica-
tions for their quality control. WHO specifications for public health pesticides are available at http://www.
who.int/whopes/quality/newspecif/en/. 
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ations with less time pressure, it is important to determine the most suitable 
LLINs with regard to shape, size, and colour. LLINs are best distributed 
before the start of the malaria season to provide maximum transmission 
reduction. However, because LLINs will last for years, distribution will be 
effective whenever it can be implemented. 
Planning and procurement – It is important to verify existing LLIN coverage 
(e.g. that there has been no recent distribution of new undamaged LLINs). 
A pre-distribution survey is ideal, though not always feasible in an emergen-
cy context. In cases where good coverage already exists, additional tools 
might still be considered for distribution (e.g. impregnated blankets). 
Beneficiaries must be clearly defined and the highest possible coverage 
aimed for in the shortest time. For example, ‘catch-up’ mass distribution 
can aim for full household coverage of 100% of target populations. Alter-
natively, if only limited numbers of LLINs are available, initial distribution 
should target high-priority vulnerable groups through ‘keep-up’ targeted 
distribution (e.g. pregnant women and children under 5 through antenatal 
clinics, routine immunization programmes, feeding centres or vaccination 
campaigns).
In planning procurement quantities, aim to distribute enough LLINs 
to achieve 100% coverage, with one LLIN for two persons. A good way to 
achieve this at household level is to distribute LLINs per household at a rate 
of one LLIN for every two household members, rounding up in households 
with odd numbers of members. The procurement ratio must be adjusted to 
allow for this rounding up. For example, this implies a procurement ratio of 
550 LLINs per 1000 population (i.e. one LLIN for 1.8 people) in a popula-
tion with a mean household size of five.
Colour and shape are important considerations. LLINs are available in 
rectangular and conical shapes and several colours. Conical nets are more 
expensive, but fit better in conical dwellings and are preferred in some set-
tings (e.g. Somalia). Some colours may be refused or misused by beneficiar-
ies because of the cultural significance of certain colours (e.g. a connection 
might exist between white colour and death). White LLINs show dirt 
and may get washed more often than coloured nets. For outside sleepers, 
impregnated hammock nets might be more appropriate (e.g. Cambodia). 
Opaque cotton sheeting (e.g. Dumuria) is preferred in some settings, such 
as South Sudan, because it provides more privacy but does not retain insec-
ticides as long as other net fibres. In emergencies, the specifications availa-
ble in stock are preferable in order to facilitate rapid deployment.
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Distribution – Define how and where LLINs will be distributed (see Table 
7.3). A successful approach used in emergencies is mass distribution to ben-
eficiaries who are invited by the community leaders to a central location 
and given nets. Another successful approach is “hang-up and use” distri-
bution, in which LLINs are installed on site by distributors. This labour 
intensive approach is slower, but may have a positive impact on the proper 
retention and use of each LLIN. Handling large numbers of new LLINs can 
result in temporary rashes or other allergic reactions, due to the build-up of 
pyrethroid on the net’s surface during storage, and as such, staff should use 
protective clothing (e.g. gloves, long sleeves). 
To reduce the risk of beneficiaries re-selling LLINs, each LLIN should be 
removed from its packaging, marked with a number or name, and recep-
tion signed for by the head of household. Some LLINs are already printed 
with an individual number, which helps with monitoring and evaluation of 
distribution. 
Table 7.3 LLIN distribution by phase of emergency and level of transmission
Acute-phase emergencies in high/moderate transmission areas
Ideally, universal LLIN coverage of the whole community should be the objective. If 
insufficient LLINs are stockpiled, prioritize highest risk groups: 
1. all beds/patients in hospitals and therapeutic feeding centres (TFC), and households 
of TFC patients on discharge;
2. pregnant women and children under 5 years of age;
3. populations living in areas of high transmission (so-called “hot spot” transmission 
zones).
Acute-phase emergencies in low-transmission areas 
Use LLINs only in clinical settings (e.g. TFC beds, hospital beds), with no community 
distribution schemes.
Post-acute or chronic emergencies in high/moderate transmission areas
Universal coverage is ideal. If resources do not allow this:
1. target distribution to areas and populations most at risk;
2. provide full LLIN coverage to households with pregnant women or children under 
5 years of age, with catch-up distribution schemes through antenatal care (ANC), 
immunization programmes and primary health care;
3. provide LLINs to People Living with HIV (PLHIV), who are more at risk of developing 
severe malaria.
Post-acute or chronic emergencies in low-transmission areas 
Select intervention according to local practice. LLINs are not the only choice.
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Health communications – LLIN distribution campaigns should be accom-
panied by comprehensive behaviour change communication approaches 
(e.g. drama, radio) to encourage appropriate usage and maintenance and 
improve intervention success. While increasing evidence from most set-
tings in Africa indicates net use is high, with up to 80% of nets being used 
(WHO, 2010), they are sometimes diverted for other uses such as fishing, 
clothing (e.g. wedding dresses), or crop protection. These alternative uses 
should be discouraged and safety should be emphasized in promotion cam-
paigns (e.g. no fire or lit cigarettes near LLINs) as should appropriate usage 
(e.g. ensuring LLINs are tucked in and are used every night even where 
mosquitoes are not heard or seen). LLINs used by anyone with a highly 
contagious disease (e.g. viral haemorrhagic fever) must be disinfected, dis-
posed of appropriately and replaced. Each LLIN must be accompanied by 
simple country-specific information (e.g. leaflets) to enable people to use 
them correctly. These should include pictorial information on how to hang 
the nets (e.g. ropes and nails when suspended indoors from walls or ceil-
ings, rounded poles for outdoor LLIN hanging – to avoid damaging LLINs, 
and UV radiation considerations if LLINs stay outdoors during the day). 
Figure 7.1 provides an example from Afghanistan.
Monitoring – Coverage should be assessed by monitoring at distribution, 
and then at one and six months, to determine appropriate use and reten-
tion. Standard indicators from a management information system (MIS) or 
Demographic and Health Survey (DHS) should be used. If standardized 
indicators are not available, appropriate indicators for inclusion are:
■• Coverage = number of LLINs distributed/target population size (%);
■• Usage rate = number of people using LLINs/number of people given 
LLINs (%);
■• Retention rate = number of people retaining LLINs/number of people 
originally given LLINs (%);Net failure rate = average number of holes 
per LLIN following WHO criteria as given in the WHO guidelines on 
monitoring LLIN durability. Indicators of survivor, attrition, and fail-
ure of LLINs are defined further in http://whqlibdoc.who.int/publica-
tions/2011/9789241501705_eng.pdf;
■• Behaviour change indicator (e.g. proportion of population that can recall 
or understand message).
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Indoor residual spraying (IRS)
IRS, when implemented properly, is a highly-effective intervention that 
provides protection to entire communities through rapidly impacting 
vector populations – reducing densities and longevity of vectors and their 
capacity to transmit malaria parasites. IRS effectiveness is dependent on the 
quality of spraying operations (i.e. at least 80% of premises in target com-
munities must be properly sprayed). IRS is usually effective for 3–6 months, 
depending on the insecticide used, type of surface sprayed, and transmis-
sion seasonality; more information may be obtained at: http://www.who.
int/whopes/en/insecticides_IRS_malaria_09.pdf. 
IRS involves spraying a residual insecticide onto the inside walls and ceil-
ings or the underside of the roof and eaves of houses, in order to kill mos-
quitoes when they come indoors to feed and rest. The basic preconditions 
for IRS are:
■• an endophilic malaria vector (i.e. mosquitoes that enter and rest inside 
houses long enough to come in contact with the insecticide);
Figure 7.1 Example approaches to hanging LLINs indoors and outdoors
Source: HealthNet-TPO
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■• an insecticide to which the vector is susceptible;
■• a population living in dwellings with sprayable surfaces (e.g. huts made 
of branches with wide voids or gaps will be difficult to spray);
■• a population that is not nomadic and structures that are permanent for 
the coming 6–12 months;
■• willingness of the population to accept IRS;
■• communities living in close proximity (e.g. villages, towns, transitional 
camps). IRS is not the correct tool for dispersed rural populations, as 
logistics become increasingly difficult;
■• capacity and training to deliver a good-quality application of insecti-
cides, as low-quality IRS campaigns may cause more harm than benefit. 
To be effective as a community control measure, IRS requires coverage 
of at least 80% of dwellings, ensuring that the majority of mosquitoes are 
exposed to the insecticide. Indoor sleeping is not strictly a requirement 
for IRS success. For example, in Afghan refugee settlements people sleep 
outdoors on hot summer nights, but indoor spraying still protects against 
malaria because mosquitoes rest indoors during the day.
Given the operational requirements, IRS is most suited to areas that are 
somewhat stable politically, where advance planning and close monitoring 
of campaign coverage are possible. In acute-phase emergencies, there may 
be opportunities for IRS during planning for refugee transit camps and oth-
er well-organized settings. An IRS campaign requires substantial advance 
planning, good logistics support, and human and material resources. Its 
effectiveness is highly dependent on operational factors – timely delivery of 
commodities, on-site expertise and capacity, good organization and plan-
ning, trained staff, supervision, and appropriate health communications. 
Timing is critical in areas of seasonal transmission and at least 80% of 
shelters (e.g. houses, temporary shelters, hospitals, orphanages, schools) 
must be sprayed with insecticide before onset of the expected peak trans-
mission season. 
Good-quality compression sprayers that comply with WHO specifica-
tions must be used for IRS. Compression sprayers are prone to wear and tear 
and may need to be imported, together with spare parts and insecticides. 
Importation requires time and adequate planning. Proper maintenance is 
important to ensure that compression sprayers are efficient and their work-
ing life is maximized. IRS campaigns have failed due to neglect of spray 
equipment (e.g. pumps, nozzles and lances becoming blocked through lack 
of daily cleaning or maintenance). Information on WHO specifications for 
spray equipment can be found at the WHOPES website: http://www.who.
int/whopes/equipment/en/.
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To achieve the desired impact, IRS campaigns must be implemented 
properly. Insecticide must be applied safely, and operations properly super-
vised. Spray teams require at least two days of intensive theoretical and 
practical training before they can start field operations and these operations 
must be closely supervised and monitored. WHO produced an illustrated 
manual that can be used for training spray teams and maintaining spraying 
equipment (http://www.who.int/whopes/equipment/en/). In addition, 
WHO/GMP has recently developed an operational manual for IRS for 
malaria transmission control and elimination, available on the WHO web-
site at http://www.who.int/malaria/publications/atoz/9789241505123/en/
index.html. This manual describes policy and strategic issues – including 
how to manage an IRS programme and conduct a house spray.
Important instructions to be followed by sprayers when implementing 
indoor residual spraying are summarized in Table 7.4.
Table 7.5 lists the insecticides commonly used for IRS, recommend-
ed application rates (g/m2), and residual life or persistence. Any WHO- 
recommended insecticides can be used if available locally and known to 
be effective. WHO specifications for public health pesticides – for quali-
ty control and international trade – are available at http://www.who.int/
whopes/quality. IRS is governed by country registration regulations. There 
have been a few exceptions in emergencies, where WHOPES-approved 
Figure 7.2 Example compression sprayer
Source: WHOPES
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products have been considered without full national registration (e.g. Libe-
ria, Chad). In areas with high LLIN usage, pyrethroids should not be used 
for IRS to avoid rapid selection of pyrethroid resistance. The use of non- 
pyrethroid insecticides should be based on the susceptibility status of the 
local vectors to those insecticides. New long-lasting formulations of non- 
pyrethroid alternatives are being evaluated by WHO and may in the future 
ease the overreliance on pyrethroids for IRS. Refer to the WHO Global Plan 
for Insecticide Resistance Management for more information http://www.
who.int/malaria/publications/atoz/gpirm/en/index.html. 
If malaria transmission is seasonal, it is important to spray just before 
or at the start of the season. In an outbreak, IRS will only achieve its full 
impact if walls are sprayed well before the epidemic peak. This requires 
detailed advance planning and considerable logistic capacity and is rarely 
possible in practice in emergency situations. 
Table 7.4 Household aspects of indoor residual spraying
Household preparations
• Inform household occupants of the spraying schedule and reasons for spraying.
• Allow occupants time to prepare and vacate living areas.
• Remove all household items, including water, food, cooking utensils and toys. Items 
that cannot be removed should be carefully covered.
• Move pets and domestic animals away from the home.
• Occupants must leave before spraying begins.
• Areas occupied by sick people who cannot be moved must not be sprayed.
Household procedures after spraying
• Advise occupants to stay outside for at least one hour while sprayed surfaces are 
drying.
• Instruct occupants to sweep or mop the floor before children and pets are allowed 
to re-enter.
• Instruct occupants not to wipe or clean sprayed surfaces.
Waste disposal
• At the end of each day’s spraying, pumps should be cleaned by the standard ‘triple 
rinse’ method so that waste water is contained. 
• Never pour insecticide into rivers, pools or drinking-water sources. 
• Never reuse or burn empty insecticide containers.
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IRS programme monitoring
Appropriate indicators for inclusion in quality and effectiveness monitoring 
are:
■• Coverage = number of structures sprayed / number of structures in the 
target areas (%);
■• Amount of insecticide used per structure = amount of insecticide used / 
number of structures sprayed (%). This is one measure of the efficiency 
and correct usage of the insecticide; 
■• Maintenance = % of pumps that were correctly maintained and function-
ing well at the end of the campaign;
■• Acceptability = % of households that refused to have their homes sprayed; 
■• Acceptability after IRS = % heads of households who complained after a 
spray campaign.
Table 7.5 WHO-recommended insecticides for IRS against malaria vectors
Insecticide compounds  
and formulationsa 
Class 
groupb
Dosage  
(g a.i./m2)
Mode of 
action
Duration of 
effective action 
(months)
DDT WP OC 1–2 contact >6
Malathion WP OP 2 contact 2–3
Fenitrothion WP OP 2
contact and 
airborne
3–6
Pirimiphos–methyl WP & EC OP 1–2
contact and 
airborne
2–3
Bendiocarb WP C 0.1–0.4
contact and 
airborne
2–6
Propoxur WP C 1–2
contact and 
airborne
3–6
Alpha–cypermethrin WP & SC PY 0.02–0.03 contact 4–6
Bifenthrin WP PY 0.025–0.05 contact 3–6
Cyfluthrin WP PY 0.02–0.05 contact 3–6
Deltamethrin WP, WG PY 0.02–0.025 contact 3–6
Etofenprox WP PY 0.1–0.3 contact 3–6
Lambda–cyhalothrin WP, CS PY 0.02–0.03 contact 3–6
a CS: capsule suspension; EC= emulsifiable concentrate; SC= suspension concentrate; WG= water dispersi-
ble granule; WP= wettable powder.
b OC Organochlorines; OP= Organophosphates; C= Carbamates; PY= Pyrethroids.
Note: WHO recommendations on the use of pesticides in public health are valid ONLY if linked to WHO specifi-
cations for their quality control. WHO specifications for public health pesticides are available on the WHP home 
page at http:/www.who.int/whopes/quality/en/.
Source: WHOPES (http:/www.who.int/whopes/Insectisides_IRS_Malaria_09.pdf
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Chemoprevention
Chemoprevention, through periodic intake of antimalarials approved for 
this purpose, can provide protection against malaria and its adverse con-
sequences during pregnancy, infancy and early childhood (see Chapter 6). 
Chemoprevention may be particularly useful during the post-acute phase 
or during chronic emergencies in sub-Saharan Africa, as it requires minimal 
specialist knowledge and can be administered by health staff. 
Intermittent preventive treatment (IPT) is one form of chemoprevention 
that involves repeated delivery of a full treatment dose of an antimalarial 
drug – usually sulfadoxine-pyrimethamine (SP) – to a particular risk group 
to prevent the consequences of malaria infection. Treatments are given to 
asymptomatic people at pre-specified times, regardless of the presence of 
malaria parasites at the time of treatment. IPT in pregnancy (IPTp) should 
be provided to women in areas of sub-Saharan Africa with moderate-to-high 
malaria transmission. When administered at all routine antenatal visits 
during the second and third trimesters, IPTp has been shown to reduce 
the adverse consequences of malaria on maternal and fetal outcomes. IPT 
in infants (IPTi), delivered through routine vaccination, reduces the inci-
dence of clinical malaria, the prevalence of anaemia, and the frequency of 
hospital admissions associated with malaria in the first year of life. WHO 
recommends IPTi as co-administration of SP with DTP2, DTP3 and mea-
sles immunization to infants, through routine Expanded Programme on 
Immunization (EPI) programmes in areas with moderate-to-high malaria 
transmission and where parasite resistance to SP is not high (prevalence of 
the pfdhps 540 mutation below 50%). 
Seasonal Malaria Chemoprevention (SMC), which involves the admin-
istration of monthly courses of antimalarials to children less than five years 
of age living in areas of highly seasonal malaria transmission, significantly 
reduces malaria incidence, anaemia and severe morbidity. A complete treat-
ment course of amodiaquine plus sulfadoxine-pyrimethamine (AQ+SP) 
should be given to children aged between 3 and 59 months at monthly 
intervals, beginning at the start of the transmission season, to a maximum 
of four doses during the malaria transmission season (provided both drugs 
retain sufficient antimalarial efficacy). The target areas for SMC implemen-
tation are those where, on average, more than 60% of clinical malaria cases 
occur within a maximum of 4 months and the clinical attack rate of malaria 
is greater than 0.1 attack per transmission season in children under five. 
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Vaccination
An effective vaccine is not yet available for malaria, although several vac-
cines are under development. A vaccine candidate known as RTS,S/AS01 
has shown potentially promising results in clinical trials in Africa. Evi-
dence-based policy recommendations are expected to be made in 2015, and 
will depend on data to become available in 2014.
Prevention developed for displaced populations
Conventional vector control interventions (e.g. LLINs, IRS) are not always 
feasible for acute-phase emergencies. The basic, semi-open shelters that 
often characterize acute-phase emergencies are usually not amenable to 
effective IRS or hanging LLINs. Space is often an issue and shelters con-
structed from sharp or abrasive materials very rapidly deteriorate LLINs 
beyond effective use or lifespan. New vector control tools for acute emer-
gencies are needed that:
■• place little or no extra burden on implementing agencies;
■• can be stockpiled for the long term; 
■• require minimal behaviour change among implementers and users.
Displaced populations have specific needs different from stable popula-
tions, and insecticide treatment of materials – tents, blankets, sheets, cloth-
ing and curtains – may be more acceptable and feasible than conventional 
interventions. At the time of publication, WHO had not made a formal 
recommendation on insecticide- treated blankets and plastic sheeting for 
malaria control. WHO will consider vector control products for policy rec-
ommendation on an individual basis as data for those products become 
available. Current evidence is reviewed below. 
Insecticide-treated plastic sheeting (ITPS) – Plastic sheeting is increasingly pro-
vided in the early stages of humanitarian emergencies to enable affected 
communities to construct temporary shelters. ITPS, a laminated polyethyl-
ene tarpaulin that is impregnated with a pyrethroid during manufacture, is 
suitable for constructing such shelters. Like IRS, ITPS is only useful against 
indoor resting mosquitoes. To be effective, ITPS should represent a high 
proportion of the surfaces that mosquitoes contact (e.g. all shelter walls, 
and ideally the ceiling, should be constructed of or lined with ITPS). ITPS 
also has potential for use as the superstructure of pit latrines as it has doc-
umented impact on fly population densities. ITPS effectiveness is likely to 
depend on local vector resistance to pyrethroids and the ratio of ITPS to 
other mosquito resting sites. In situations where commercially available 
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ITPS is used, the duration of effectiveness against malaria and safety under 
field conditions should be independently assessed and reported to build 
the evidence base. Since insecticide migrates and accumulates at the surface 
of ITPS during transportation and when it is stored in packaging, the ITPS 
should be aired before use. 
Entomological trials in refugee settlements in Pakistan showed that 
insecticide was present on ITPS for at least a year and killed mosquitoes 
coming into contact with it (Graham et al, 2002). Research to determine 
ITPS effectiveness during its increasing provision as emergency shelter in 
Africa remains limited. The results of a recently published trial (Burns et 
al., 2012) are summarized below (see Box 7.1). Given the limited body of 
evidence, ITPS cannot replace LLINs or IRS, but can be considered by local 
experts and authorities for use in situations where tarpaulins will be distrib-
uted and LLINs or IRS would be impractical.
Box 7.1 Evidence for ITPS prevention of malaria in an emergency setting  
 in Sierra Leone
Evidence that ITPS can provide malaria control in emergencies was obtained 
during two cluster randomized trials conducted in two refugees camps in Sierra 
Leone. In the first camp, ITPS or untreated plastic sheeting (UPS) were attached 
to inner walls and ceilings of shelters. In the second camp, ITPS or UPS were 
used to line ceilings and roofs only. 
In the camp with all inner surfaces lined with plastic sheeting, malaria 
incidence was 1.63 infections per child under UPS and 0.63 under ITPS, a 61% 
level of protection. In the camp with ceilings lined, the level of protection was 
only 15%.
ITPS demonstrated potential to prevent malaria when used at high levels 
of coverage over all interior surfaces but not when restricted to roofs only. 
Protection continued for at least a year, after which monitoring stopped. Thus, 
ITPS proved an appropriate and long-lasting method of malaria control in this 
emergency setting.
Insecticide-impregnated tents – The inner surface of tents can be sprayed using 
compression sprayers, either in the same way as house spraying or by lay-
ing the tent flat before spraying. Data on the efficacy of this approach also 
remains relatively limited. Tent spraying has been tried with Afghan and 
Vietnamese refugees, and is carried out each year among nomadic refu-
gees who migrate annually between the Punjab and the mountainous are-
as of Pakistan. In the latter case, tent spraying has been shown to provide 
60–80% protection against falciparum malaria (Bouma et al., 1996). The 
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most suitable insecticides for tent spraying are permethrin and deltame-
thrin, in suspension concentrate formulation. The wettable powder formu-
lation used for house spraying is not suitable. Data suggest that pyrethroid 
insecticide may persist for more than 12 months on double-sheeted tents 
and up to 6 months on single-sheeted tents (Hewitt et al., 1995). Addition-
ally, a tent of canvas interwoven with insecticide-impregnated polyethylene 
threads was shown to be highly effective against mosquitoes (Graham et 
al., 2004). 
Insecticide-treated hammock nets – These are sometimes promoted for use by 
populations who sleep outdoors or in hammocks, such as forest workers in 
Cambodia (Sochantha et al., 2010). However, data about their effectiveness 
remains limited, and their role in emergencies is also likely to be limited.
Long-lasting impregnated blankets and topsheets – These have the potential to 
play an important role in malaria prevention during humanitarian emergen-
cies. Blankets are often included in emergency relief kits, while lightweight 
blankets or topsheets are widely used in tropical areas. One advantage of 
blankets and topsheets is they can be used anywhere people sleep (e.g. 
indoors, outdoors, any type of shelter). The wash resistance of these prod-
ucts is consistent with that of LLINs. 
Long-lasting permethrin-treated wash-resistant blankets and topsheets 
are currently undergoing community randomized trials for malaria control. 
Permethrin treatment of topsheets, blankets and chaddars (i.e. a covering 
worn by many Afghan women) has been shown to provide 62% protec-
tion against falciparum malaria and 46% protection against vivax malar-
ia compared to a placebo treatment among Afghan refugees (Rowland et 
al., 1999). Studies have shown permethrin-treated sheets among Kenyan 
nomads provided personal protection to users (Macintyre et al., 2003), but 
further research is required to determine whether they can provide com-
munity protection at high population coverage levels. The personal protec-
tion afforded by insecticide-treated blankets is due mostly to the repellent 
effect of the permethrin. Permethrin is the preferred insecticide because of 
its low toxicity, at a target dose of 0.5–1 g/m2 (Graham et al., 2002). 
Clarification of potential role and context is needed before generalized 
recommendations can be made (e.g. can permethrin--treated topsheets, 
blankets and chaddars be used as an adjunct to ITPS as they have comple-
mentary modes of action and both are distributed in emergencies and do 
not require technical expertise? What accompanying promotional activities 
would be needed?). 
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Permethrin-impregnated clothing – This has been used by the US military for 
over twenty years and is increasingly popular in the leisure industry (e.g. 
fishing, hunting). Available toxicology data indicates skin sensitization (e.g. 
temporary rashes) in hypersensitive individuals, but no significant risk to 
humans, and permethrin has US Environmental Protection Agency (EPA) 
approval for use on clothing (Commission on Life Sciences, 1994). Effica-
cy data of permethrin-impregnated clothing in the prevention of malaria is 
scant.
Prevention for specific circumstances 
Outdoor and evening-biting vectors – In South-east Asia and South America par-
ticularly, many vector mosquitoes bite in the evenings or mainly outdoors, 
potentially limiting the effectiveness of LLINs and IRS. For example, where 
primary and secondary vector species coexist (e.g. Myanmar), IRS or LLINs 
may control late-biting vectors (e.g. An. dirus) and leave evening-biting sec-
ondary vectors free to continue residual malaria transmission. However, 
even in such settings, LLINs and IRS may remain important vector control 
tools as the Anopheles mosquitoes, which they do affect, may be the most 
efficient malaria vectors. Aerosol insecticides, mosquito coils, and vaporiz-
ing mats are used by householders in these settings, but to date, there is not 
sufficient evidence of cost-effectiveness to justify encouraging their gener-
alized use or providing them on a broader scale. This evidence is currently 
being collected.
Topical repellents for application on skin or clothing may have some value 
during emergencies, particularly as an adjunct to LLINs or IRS. Repellents 
need to be applied appropriately every evening and are relatively expen-
sive, but may provide a temporary solution provided recipients are disci-
plined about applying them. In acute-phase emergencies, topical repellents 
may have logistical advantages over other methods (e.g. speed, size), and 
a trial among Afghan refugees demonstrated up to 50% protective efficacy 
against falciparum malaria (Rowland et al., 2004). 
Larval control – Used successfully in dengue control, larviciding remains 
a major undertaking and the evidence for impact, feasibility and cost- 
effectiveness in malaria control is equivocal. Emergency responses can gen-
erate risk through the creation of multiple surface wastewater sites (e.g. 
installation of leaking emergency water distribution facilities in arid zones). 
Newly displaced populations may create breeding sites (e.g. through dig-
ging borrow pits for house construction), something which is difficult to 
prevent. Sudden environmental changes can create new breeding sites (e.g. 
MALARIA CONTROL IN HUMANITARIAN EMERGENCIES
100
An. sundaicus was observed breeding more frequently in brackish water 
after the 2006 Asian tsunami). An appropriate response to human-made 
localized breeding sites is preventing the cause. Larval control should only 
be considered where vector breeding sites are limited in number, relative-
ly permanent, and can be easily identified and accessed (few, fixed and 
findable). In sub-Saharan Africa, such places are most frequently found in 
urban and peri-urban areas; in rural areas breeding sites tend to be widely 
dispersed and difficult to find, rendering larviciding a poor vector control 
strategy (see WHO statement: http://www.who.int/malaria/publications/
atoz/larviciding_position_statement/en/). Larval control has not been 
widely used in humanitarian emergencies, and it is not advised unless there 
is professional entomological expertise available to provide support in 
defining the intervention strategy. The list of WHOPES-recommended lar-
vicides is found at http://www.who.int/whopes/en/mosquito_larvicides_
Sept_2012.pdf. Table 7.6 lists currently recommended larvicides and their 
alternatives for use in humanitarian emergencies. 
Insecticide zooprophylaxis – Malaria control by application of insecticide to the 
surfaces of domestic animals has been used in chronic emergencies where 
vectors bite domestic animals as well as humans (e.g. in south and south-
west Asia, where An. culicifacies and An. stephensi feed on cattle more than on 
humans). The insecticide – usually deltamethrin – is applied to the hair and 
skin of cattle, goats and sheep by dipping or sponge. Mosquitoes pick up a 
lethal dose of insecticide when they attempt to feed on the treated animal.
Zooprophylaxis had a similar effect on malaria to that of IRS, when test-
ed in Afghan refugee settlements – at 20% of the cost as far less insecticide 
was required (Rowland et al., 2001). Insecticide zooprophylaxis is widely 
used in Afghan refugee settlements in Pakistan, but only works where vec-
tors are highly zoophilic; trials are being considered against An. arabiensis 
in Africa. Given the limitations of this approach and lack of generalizable 
data, advice from a medical entomologist is necessary before attempting 
this method in a new area.
Prevention methods that are not recommended
Scrub removal – There is no evidence that cutting down grass and scrub 
around houses, to reduce the number of mosquito resting sites, has any 
impact on malaria transmission; it is therefore not recommended.
Ultra-low volume aerosol spraying and fogging – Whether from a plane, vehicle 
or motorized sprayer, these methods look impressive. However, there is a 
risk of usage for promotional rather than malaria control purposes, as there 
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is little evidence of any impact on malaria. Thus, these are generally not 
recommended, but can be considered in exceptional circumstances (e.g. 
outdoor biting and resting mosquitoes). However, such activities would 
need to be maintained over time to have any impact, and professional ento-
mological expertise is required if consideration is given to deploying this 
strategy.
Selecting and implementing prevention methods
Once it is determined that malaria prevention is feasible and likely to have 
impact, the next steps are selecting appropriate prevention methods, plan-
Table 7.6 Recommended insecticides for larval control of malaria vectors  
 in humanitarian emergencies
Insecticide compounds and 
formulation(s)a
Dosage (active ingredient)
Class groupb General  (g/ha)
Container  
breeding mg/L
Bacillus thuringiensis israelensis strain 
AM65-52, WG (3000 ITU/mg)
BL 125–750c 1.53
Bacillus thuringiensis israelensis strain 
AM65-52, GR (200 ITU/mg)
BL
5,000–
20,000c
–
Chlorpyrifos EC OP 11–25 –
Diflubenzuron DT, GR, WP BU 25–100 0.02–0.25
Novaluron EC BU 10–100 0.01–0.05
Pyriproxyfen GR JH 10–50 0.01
Fenthion EC OP 22–112 –
Pirimiphos–methyl EC OP 50–500 1
Temephos EC, GR OP 56–112 1
Spinosad DT, EC, Gr, SC SP 20–500 0.1–0.5
a DT = tablet for direct application; GR = granule; EC = emulsifiable concentration; WG = water-dispersible 
granule; WP = wettable powder.
b BL = Bacterial Larvicide; BU = Benzoylureas; JH = Juvenile Hormone Mimics; OP = Organophosphates; SP = 
Spinosyns.
c Formulated product.
Notes:
1. Reports of the WHOPES Working Group Meetings (available at http://www.who.int/whopes/recommen-
dations/wgm/en/) and the WHOPES publication Pesticides and their application for control of vectors 
and pests of public health importance (available at http://whqlibdoc.who.int/hq/2006/WHO_CDS_NTD_
WHOPES_GCDPP_2006.1_eng.pdf) should be consulted for guidance on use and recommendations;
2. The WHO Guidelines for drinking-water quality (http://www.who.int/water_sanitation_health/dwq/
gdwq3rev/en/) provides authoritative guidance and should be consulted for application of insecticides in 
potable water for mosquito larviciding; and
3. WHO recommendations on the use of pesticides in public health are valid ONLY if linked to WHO specifica-
tions for their quality control (available at http://www.who.int/whopes/quality/newspecif/en/).
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ning and organizing implementation, and developing monitoring systems. 
Thus, necessary decisions include:
■• whether to start; 
■• which tools to use;
■• when to change tools to fit changing needs;
■• how to transition to country-owned and led vector control; 
■• when to stop.
Selecting prevention interventions 
The main selection criteria and information required for prevention are:
■• Suitability and effectiveness compared to other malaria control methods – Effica-
cy is the inherent impact that an intervention can have under ideal or con-
trolled conditions, while effectiveness describes what can be achieved 
under operational conditions. In emergencies, the principal concern is 
effectiveness under difficult circumstances. All tools considered here 
have an evidence base generated from trials conducted in emergency 
situations. It is also important to remember that emergency situations 
change over time and need to be reviewed regularly, using relevant data, 
to ensure selected prevention methods are still appropriate. 
■• Feasibility of implementation – This is affected by contextual issues such as 
health system logistics; effectiveness of information systems; access to 
high-risk groups; population movement, behaviour and housing; prior 
experience of vector control; availability of trained human and materi-
al resources; possibilities for supervision and monitoring of activities; 
existing national policy and government commitment; costs and cost 
effectiveness; and speed of availability and amount of funding. 
Activity selection and planning requires comparison of appropriate and 
available tools for the different emergency stages (e.g. acute, early recov-
ery), affected populations (e.g. sleeping habits, household construction), 
and vectors (e.g. night biting, indoor resting). Tables 7.7 and 7.8 list geo-
graphical and contextual issues for consideration when selecting optimal 
prevention activities.
LLINs, and to a lesser extent IRS, are the usual tools of choice to achieve 
full population coverage. Prevention tools developed for displaced popu-
lations should also be considered. Table 7.8 provides a comparison of tools 
and a list of context-specific characteristics to take into consideration when 
selecting optimal approaches.
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Table 7.7 Geographical issues to consider in selecting prevention activities
Epidemiological  Characteristics Possible prevention 
type of malaria activities
Savannah or grassland  • Generally present  • Insecticide-treated
(sub-Saharan Africa,   throughout the year  mosquito nets
Papua New Guinea) • Seasonal increase • Other types of 
 • Drug resistance, mainly   personal protection
  P. falciparum • Health promotion
 • Affects mainly children 
  and pregnant women  
Plains and valleys  • Moderate transmission • Spraying of houses
outside Africa (Central • Often mainly P. vivax  • Insecticide-treated
America, China, Indian  • Major seasonal variation  mosquito nets
subcontinent) • Risk of outbreaks • Other types of 
    personal protection
   • Livestock treatment
   • Health promotion
Highland and desert  • High risk of outbreaks • Spraying of houses
fringe (African and  • Major seasonal variation  may be considered
south-east Asian high- • Influenced by agricultural  • Localized house spray-
lands, Sahel, southern   practices  ing for prevention
Africa, south-west  • Migration may lead to   of outbreaks
Pacific)  outbreaks • Insecticide-treated 
    mosquito nets 
   • Health promotion
Urban and peri-urban  • Highly variable  • Insecticide-treated
(Africa, South America,   transmission  mosquito nets
south Asia) • Immunity of the  • Other personal
  population variable  protection
 • Specially adapted urban  • Control of breeding
  vectors responsible for   sites by larviciding or
  outbreaks in south Asia  environmental planning  
    and management
   • Spraying of houses in 
    selected areas
   • Health promotion
Forest and forest fringe  • Focal intense transmission • Insecticide-treated
(south-east Asia, South  • Many risk groups, often   mosquito nets
America)  occupational • Other personal 
    protection
   • Consider siting of 
    dwellings
   • Health promotion
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Planning malaria prevention activities
Information collected during initial assessment (see Chapter 2) should be 
used to plan and organize malaria prevention activities. Additional specific 
information (e.g. about vectors in each site) may be needed to guide organi-
zation and monitoring of activities. Table 7.9 shows how information about 
affected populations, vectors and environment can be used in organizing 
malaria prevention.
Important steps in setting-up and implementing prevention activities are:
■• collecting information (e.g. epidemiological, entomological, demo-
graphic, logistic) from international sources and local experts;
■• where populations are displaced, choosing resettlement sites away from 
vector breeding sites whenever possible;
■• defining control objectives based on problem severity, available resourc-
es and the level of health care in the area;
■• choosing control measures;
■• collaborating with appropriate agencies to build community acceptance 
(e.g. sensitizing local authorities and communities) of programme imple-
mentation;
■• recruiting and training local staff;
■• implementing chosen control measures, with entomological advice 
where feasible and appropriate;
■• monitoring and evaluating control measures in terms of coverage (avail-
ability and use).
Monitoring prevention activities 
Programmes should implement a basic entomological monitoring package 
of 4–5 essential indicators: 
■• vector presence and identification (i.e. is there really transmission, and if 
so, what is the vector?);
■• time and place of vector feeding (Note: if resources do not exist to deter-
mine in situ these may be inferred by the species identification. However, 
in cases where there are multiple members of a species complex, such as 
An. gambiae present, it may be necessary – in addition to morphological 
identification of the complex – to include molecular determination of 
the species);
■• vector resting habits (see Note above);
■• insecticide susceptibility status (e.g. this can be determined initially with 
standard WHO Tube or CDC Bottle assays); 
■• wall bioassays may also be conducted for IRS programmes where appro-
priate.
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Table 7.9 Information to guide planning of malaria prevention activities
Information type Importance How information can be used
Environment
Seasonality of trans-
mission according to 
rainfall, surface water, 
temperature
Affects selection and 
timing of interventions
To determine mosquito 
control strategies and predict 
outbreaks
Host 
Population size Indicates total number of 
people at risk
To plan the amount of supplies 
needed
Distribution Indicates accessibility To determine the type of 
malaria control activities
Mobility Increases possibility of 
outbreaks
To determine the type of 
malaria control activities
Types of dwellings and 
location in relation to 
breeding sites
Open dwellings are difficult 
to spray; different types of 
dwellings need different 
LLIN designs; proximity of 
breeding sites increases 
risk.
To determine the type of 
malaria control activities
Exposure behaviour If people are outside during 
biting times their infection 
risk is higher.
To recommend when LLIN 
protection is necessary
Vector 
Species Different species have 
different behaviours
To influence control strategy
Preferred breeding sites Indicates which water 
bodies are important and 
whether larval control is 
feasible
To help determine control 
methods and communication 
messages
Resting habits (indoors, 
outdoors)
IRS and LLINs may be more 
effective against indoor-
resting vectors
To help determine control 
methods and communication 
messages
Feeding habits (location, 
time, host preference)
IRS and LLINs may be more 
effective against indoor 
biters and also if people 
are inside at peak biting 
times
To help determine control 
methods and communication 
messages
Seasonal density Affects seasonal disease 
patterns
To help determine content of
communication messages and 
timing of control activities
Insecticide susceptibility 
status
Affects choice of 
insecticide
For insecticide procurement
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Operational aspects of mosquito biology and behaviour
For the purposes of vector control, it is important to have a basic under-
standing of:
■• how to identify different types of mosquito;
■• the life-cycle of mosquitoes; 
■• mosquito behaviour; 
■• mosquito insecticide susceptibility.
Types of mosquito
Of approximately 3500 known mosquito species, organized into either 
Anophelinae or Culicinae sub-families, only 40 species of the genus Anoph-
eles are considered important malaria vectors. Of the 420 Anopheles species 
currently identified, some can also transmit filariasis and some arboviruses, 
but these are more commonly transmitted by culicine mosquitoes. 
Table 7.10 provides three main ways to distinguish Anopheles from culi-
cine mosquitoes of medical importance, such as Aedes and Culex. Aedes 
mosquitoes are important vectors of yellow fever and dengue, while some 
Culex species transmit filariasis and Japanese encephalitis.
Table 7.10 Three ways to distinguish anopheline from culicine mosquitoes 
Characteristics Anophelines Culicines
Resting position Normally rest at an angle to the 
surface.
Normally rest with the body 
parallel to the surface.
Wings Appear to have black and white 
spots, because dark and pale wing 
scales are arranged in blocks. 
Do not appear to have black 
and white spots.
Palps in female 
mosquitoes
Are the same length as the 
proboscis.
Are only a third of the length of 
the proboscis.
Mosquito life-cycle
The four main stages in the mosquito life-cycle are egg, larva, pupa and 
adult. The first three stages are aquatic, lasting approximately 5–14 days 
depending on species and ambient temperature. Key differences between 
anopheline and culicine mosquitoes are also indicated below:
■• Egg. Mosquitoes lay eggs on water, in batches of 70–200, every few days. 
Anopheles eggs are about 0.5 mm long and float on the surface of water 
for 2–3 days until they hatch. Unlike Aedes eggs, they cannot survive if 
they dry out.
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■• Larva. Each egg hatches into a larva, which swims and feeds. Anophe-
les larvae float horizontally on the surface of the water, while Aedes and 
Culex larvae hang down into the water with only their breathing tubes 
at the surface. In tropical areas, mosquitoes can complete the larval stage 
in 7 days.
■• Pupa. The larva develops into a comma-shaped pupa, which does not 
feed but comes to the water surface to breathe. This stage lasts 2–3 days.
■• Adult. In most species, the female only produces eggs after feeding on 
blood. A 2–3-day cycle of feeding, resting/developing eggs, and egg-lay-
ing is repeated throughout the adult lifespan of the female mosquito. In 
favourable conditions, this lifespan averages 10–14 days, although some 
live longer. The adult female lifespan is crucial in malaria transmission, 
since it takes at least 10 days for malaria parasites ingested by the mosqui-
to to become infective to humans. Thus, only those infected females who 
live over 10 days will be able to transmit malaria. Factors affecting adult 
lifespan include temperature, humidity, natural enemies, and vector 
control measures. For example, where temperatures exceed 35 °C and 
the humidity is less than 50%, mosquitoes die much sooner. 
Vector control in humanitarian emergencies generally focuses on adult stag-
es, though larval stages may be addressed in specific circumstances. Figure 
7.3 shows differences in each stage of the life cycle of anopheline and culi-
cine mosquitoes.
Mosquito behaviour
Aspects of mosquito behaviour that are particularly relevant for vector con-
trol are: (i) resting location; (ii) feeding time and location; (iii) host prefer-
ence; (iv) flight range; and (v) breeding site preferences.
Resting location – After feeding, a female adult mosquito needs to rest 
while digesting and while developing eggs. Some species rest indoors, 
while others find outdoor resting sites. It is easier to control indoor-rest-
ing vectors with IRS (e.g. IRS is used to control indoor-resting vectors An. 
culicifacies and An. stephensi in the Indian subcontinent and An. gambiae and 
An. funestus in Africa).
Feeding time and location – Most Anopheles feed at night and each spe-
cies has a preferred feeding time. For example, An. farauti in the Solomon 
Islands and An. maculatus in Myanmar usually feed in the early evening as 
soon as it gets dark, while An. gambiae in Africa and An. dirus in South-east 
Asia usually feed late at night. As with resting locations, some mosquitoes 
prefer to feed inside houses and others outside. IRS is more effective for 
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Source: Warrell DA, Gilles HM, eds (2002). Essential malariology, 4th ed. London, Hodder Arnold. Reproduced 
by kind permission of the publisher.
Figure 7.3 Life-cycles of anopheline and culicine mosquitoes
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controlling vectors that feed and/or rest indoors while LLINs can be effec-
tive in controlling vectors that feed outside. 
Host preference – Some anopheline species prefer to feed on humans and 
others on animals, while several species feed on both. Species with a strong 
preference for feeding on humans (e.g. An. gambiae in Africa) tend to be the 
most dangerous vectors because they are the most likely to pick up and pass 
on malaria parasites.
Flight range – Most Anopheles mosquitoes do not fly more than 3 km from 
the breeding site from which they emerged. As such, malaria risk can be 
reduced by siting dwellings more than 3 km from known breeding sites.
Preferred breeding sites – Anopheles mosquitoes have different breeding 
site preferences (i.e. larval habitats), and lay eggs in a wide variety of types 
and sizes of water bodies, depending on individual species.
A source of vector information and identification keys is the US Armed 
Forces Pest Management Board, which publishes information on malaria 
vectors in its disease vector ecology profiles (currently http://www.afpmb.
org/content/disease-vector-ecology-profiles). Tables 7.11–7.14 summarize 
the relevant features of important malaria vectors in Africa, South and 
South-east Asia, and South America. 
Table 7.11 Important malaria vectors in Africa
Anopheles 
species
Resting 
location
Feeding time 
and location
Host 
preferences
Breeding  
sites
An. gambiae Mainly 
inside
Mainly late;
Inside
Mainly human Sunlit temporary 
pools, rice fields.
An. arabiensis Outside 
and inside
Mainly late;
Outside and 
inside
Human and 
animal
Temporary pools, rice 
fields.
An. funestus Inside Mainly late;
Inside
Mainly human Semi-permanent 
and permanent, 
especially with 
vegetation, swamps, 
slow streams, ditch 
edges.
An. melas Outside 
and inside
Mainly late;
Outside and 
inside
Human and 
animal
Saltwater lagoons, 
mangrove swamps.
An. merus Outside 
and inside
Mainly late;
Outside and 
inside
Mainly animal Saltwater lagoons, 
mangrove swamps.
Source: Mehra (1995)
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Table 7.12 Important malaria vectors in South-east Asia (e.g. Myanmar,  
 Thailand, Cambodia, Lao PDR, Viet Nam)
Anopheles 
species
Resting  
location
Feeding time and 
location
Host 
preferences
Breeding  
sites
An. dirus 
complex 
(7 sibling 
species, 
previously 
described as 
An. balaba-
censis)
Mainly 
outside
Mainly late 
(20:00–22:00h);
Outside and inside
Mainly 
human
Small shady pools, 
mainly in forests 
and forest fringe; 
stream seepages, 
footprints, wheel 
ruts, gem pits, 
hollow logs, wells.
An. minimus 
(at least 
2 sibling 
species)
Mainly 
outside but 
adaptable
From early evening 
to early morning;
Mainly outside but 
adaptable
Human and 
animal
Streams in forest/
forest fringe.
An. maculates 
complex 
(8 sibling 
species)
Mainly 
outside
All night (peak 
19:00–24:00h);
Mainly outside
Mainly 
animal 
Sunlit streams, 
ponds, tanks, 
riverbed pools.
An. sundaicus 
(2 sibling 
species)
Outside and 
inside
All night (peak 
20:00–24:00h);
Outside and inside
Human and 
animal
Brackish water 
near coast, 
rock pools, river 
mouths.
Source: Adapted from Meek (1995). 
Table 7.13 Important malaria vectors in South Asia
Anopheles 
species
Resting 
location
Feeding time and 
location
Host 
preferences
Breeding  
sites
An. stephensi Mainly 
inside
Late evening and 
night;
Outside and inside
Mainly 
domestic 
animals  
(e.g. cattle)
Urban: domestic 
water containers, 
construction sites;
Rural: borrow pits, 
river margins, rice 
fields.
An. culicifacies 
(at least 
5 sibling 
species)
Mainly 
inside
Late evening and 
night;
Outside and inside
Mainly 
domestic 
animals  
(e.g. cattle)
Clean water, river 
margins, rice 
fields, pits, pools.
Source: WHO (2005)
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Table 7.14 Important malaria vectors in South America
Anopheles 
species
Resting 
location
Feeding time 
and location
Host 
preferences
Breeding  
sites
An. albimanus 
(Central and 
northern South 
America)
Mainly outside Late evening;
Inside
Mainly 
domestic 
animals (e.g. 
cattle, horses), 
20% human
Stagnant water, 
flooded pasture, 
water with 
25% emergent 
vegetation.
An. darlingi 
(Mexico to 
Brazil)
Outside and 
inside
All night 
(peaks dusk 
and dawn);
Mainly inside
Human Temporary 
freshwater, 
deforestation 
and mining 
areas.
An. aquasalis 
(coastal, from 
Venezuela to 
Brazil)
Outside Late night;
Outside 
Mainly 
domestic 
animals (e.g. 
cattle, horses, 
pigs)
Brackish water, 
mangrove 
swamps, 
temporary 
freshwater.
Source: WHO (2005)
Insecticide susceptibility
Mosquitoes that become resistant to a particular insecticide are less likely 
to be killed by that insecticide. A species of mosquito that is exposed to 
an insecticide for many generations may develop physiological resistance. 
This is an evolutionary process in which mosquitoes that carry genes for 
resistance survive exposure to the insecticide and pass on these genes to the 
next generation. Selection of mosquitoes resistant to DDT was one of the 
reasons for the failure of malaria eradication efforts in the 1950s and 1960s. 
The evolution of insecticide resistance does not necessarily mean that the 
insecticide no longer controls malaria. If only a small proportion of mos-
quitoes carry the resistance gene or if it is a weak resistance, the insecticide 
may continue to kill mosquitoes before they become old enough to transmit 
malaria parasites. 
The primary malaria prevention tools, LLINs and IRS, remain highly 
effective in most settings. However, insecticide resistance among malaria 
vectors has been identified in 64 countries with ongoing malaria transmis-
sion, with resistance detected to all four classes of insecticide used in public 
health (organochlorines, organophosphates, carbamates, pyrethroids). For 
example, IRS with pyrethroids showed reduced effectiveness against resist-
ant An. funestus in South Africa and An. gambiae in Equatorial Guinea (Bioko 
Island), necessitating a switch to IRS with non-pyrethroids. Evidence from 
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some countries in West Africa indicates that less intact LLINs may be less 
protective against pyrethroid-resistant An. gambiae in selected areas (Asidi 
et al., 2012).
 An important driver of increasing resistance is over-reliance globally on 
pyrethroids for vector control. Pyrethroids are the most commonly used 
insecticides in endemic regions as they are relatively inexpensive, long-last-
ing, effective at both repelling and killing mosquitoes, and safe for humans. 
All currently-approved LLINs are treated with pyrethroids, and many IRS 
programmes still rely on them – despite WHO recommendations that the 
use of pyrethroid IRS be discontinued where LLINs are widely used. Agri-
cultural applications in some areas may also have contributed to resistance. 
The WHOPES and the Global Malaria Programme websites are a good 
source of updated information on appropriate insecticides for malaria con-
trol and in relation to insecticide resistance management. 
Resistance management 
All vector control programmes should incorporate insecticide resistance 
management policies and activities at onset, rather than after resistance has 
appeared or grown. The Global Plan for Insecticide Resistance Manage-
ment in Malaria Vectors (GPIRM) (WHO, 2012a) provides a framework for 
insecticide resistance monitoring and management at global and national 
levels, for implementation in both stable national programmes and emer-
gency settings – http://www.who.int/malaria/publications/atoz/gpirm/
en/index.html Several insecticide resistance management strategies exist 
for vector control using LLINs and IRS, including:
■• rotation of IRS insecticides (e.g. as a minimum strategy, this means 
regularly alternating between insecticide classes with different modes 
of action – changing from one pyrethroid to another is not rotation. A 
pyrethroid may be used as one rotation element, except where there is 
high LLIN coverage);
■• combination interventions (e.g. the combination of LLINs with non-py-
rethroid IRS);
■• mosaic spraying (e.g. using different insecticides in proximity – like tiles 
on a mosaic).
The GPIRM recommends pre-emptive rotation for IRS, and case-by-case 
consideration of focal non-pyrethroid IRS combinations in resistance hot-
spots where LLINs are used extensively. 
Resistance monitoring requires much greater attention and resources 
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today than in the past. Ideally resistance data should be collected from sev-
eral locations once a year and tracked not only with conventional bioassays, 
but also with molecular genotyping methods. This requires expertise that is 
rarely possible in emergencies, but it is desirable to involve national control 
programmes in data gathering and to share information with them.
In humanitarian programmes where LLINs are to be used, it is very use-
ful to confirm local insecticide susceptibility. Even in countries with high 
levels of resistance, LLIN usage can provide mechanical personal protec-
tion effect. If IRS is to be used, it is mandatory to do susceptibility monitor-
ing. If the insecticide used in IRS is no longer achieving the level of malaria 
control it previously did, it should be changed. As the alternatives to pyre-
throids tend to be more toxic, their application requires better protective 
materials for spray teams.
Before procuring insecticide, funding agencies should seek advice on 
local insecticide resistance or take steps to have it measured or monitored 
by a national control programme or research organization. Updated WHO 
recommendations on resistance testing methods, and on the collation and 
interpretation of such data, will be released in early 2013. The impact of 
resistance on the effectiveness of vector control is a key question. Monitor-
ing schemes can help to show whether vector control operations have less 
impact in areas with relatively high levels of resistance. Establishment of a 
global database on resistance is planned by the GPIRM. Until then, control 
programme data, the African Network on Vector Resistance (ANVR), and 
other sources should be consulted.
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Community participation 
This chapter: 
■■ outlines principles and key messages for community participation 
and health communication related to malaria control in humanitarian 
emergencies
■■ describes how to involve communities in malaria control and health 
education 
■■ identifies issues to consider when planning and implementing health 
communications related to malaria control. 
Principles for community participation
Background 
Community participation and health education are often seen as being of 
low priority in humanitarian emergencies. In conflict-affected areas, reach-
ing populations – especially IDPs – poses multiple challenges, including 
access to those displaced and security threats. Despite this, community par-
ticipation and health education are essential to the success of malaria con-
trol interventions in emergencies (see Table 8.1). Health education has been 
defined by WHO as “…any combination of learning experiences designed 
to help individuals and communities improve their health, by increasing 
their knowledge or influencing their attitudes.” Health education can be 
conducted at any point during an emergency, directed at either individuals 
or communities. Communities provide front-line protection from malaria 
during an emergency because: 
■• local knowledge of local risks ensures that the actual needs of the com-
munity are addressed;
■• local actions prevent risks at the source, by avoiding exposure to local 
hazards;
■• a prepared, active and well-organized community can reduce both risks 
and impact of emergencies;
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■• many lives can be saved in the first hours after an emergency before 
external help arrives (Global Health Workforce Alliance 2011).
A well-prepared community can prevent excess illness and death from 
malaria when an emergency occurs and can prevent outbreaks of malaria 
when detection, prevention, and treatment systems have been disrupted or 
populations are mobile. Successful prevention and preparedness requires 
the active involvement of communities in malaria control programmes and 
that behaviour and social-change programmes are in place before an emer-
gency occurs. After the onset of an emergency, key messages and risk com-
munication strategies need to be ready for rapid implementation. 
Guiding principles for effective education participation and malaria-re-
lated health communication during emergencies are to: (i) establish mech-
anisms that promote good communication and enable representatives of 
the displaced or affected population, the host population, and local and 
international emergency partners to participate in malaria control; (ii) 
implement key messages that stress preventive strategies, how to identify 
malaria, and need for prompt diagnostic testing, complete treatment, and 
supportive care.
Key messages 
Work with existing messages and communication strategies – Education target-
ing malaria-specific risk communication and behaviour and social change 
should be integrated into an overall health communications strategy devel-
oped and adapted to local settings as part of regular malaria control efforts, 
particularly in malaria-endemic or epidemic-prone areas. It is important not 
to disrupt this system during an emergency but to continue and extend it to 
the affected areas. The messages below are examples of key messages during 
any emergency.
Key message 1: Know the disease
■• Malaria is transmitted through the bites of some mosquitoes;
■• Malaria frequently causes fever; 
■• Wherever malaria is present, children and pregnant women are in par-
ticular danger;
■• In an emergency, malaria prevention and treatment programmes can be 
disrupted and families and communities need to know what to do. 
Rationale: Community members, especially caregivers, should be informed 
about malaria (e.g. how it is transmitted, symptoms of the disease, how to 
prevent it, what to do if someone becomes ill with fever). Communities and 
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families have a right to information about potential changes in programmes 
during emergencies, about how to continue to access care and prevention, 
and about how to prepare for increased risks. Intended behaviour outcomes 
include:
■• consulting with community health workers (CHWs) on basic informa-
tion about malaria and how it can affect family members, especially chil-
dren and pregnant women;
■• consulting with CHWs about how the family can prepare for possible 
emergencies, including how to access care during malaria outbreaks and 
what the role of family members may be.
Key message 2: Recognize danger signs and seek prompt care 
Rationale: People in the community, especially caregivers, should know the 
danger signs of malaria. It is important to be able to identify children and 
other community members who require immediate medical attention and 
need to be taken to health facilities. During epidemics, all persons regard-
less of age are often at risk, especially in settings where malaria was previ-
ously absent or infrequent. However, children and pregnant women should 
be prioritized for care in most settings as they are likely to suffer adverse out-
comes from malaria more quickly. Intended behaviour outcomes include: 
■• families learn malaria danger signs from the health care worker;
■• families take the sick family member to a health care provider for imme-
diate care and follow the advice of the health worker;
■• families prioritize care seeking for children and pregnant women. 
Key message 3: Malaria is preventable
Rationale: Sleeping under an LLIN is the best way to prevent mosquito 
bites during the night. Since children and pregnant women are at most risk 
of severe illness and death from malaria, they should be given priority in 
sleeping under LLINs if there are not enough LLINs for everyone. In mod-
erate-to-high-transmission areas in Africa, pregnant women can help pro-
tect themselves by taking IPTp. Intended behaviour outcomes include: 
■• everyone should sleep under an insecticide-treated bednet, preferably an 
LLIN every night – even when they don’t see or hear mosquitoes around;
■• if there are not enough LLINs, then preference should be given to chil-
dren and pregnant women; 
■• pregnant women should take IPTp, where recommended by health 
workers, and sleep under an LLIN.
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Key message 4: Malaria is treatable and you can learn to care for family members 
sick with fever 
Rationale: A child suffering or recovering from malaria needs plenty of 
liquids and food. Preventing dehydration and ensuring continued and 
adequate nutrition are key practices that contribute to limiting severe com-
plications and death from common childhood illnesses such as malaria. 
When a child is sick, families should be encouraged to feed and offer addi-
tional fluids. This should include continued and increased breastfeeding.
A child with a fever should be examined immediately by a trained health 
worker and receive appropriate antimalarial treatment as soon as possible if 
diagnosed with malaria. Intended behaviour outcomes include: 
■• mothers continue breastfeeding sick babies and increase frequency or 
duration of feedings;
■• families continue to feed the sick person and provide additional fluids 
for non-nursing children, such as clean water, soups, broths, teas, fruit 
juices.
Involving communities
Community involvement and effective health education and communica-
tion play a critical role in both treatment-seeking and malaria prevention. 
Table 8.1 provides some benefits of community participation.
Table 8.1 Community participation and health education in malaria control 
Malaria treatment-seeking 
Community understanding and action influence the effectiveness of case management. 
One of the reasons for high malaria mortality in both emergency and non-emergency 
situations is late presentation of cases to, or failure to seek treatment from, health 
facilities. Communities need to be able to recognize the signs of malaria illness and 
seek diagnostic testing and effective treatment promptly.
Malaria prevention 
Community understanding and action also influence the effectiveness of most 
prevention methods. For example, communities need to know why the use of LLINs 
is important and why young children and pregnant women are particularly vulnerable 
and should be prioritized to sleep under LLINs when adequate supplies for universal 
coverage are not available. Community cooperation is essential for the success of IRS. 
Identifying and coordinating with partners
During an emergency, it is important to coordinate with other partners 
working on community-based programmes and communication strategies. 
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Although malaria is a specific topic, education messages and strategies will 
be rolled out through inclusive, multi-disciplinary social mobilization pro-
grammes and other channels such as the media. Key messages for malaria 
and mobilization of communities should be coordinated through a specific 
social mobilization working group under the overall health sector/cluster 
coordination mechanism. This group will help define the messages and the 
strategies for dissemination. 
It is essential to remember that affected communities are vital partners 
to include when identifying priority needs and interventions to address 
those needs. Communication with the affected communities assures that 
priorities are jointly set and helps the affected population feel more in con-
trol of their situation. Not including affected communities as partners risks 
malaria-control interventions not being supported or not being recognized 
as important. Community involvement ensures that malaria control activ-
ities and communication strategies are socially and culturally appropriate. 
Messages can be brought to communities through a variety of interper-
sonal and media mechanisms used in risk communications, aimed at rapid 
dissemination of urgent information, and longer-term behaviour change 
communications strategies. The International Federation of Red Cross and 
Red Crescent Societies (IFRC) and UNICEF are international agencies with 
particular expertise in risk and behaviour change communications during 
emergencies.
Risk communication
Risk communication is an interactive process of exchanging information 
and perceptions on risk among assessors/evaluators, implementers, and 
other interested parties (e.g. affected communities) and is an integral part of 
risk assessment. It can be used in malaria control in emergencies, for exam-
ple, to inform communities of outbreak risks, of where to seek treatment if 
routine services have been disrupted, or of how to report a problem that 
they have observed.
Behaviour change communication (BCC) 
BCC is most commonly used during the post-acute stabilization phase and 
during chronic emergencies. It is an approach defined as the strategic use of 
communication to promote positive health outcomes, based on established 
theoretical models of behaviour change. BCC employs a systematic process 
beginning with formative research and behaviour analysis, communication 
planning, implementation, monitoring, and evaluation. Key features are:
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■• inclusion of both children and adults; 
■• sharing of relevant and action-oriented information;
■• using a consultative process among technical experts, community mem-
bers, local change agents, and communication specialists (UNICEF-RO-
SA, 2006). 
BCC can be used in malaria control, for example, to encourage appropri-
ate use of LLINs, compliance with antimalarial drug regimens, or increase 
participation in IRS campaigns (Mushi et al, 2008; Panter-Brick, et al, 
2006). Information, education, and communication (IEC), which focuses 
on knowledge change, can be combined with more participatory BCC to 
enhance communication with affected communities. 
Two recent projects that have used BCC to increase involvement in 
malaria control activities in the context of emergency settings are (i) the 
Health Initiative in the Private Sector Project (HIPS) working with IDPs in 
northern Uganda, and (ii) the Liberia Rebuilding Basic Health Services (RBHS) 
Project. Applying lessons learnt from such projects that have used BCC in 
malaria control will increase the likelihood of successful implementation. 
These lessons include: 
■• reinforce messages multiple times with both interpersonal and commu-
nity support; 
■• obtain financial and political support; 
■• focus on positive outcome expectations that are relevant to the target 
audience; 
■• provide messages in simple formats that are repeated in many different 
ways and contexts; 
■• address situational constraints that might affect people’s abilities to 
change;
■• develop new skills in the targeted audience (Malaria Consortium, 2009; 
Panter-Brick et al, 2006). 
The first example in Box 8.1 illustrates the importance of giving community 
leaders an opportunity to express their concerns and be understood. 
Box 8.2 offers an example of adapting symptom control measures to 
local belief systems to improve their acceptability. 
Understanding communities
To strengthen communication with affected communities, develop appro-
priate communication strategies, and increase positive behaviour, it is 
necessary to understand what might influence behaviours. In emergency 
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contexts, ‘community’ may involve those displaced, host communities, and 
the humanitarian community as these all interact with one another in meet-
ing health needs.
Social factors (e.g. structures, organization) and cultural factors (e.g. 
language, beliefs, common behaviours) play an important role in malaria 
control during emergencies. To promote effective community participation 
it is helpful to learn about social and cultural contexts within displaced and 
host communities. Displaced populations may not share the same culture 
as host communities. Within displaced communities, there may be differ-
ing ethnicities, values, and priorities represented. Within the humanitarian 
community, different organizations – UN, bilateral and government agen-
cies, international and local NGOs – may share many values and beliefs but 
will also have different organizational cultures and priorities. Successful 
coordination depends on recognizing and working with these differences. 
For both displaced and host populations, it is essential to identify how 
social organization has been changed by the emergency and how social 
structures similar to those pre-existing the emergency can redevelop as 
quickly as possible. It is particularly important to: 
Box 8.1 Importance of communicating and listening to community concerns 
In an African refugee camp, antimalarial drug efficacy studies were planned 
for children under 5 years of age. To ensure that this was acceptable to the 
community, meetings were held with camp officials, CHWs and refugee leaders 
prior to initiating the drug studies. One of the major concerns voiced by the 
community was why the studies only included children younger than 5 years 
of age when adults were also suffering from malaria. Once it was clarified that 
children are particularly vulnerable to malaria and that appropriate treatment 
for children would also benefit the adult population, community leaders agreed 
to support the research, and messages were sent out to the residential blocks 
encouraging people to participate if asked. 
Box 8.2 Importance of understanding local context 
Refugees from Angola have been settling in the north-west border area of 
Zambia since the late 1960s. Because both the displaced and host populations 
believed that people with fever should not drink water, promotion of hydration 
in people with febrile illness, particularly children, was failing. However, when 
food colouring and sugar were added to the water and the resulting solution 
was described as medicinal, hydration with this solution became acceptable.
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■• ask about social organization, the roles played by different groups and 
individuals, and who influences attitudes and behaviours. Learning how 
residential units are organized will provide information about the social 
structure and any political divisions that might affect implementation of 
control activities; 
■• be sensitive to people’s need to regain control, self-determination, and a 
sense of meaning in their lives. 
■• identify all vulnerable groups – not only those that are physiologically 
vulnerable (e.g. pregnant women and young children) but those that 
may be vulnerable for political, ethnic, social or cultural reasons. For 
example, minority ethnic groups may be politically vulnerable and so 
unable to access health facilities or to participate fully in community edu-
cation or prevention activities. 
Table 8.2 Potential roles of community organizations after crisis
Type of 
organization
Example organizations 
and networks 
Potential role after  
crisis/displacement
Formal Government services 
(e.g. health, welfare, 
education, justice)
May be absent, run by non-state (NGO, 
opposition) agencies, and/or focused on 
religious or other groups.
UN and donor support Will change over time, with different 
agencies leading (e.g. cluster approach).
Semi-formal Religious organizations Religious leaders and organizations may 
be significantly involved throughout all 
phases of a crisis.
Political organizations Political organizations may focus primarily 
on national influence or become more 
active in later phases.
Opinion leaders These may be formal or informal; 
community health workers or midwives 
may play this role. 
Informal/Social Family networks May be absent or widely dispersed and 
need to be rebuilt. 
Social networks Existing networks may be strengthened 
or weakened; ad-hoc networks may form 
through shared displacement or other 
experiences.
Source: Adapted by N Howard from Person & Cotton (1996)
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Working with communities to identify priority needs and activities 
Involving communities in defining priority needs and activities (see Table 
8.3) can improve the effectiveness of malaria control activities. Malaria 
control priorities should be based on community needs and perspectives, 
but will also depend on resources available to agencies and on what can be 
achieved. Given the limited resources often available in emergencies, it is 
important to think creatively with the community to determine the best 
ways to link malaria control activities with other public health interven-
tions. For example, UNICEF has implemented LLIN distribution during 
routine ANC visits, child immunization campaigns, and child health days. 
In the acute phase of an emergency, however, health professionals often 
determine immediate needs (e.g. dealing with a malaria outbreak). Once 
the situation stabilizes, community priorities and activities (e.g. preven-
tion) can receive more attention. 
Table 8.3 Involving the community 
• Find out how to show respect to community leaders. 
• Listen to the concerns of displaced and host populations. 
• Allow community representatives to define their own concerns and priorities 
first. This is important because people in some cultures will agree with those they 
perceive to be more powerful, even if they do not support what is being said. As 
such, community agreement to proposals from international agencies may not 
reflect the community’s actual concerns and priorities. 
• Define together the problems, causes and possible solutions. 
• Involve community representatives in planning and implementing qualitative 
research to gather information and to analyse the data collected. 
• Relate malaria control activities to local ideas about cause, symptoms and cure. If 
feasible, involve traditional healers in case management and referral. 
• Provide clear information about how and where malaria control activities will 
take place (e.g. specify the location of clinics and outreach centres and the timing 
and location of spraying and LLIN distribution). If possible, involve community 
representatives in conducting prevention measures such as house spraying (IRS) 
and LLIN distribution. 
• Be sensitive to gender and ethnicity. Community leaders may not represent 
the views of women, the most vulnerable, or minority groups. Try to include 
representatives from these groups (e.g. link malaria control to the activities of 
women’s groups or programmes that target women).
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Involving communities in information collection
Individuals recruited from the displaced population can help collect infor-
mation about the community and priorities. As members of the affected 
population, they can facilitate communication and provide useful detail 
(e.g. about community leadership, structure, politics). Initial contact will 
often be with the most educated and influential people, and additional 
information is needed from other subgroups that may not be represented 
by community leaders. 
One way to learn about the community and identify vulnerable sub-
groups is to walk through the resettlement areas with community members. 
■• Walk with trusted volunteers identified by CHWs. If you walk with the 
most visible or important leaders, community members may be reluctant 
to voice concerns in front of these leaders or to reveal what is happening 
in their residences. 
■• Conduct walks at randomly chosen times of day, on several different 
days and in different areas. 
■• Make visits a surprise so that people will be engaged in typical daily activ-
ities rather than preparing for a “guest.” However, if an unannounced 
visit violates cultural ideas of politeness or poses a security risk, com-
munity leaders should be alerted about the timing and purpose of visits. 
■• Hold informal conversations with community members during the 
walk. Ask them about the community. Who is in need of what services? 
Who has been sick recently? Who is frequently sick? This approach will 
help to provide information about community dynamics, which some 
leaders may be reluctant to discuss.
■• If possible, take notes as you walk, recording what you observe as well as 
what people tell you. 
To identify priorities, it is essential to collect community answers to the fol-
lowing questions: 
■• What is the community’s previous experience with malaria control activ-
ities? 
■• What malaria control activities are in place? 
■• What do local people think and do about febrile illnesses, including 
malaria? 
■• What local words and terms are used to describe malaria? 
■• What does the community believe about the causes, symptoms and treat-
ment of malaria? 
■• What sources of information are used and trusted by the community? 
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Table 8.4 Qualitative methods 
Individual interviews
These are guided by a mixture of structured and open-ended questions to explore 
topics related to malaria control. Interviewees can either be selected purposively 
(e.g. as key informants, community leaders or health workers) or selected randomly. 
An advantage of individual interviews is that questions can be flexibly structured and 
topics raised by the interviewee can be pursued. 
Focus group discussions (FGDs)
These involve discussions with groups of 8–15 people with similar backgrounds. A 
facilitator guides the discussion using a checklist of topics. A second person records 
what participants say and notes how they interact. FGDs are a useful initial method 
for determining what topics are important to people and can also be used to clarify or 
check information collected during individual interviews. 
Free listing
Participants are asked to list as many different aspects as possible of the topic of 
interest e.g. “What methods are used in this community to prevent malaria?” This can 
generate a wealth of information that can be used to develop questions for interviews, 
topics for FGDs, and guide the design of malaria control interventions. An advantage of 
free listing is that it provides a large amount of information in a short time period and 
can be conducted as a game. 
Pile sorting
Individually or in groups, participants are asked to sort the issues they have listed into 
categories (e.g. asking them to sort a list of malaria treatments into logical categories 
may provide information about local remedies for different types of malaria). Thus the 
information identified through free listing can be used to find out how people perceive 
and make sense of various issues, which can feed into the design of interventions. 
Mapping
Uses maps drawn by community members to show different community features, such 
as where clinics are located or where malaria is a particular problem. Mapping provides 
useful information about community perspectives. 
Venn diagrams 
These are developed in participation with community members to illustrate how groups 
and individuals in the community interact with each other (e.g. degree of cooperation 
or influence, potential roles). Diagrams are developed by listing community groups 
and key individuals and drawing different sized circles to represent each, with circle 
size indicating decision-making importance, distance between circles indicating 
degree of contact, and overlap indicating level of interaction (e.g. large overlap for 
high interaction). This can help identify who might support or oppose malaria control 
activities.
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■• When and where do people seek treatment for malaria? 
■• What does the community do to prevent malaria? 
■• What are the community’s priorities for malaria control? 
■• What factors would encourage the community to take prevention meas-
ures and to seek treatment? 
■• What factors might stop the community from taking prevention meas-
ures or seeking treatment? 
This information can be collected qualitatively. Table 8.4 summarizes dif-
ferent qualitative methods. Ideally, a social scientist should help design 
qualitative research tools and collect information. Local expertise can also 
be consulted. If time and resources are limited, rapid assessment techniques 
can be used to collect information. Annex IX includes examples of ques-
tions to guide development of malaria control activities. 
Using qualitative research approaches to working with and learning 
from communities can be daunting for humanitarian workers who have not 
previously used these methods. Table 8.5 offers reflections that may help in 
developing a rapport with communities. 
Involving the community in implementation 
The affected community is a partner, not the target, during control activ-
ities. Individuals who are known and trusted in the community must be 
involved in implementation. Consider how a cadre of community “activ-
ists” can be developed and how community organizations (e.g. women’s 
groups, centres of worship) can be used to mobilize others to participate in 
malaria control activities. 
A joint agency statement on the importance of scaling up a communi-
ty-based health workforce for emergencies, released in October 2011 and 
endorsed by the humanitarian community (Global Health Workforce Alli-
ance et al, 2011), illustrates the critical role of community involvement and 
outlines the roles of CHWs in all aspects of public health, including malaria 
control. Community members and CHWs often already play an important 
role in a range of malaria control activities, working to detect malaria with 
RDTs, providing treatment, identifying danger signs and referring severe 
cases to health centres, as well as delivering LLINs and health communica-
tion messages. Opportunities for case management include:
■• integrating traditional healers into some health clinics (see Box 8.3);
■• training community members as peer role models to improve the process 
of giving antimalarials to small children (see Box 8.4).
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Box 8.3 Involving traditional healers in case management in Cambodia 
In the paediatric ward of a large refugee camp on the Cambodia-Thailand 
border, traditional healers (Kru Khmer) were encouraged to work alongside 
health workers. Ward rounds included both clinical staff and Kru Khmer. 
Families liked this approach and the Kru Khmer provided valuable inputs into 
clinical decisions. Together, clinical staff and the Kru Khmer were able to 
provide complementary care, rather than competing treatment options. For 
example, a child might receive standard treatment for malaria along with a 
herbal drink or massage from a traditional healer. The Kru Khmer appreciated 
the recognition of their role and the health workers appreciated the cultural 
knowledge of the traditional healers. 
Table 8.5 Reflections on ‘lessons learnt’ from fieldwork
Do your homework before going to the field (e.g. relevant terms and acronyms, 
political/administrative divisions). Once you are on the ground, you will receive a lot 
of information quickly. The more you understand during data collection, the easier it 
will be for you to ask relevant follow-up questions.
Choose key informants wisely. Political leaders may not be the most knowledgeable 
or represent all segments of society (e.g. district-level officials may be politically 
appointed, may not be local, and may not understand the nuances of the communities 
that they serve).
Learn what is and what is not culturally appropriate, and act accordingly. 
Your behaviour should reflect local culture, including clothes, eating, greeting, body 
language, and the way in which you sit during an interview (e.g. level relative to 
others, not showing the soles of your shoes). Greet people with respect and humility. 
If possible, learn greetings and words of respect in the local language. These practices 
are not only polite, they may also help community members feel more comfortable 
sharing their thoughts with you.
Be sensitive in your use of technology. Use of items such as laptops, tablets, and 
smartphones can distance you from communities who are not accustomed to them. It 
may also attract unwanted attention, frighten people, and compromise your safety in 
the field.
Expect the unexpected, and make the best of unplanned disruptions to field 
work. Even during displacement, community members may be busy attending to tasks 
of daily living, such as finding firewood. It can be frustrating when you are scheduled to 
meet with the community and few or no people show up. Rather than being frustrated, 
use the unexpected free time to speak with your local staff or community members 
who are present, to plan additional work, or simply to rest.
Keep eyes and ears open, even when your notebook is closed. Some of your most 
profound insights about the community of interest will occur at unexpected moments 
– with a driver in transit to a research site, with staff over lunch, or with a fruit vendor 
after work.
Source: adapted from Becknell (2012). 
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Box 8.4 Caregivers as peer role models 
One of the unexpected benefits of a drug efficacy trial in a refugee camp in 
the United Republic of Tanzania was the emergence of caregivers as peer 
role models for the rest of the community. Those caring for children enrolled 
in the trial learnt how administer antimalarial drugs properly. They were able 
to watch the team members administer the drugs used in the trial and ask 
questions about what they were doing. This provided an excellent opportunity 
to teach caregivers – mothers, fathers, older siblings and grandparents – safer 
techniques for holding children while giving medication, different ways to 
give the drugs (e.g. crushing tablets to mix with liquid in a bottle or with a 
spoon), and what to do if a child vomited the drug shortly after administration. 
Caregivers said that, because regular health workers were often too busy to 
offer these explanations, they had not always known what to do with a child 
who refused to take medication or had vomited. Now that they knew what to 
do and they planned to share this knowledge with their family, friends, and 
neighbours. 
Opportunities for prevention include:
■• training community members as community health educators (see Box 
8.5);
■• employing community members to distribute or repair LLINs, or to 
serve on IRS spray teams. 
Box 8.5 Training community health educators in malaria prevention in  
 refugee camps on the Myanmar–Thailand border 
NGOs trained members of local ethnic minority groups as community health 
educators in refugee camps along the Myanmar–Thailand border. During the 
mid-1990s, previously stable camp populations were relocated due to shelling 
and border incursions. Community health educators ensured the continuity of 
malaria control activities. As the population moved to a new site, educators 
were able to go from tent to tent and provide essential services including: 
(a) information about the new location of health services and general health 
messages; (b) active case detection for presumed cases of malaria and other 
common illnesses; and (c) education in the correct use of insecticide-treated 
nets. Because they belonged to the same ethnic group as the displaced 
population, community educators were able to bridge the gap between 
refugees and the agencies working in malaria control. This was particularly 
important for some of the more isolated ethnic groups who had little previous 
exposure to, or knowledge of, this kind of health care. 
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Opportunities for research include training local health workers to inter-
pret the routine information they collect to help in designing malaria con-
trol interventions (see Box 8.6).
 
Box 8.6 Training community health workers 
In settlements along the Myanmar-Thailand border, NGOs trained community 
health workers to interpret the routine data that they were collecting, and to 
increase their understanding of how this information could be used to design 
malaria control activities. This method, called community-oriented primary 
care, combined elements of primary health care, public health and community 
mobilization. Meetings and workshops were held on a regular basis to provide 
training for CHWs and to review data collection and analysis, implementation, 
monitoring and evaluation. 
Many community approaches will have originally been used in stable situ-
ations, and adjustments to commonly applied interventions may be neces-
sary, depending on the current level of security, the relationship between 
displaced and host communities, and the length of stay in the host commu-
nity. To improve the success of these interventions it is important to stress 
the following: 
■• conduct thorough and repeated trainings;
■• institute field supervision;
■• use multiple methods to stress key points;
■• ensure adequate supplies for interventions (e.g. reliable antimalarial sup-
plies);
■• understand the context in which interventions are applied and how that 
context might affect acceptance of the intervention (Atkinson, et al., 
2011). 
There is limited evidence to support the assumption that community partic-
ipation contributes to reductions in disease transmission (Atkinson, 2011). 
Recognizing this, operational research on common community-based 
malaria control interventions in emergency settings is needed to determine 
whether these efforts affect disease transmission in the context of displace-
ment. 
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Health communication in malaria control 
Establishing priorities 
The goal of health communication (e.g. risk communication, health educa-
tion, BCC) should be to inform populations at risk about behaviour changes 
that could reduce their risk of malaria infection and improve their manage-
ment of malaria illness. Health communication should address specifically 
the concerns identified by displaced and host communities, in addition to: 
■• causes of malaria and the role of mosquitoes in transmission;
■• groups that are particularly vulnerable to malaria;
■• differences between uncomplicated and severe malaria;
■• diagnosis and treatment of malaria, including the importance of diag-
nostic testing;
■• location and opening hours of health services;
■• danger signs for severe malaria that mean a patient should go back to the 
clinic;
■• measures that can be taken to protect against mosquito bites, including 
use of LLINs and other forms of personal protection. 
The emphasis placed on each of these points will depend on the phase of the 
emergency. In the first few days of the acute phase, it is essential that people 
know both how to recognize the signs of severe malaria and where and how 
to access care. As an emergency evolves and the situation stabilizes, more 
attention will be given to preventing transmission or sustaining preventive 
measures. 
Emphasis will also depend on the local context. For example, if the dis-
placed population has moved from a non-endemic area to an endemic area, 
information about transmission risk will be important. 
Designing health communication 
In the acute phase of an emergency, with competing urgent priorities, it is 
seldom possible to develop a formal health communications strategy. Dur-
ing this phase, information passed by word of mouth can be a useful way to 
publicize urgent messages in the community. 
In the post-acute phase as the situation stabilizes, a health communica-
tions strategy can be designed and implemented. It is important to invest 
time and resources in doing this with communities, who should be involved 
in designing and pretesting messages and making necessary revisions. Fail-
ing to do this can waste limited time and resources, producing ineffective 
messages and materials. 
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Health communication should focus on learning (not teaching), active 
participation, action, and behaviour change. The principles of successful 
health communication include: 
■• Define objectives – for example, the desired improvement in knowledge, 
change in behaviour, or change in attitude; 
■• Identify the target audience – for example, pregnant women, parents of 
young children, community leaders, traditional healers, drug sellers;
■• Develop clear messages – in such a way that the target audience can under-
stand them; 
■• Provide information about what people can do – for example, where they can 
get LLINs or when to seek treatment – with a limited number of clear, 
simple messages, such as “prompt treatment for fever saves lives”, repeat-
ed in different ways;
■• Use methods that are culturally acceptable – and appropriate for the target 
audience; 
■• Deliver messages through trusted and respected individuals and channels; 
■• Provide training and materials – to those who will conduct health commu-
nication (e.g. community educators, health workers, traditional healers). 
Effective health communication depends, in part, on understanding aspects 
of the community being targeted. Specific information from the targeted 
community, such as knowing where and how people expect to receive 
important information, will help to inform decisions about the design of 
communication materials (see Table 8.6). 
Visual messages should be clear enough that anyone, including children 
and people who speak other languages, can understand what they are try-
ing to convey. Written messages should be short, simple, fun, and written 
in a way that catches the interest of the intended audience. The primary 
communication objective should be identified and the message focused on 
communicating that idea. The essence of the message should be delivered 
through a ‘SOCO,’ or single, over-riding communication objective.
Implementing health communication 
During emergencies, it is important to plan the timing of health communi-
cation activities carefully:
■• Avoid days or times when other activities are taking place (e.g. rations are 
being distributed, cultural or religious events); 
■• Take advantage of occasions when people are already meeting together, 
for example, meetings with block or camp leaders; 
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Table 8.6 Communication channels, messages and methods 
Channels
Effective delivery of health communication messages depends on choosing 
communication channels appropriate to the community’s culture, knowledge, 
beliefs, values, and literacy level. In some cultures, community leaders and elders 
may be the best people to transmit messages, while in others, teachers, health 
workers or the media may have more credibility. Messages can be relayed through 
community workers, such as those who dig latrines or do manual tasks. Other possible 
dissemination channels include: 
• camp management meetings; 
• health and water coordination meetings; 
• health facilities; 
• community health programmes, such as vaccination campaigns; 
• central message boards, particularly in transit areas. 
Messages 
The following principles should govern the development of messages: 
• target the message to the lowest level of literacy;
• explain what people are expected to do and the expected outcomes from their 
behaviours;
• ensure that messages are realistic and feasible;
• understand local behaviours;
• use local language for the messages;
• ensure that messages are culturally acceptable;
• change messages as the situation changes;
• use creative approaches in the messages: for example, promoting LLINs may be 
more successful if the messages describe the nets as a way of “preventing nuisance 
insects from disturbing your sleep”, as well as a way to prevent malaria.
Methods 
Methods must be appropriate for the setting. Printed messages are fine for literate 
populations, but oral and visual methods will be better for conveying messages to 
mixed-literacy populations. In most situations, it is useful to use a mixture of methods. 
Possible methods include: 
• Print – posters, flipcharts and picture guides can combine words and pictures. 
Posters should be displayed in places where people will see them (e.g. clinics, 
registration centres). Flipcharts and picture guides are useful for face-to-face teaching 
(e.g. about how to give an antimalarial drug to a young child). 
• Oral – talks, person-to-person communication, songs, poetry and informal 
conversations (e.g. to religious or women’s groups or at times when people are 
waiting at the clinic). 
• Visual – drama, role-play, dance, demonstrations. Drama and similar methods use 
stories to get across messages. Demonstrations are a useful way to show people how 
to do something, for example how to use a treated net.
• Broadcast media – public broadcasting or radio. Public announcements through 
loudspeakers or megaphones can be especially useful in the acute phase of an 
emergency when people are still arriving.
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■• Alert the community in advance about campaigns or activities (e.g. IRS 
or distribution of LLINs during immunization campaigns);
■• Use opportunities to target specific groups (e.g. pregnant women, moth-
ers of young children). In many emergencies, women spend time waiting 
in outpatient clinics or at supplementary feeding centres. This time can 
be used for health communication about malaria (e.g. what to do when 
a child has fever). Men also bring sick children to clinics and should not 
be ignored. 
Monitoring and evaluation 
As with all aspects of malaria control, community participation and health 
communication activities must be monitored and evaluated to determine 
whether activities have succeeded in changing targeted behaviour. For 
example, it may be necessary to assess whether there have been changes in 
use of individual protection methods – by monitoring and evaluating LLIN 
coverage and proper usage. Alternatively, it may be important to assess 
changes in treatment-seeking and case management – by monitoring and 
evaluating the number of children brought for treatment, treatment com-
pliance, the length of time between initial symptoms and seeking care at a 
health care facility, or the number of return visits. 
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CHAPTER 9
Operational research and 
associated routine monitoring
This chapter:
■■ describes how malaria operational research can help develop more 
effective responses in humanitarian emergencies
■■ identifies priority areas for operational research in humanitarian 
emergencies
■■ outlines planning and design of operational research
Importance of operational research in humanitarian emergencies
The essential interventions for malaria control in acute-phase emergencies 
are increasingly well defined, with malaria case identification and establish-
ment of outbreak early warning systems as clear priorities. The choices of 
optimal preventive interventions, service delivery approaches, and behav-
iour change strategies are less certain and dependent on local context – 
which is why operational research is important. 
Operational research, as defined here, is the search for information on 
strategies, interventions, or technologies that can improve the quality, 
effectiveness, or coverage of the control programme being studied (Zachar-
ia et al. 2012). By addressing practical issues, operational research can guide 
intervention choices during specific emergencies, improving programme 
delivery and uptake by target populations. Additionally, good operational 
research can add to the evidence-base for malaria control programmes in 
humanitarian emergencies. There are many different approaches to malaria 
control, and no approach is 100% effective or appropriate in every situation. 
Thus, the purpose of operational research is to improve control tools, their 
application, and their impact.
Operational research should be distinguished from programmatic mon-
itoring. Monitoring implementation of interventions (such as the extent to 
which patients with malaria are treated with effective antimalarials) and 
factors which may guide implementation of these interventions (such as the 
therapeutic efficacy of antimalarial treatments used) are routine activities 
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for a well-managed malaria control programme. Operational research, in 
contrast, can address questions that arise in implementing an interven-
tion in a specific context, such as identifying factors that influence treat-
ment-seeking behaviour in a given emergency situation. 
In the past decade, there has been increased recognition of the need 
for good-quality operational research in emergencies and of the role that 
research can play in improving malaria control in these settings. Opera-
tional research is no longer seen as the prerogative of external experts but 
is something in which many agencies are actively engaged, in identifying 
locally effective delivery of antimalarial treatments, appropriate prevention 
methods, and cultural and behavioural factors that affect control measures. 
Because emergencies are fluid – moving from acute to early recovery 
or chronic situations – the feasibility and effectiveness of malaria control 
approaches will change as the situation progresses. Operational research 
can identify effective approaches in different phases of an emergency, and 
help guide necessary modifications as the situation changes. It can help in 
assessing the effectiveness of case management and prevention or outbreak 
control. Integration of operational research into normal control activities 
has helped solve malaria control issues arising in refugee settlements during 
the past decades (e.g. Afghanistan, Myanmar, Burundi).
The examples and issues identified in this chapter should encourage 
more agencies working in emergencies to conduct or participate in oper-
ational research and link with public health institutes and researchers 
who are engaged in improving health interventions in emergencies. An 
increasing number of humanitarian agencies now incorporate operational 
research into their relief efforts and have developed strong academic ties 
(e.g. Medecins Sans Frontiers, see http://fieldresearch.msf.org/msf/).
Guiding principles for operational research in humanitarian emergencies
Strict criteria must be met before operational research is conducted in 
humanitarian emergencies (see Table 9.1). As with all health research, the 
rights of individuals and communities must be protected and informed 
consent must be obtained. Approval from an independent and qualified 
ethics committee is necessary, which can be international if an appropriate 
local body is not available. Results must, where possible, be shared with 
stakeholders (e.g. study participants, government, NGOs, UN agencies) 
with the aim of improving local malaria control practices and informing 
necessary policy changes. 
Acute and early recovery phases – when mortality reduction is the priority and 
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resources may be stretched, operational research tends to be an opportun-
istic addition to operational priorities and should be:
■• relevant and focused on local needs;
■• as simple as possible;
■• appropriately timed (e.g. as the situation may change before outcomes 
can be measured);
■• designed to provide practical information to enable agencies to over-
come operational problems and provide better interventions;
■• planned and conducted in coordination with relevant government insti-
tutions (e.g. MOH) where feasible.
Chronic emergencies – where displacement camps and communities remain 
stable for several years, longer-term research is feasible and appropriate. It 
should be conducted as far as possible by local staff, with external support 
as necessary to build local skills.
Table 9.1 Operational research considerations
Relevance
How significant or severe is the problem?
Can it be solved by other means that do not require research?
Avoiding duplication
Has the research already been done somewhere else? 
Was the context comparable?
Feasibility
How adequate are security, expertise, staff, time, and budget?
Support
Does the research have the interest and support of relevant stakeholders (e.g. MOH, 
donor, implementing partners)?
Applicability
Will the findings be applied and necessary resources made available?
Cost-effectiveness
Will the expected results justify the time, money and human resources invested?
What difference will the study make to existing programmes?
Timeliness
Will the findings be available in time to inform decision-making?
Ethics
Is the research ethical?
Will it benefit the individual participants and research subjects?
Can informed consent be obtained?
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Operational research areas
Two important areas of operational research for malaria control in humani-
tarian emergencies are improving the effectiveness of:
■• diagnostic testing and treatment;
■• prevention.
Other important areas include identifying implementation barriers and 
opportunities, social and behavioural constraints or opportunities, service 
delivery strategies, costs and cost-effectiveness of control activities. 
Accurate diagnosis 
Operational research can help assess the effectiveness of malaria diagnosis. 
Prompt and accurate diagnosis is critical but was often difficult in the acute 
phase of emergencies before RDTs became routinely available during the 
last decade. Clinical diagnosis of malaria is inaccurate and unreliable, while 
laboratory confirmation using microscopy is not always feasible in acute-
phase or underfunded chronic emergencies. 
RDTs are now considered an essential tool in non-emergency and emer-
gency settings for diagnostic testing and estimating malaria prevalence. 
Despite the obvious advantages of malaria RDTs over clinical diagnosis, a 
number of operational challenges remain. Some useful operational research 
topics include:
■• Deploying RDTs in emergency settings – If RDTs have not been fully scaled 
up in an area where an emergency is taking place, or if groups providing 
clinical care in the emergency setting have not previously used them on 
a large scale, they will need to be incorporated into clinical care proto-
cols quickly. Previous experience in scaling up RDTs in non-emergency 
settings can be helpful, however, specific questions regarding scaling up 
a new diagnostic test in an emergency setting may need to be addressed 
through operational research.
■• RDT cost-effectiveness – The scale up of RDTs is the priority in acute emer-
gencies. In chronic emergencies, the role of microscopy and the cost-ef-
fectiveness of microscopy versus RDTs may need to be assessed, and 
there may be specific factors that influence the approach taken for the 
provision of diagnostic testing services. For information on collection of 
cost-effectiveness data see the ACT Consortium website (http://www.
actconsortium.org/pages/guidance-notes.html).
■• Community usage of RDTs – The optimal strategy for implementing RDTs 
among CHWs in an emergency setting may vary by setting, and opera-
tional research in this area may help guide programme decisions. 
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■• Clinical management of RDT negative febrile patients – There is growing 
experience in the management of RDT-negative patients with febrile 
illness due to other causes, though there may be factors that are specific 
to their management in emergency settings. How these cases can best be 
diagnosed and treated will vary by location, and operational research 
can help develop guidance on this. 
A range of methods can be used to conduct operational research into RDTs. 
Multidisciplinary approaches are often necessary, including clinical, parasi-
tological, economic and social research. Social research is particularly use-
ful in evaluating behavioural and attitudinal factors, such as how RDTs are 
being used in the field by clinic staff, or how patients and providers respond 
to negative RDT results. 
Effective treatment
Plasmodium resistance to antimalarials as well as treatment provision issues 
(e.g. access to health facilities, treatment-seeking behaviour, adherence to 
treatment, drug quality, and quality of care) have an impact on the effec-
tiveness of malaria treatment. 
Drug resistance – During the last 20 years, resistance to sulfadoxine-py-
rimethamine (SP) has become widespread in Africa and, more alarmingly, 
resistance to artemisinins has emerged in countries in the Greater Mekong 
subregion (Cambodia, Myanmar, Thailand, and Viet Nam as of 2012). The 
choice of antimalarial in the acute phase of an emergency should be guid-
ed by available information on efficacy of antimalarials in the area. Though 
typically considered part of programme monitoring rather than operational 
research, a therapeutic efficacy study may be considered in the acute phase 
of an emergency if clinical treatment failures raise suspicion of decreased 
efficacy of the chosen therapeutic agent. In chronic emergencies, two-year-
ly therapeutic efficacy testing in sentinel sites should be conducted as part 
of programme monitoring activities to ascertain that the chosen antimalar-
ial agent remains effective (see chapter 4). 
 The Global Plan for Artemisinin Resistance Containment (GPARC) describes 
strategies to prevent, contain or eliminate artemisinin resistance through 
stopping its spread, increasing monitoring and surveillance, improving 
access to diagnostics and rational treatment, increasing action and resourc-
es, and investing in related research. GPARC research priorities include 
operational research to improve the field effectiveness of current and new 
tools, interventions and programmes for combating artemisinin resistance. 
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Certain emergency situations may be appropriate settings in which to 
explore some of the operational research priorities described in GPARC.
Treatment provision – Operational social research can help identify both 
the factors that prevent people from receiving effective malaria treatment 
and the changes that are needed in order to improve treatment quality. For 
example, it can help improve treatment access (e.g. by assessing whether 
health facilities are easily accessible and located in appropriate sites, or 
whether socially vulnerable groups have equal access to treatment) and 
treatment-seeking behaviour (e.g. whether people prefer private or public 
sector malaria treatment and why). This type of operational research can 
complement ongoing activities that monitor standards of care, to ensure 
that the quality of treatment provided by MOH, NGO and private health 
facilities is adequate and that health workers adhere to recommended drug 
treatment protocols. Surveys of public and private-sector coverage and pre-
scription practices are recommended in every phase of an emergency. Such 
research, in conjunction with monitoring of quality care provision, and 
followed up by training and accreditation of competent practitioners, can 
help to improve standards, enable people to make informed choices about 
health providers, and assist the MOH to regulate standards in both public 
and private sectors.
Drug quality assurance – Poor quality drugs are a major problem that can 
result in patient death if unrecognized. Poor quality can be due to poor 
manufacturing practices or deliberate and sophisticated counterfeiting. 
Trademarks can be forged, so it is dangerous to buy drugs from nonofficial 
sources. ACT quality can only be assured by obtaining supplies from rep-
utable, WHO-prequalified pharmaceutical companies, preferably directly 
from producers. Drug quality assessment would usually be considered a 
routine monitoring activity, most often carried out by those with special-
ized expertise in this area. In emergencies, where ensuring a supply of 
drugs may require purchase from local markets or other sources of uncer-
tain quality, drug quality testing may be approached as an operational 
research study. 
Standard protocols exist for collecting, documenting, storing and test-
ing drugs from the formal, informal and private sectors. Advanced testing 
using High-Performance Liquid Chromatography (HPLC and mass spec-
trometry requires specialist laboratories. Some field-based laboratory kits 
(e.g. the GPHF-Minilab®) can detect seriously flawed drugs that contain 
either the wrong ingredients or no active ingredients. 
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Effective prevention
Operational research can help assess the effectiveness of prevention meas-
ures in a particular setting, playing an important role in evaluating trans-
mission control and personal protection interventions during emergencies. 
It can help identify ways to improve delivery and usage (e.g. social research 
on community preferences, and testing coverage achieved by different 
delivery methods). With the rapid scale-up of LLIN coverage globally, 
resistance to pyrethroid insecticides is increasing, and insecticide resistance 
testing may be necessary in many emergency settings. More detail on ento-
mological monitoring and insecticide susceptibility testing is provided in 
Chapter 7. 
LLINs – Research has shown that LLINs provide personal protection in 
many settings and can provide additional benefits in high-endemicity set-
tings such as in Africa, if population coverage is high, through a mass killing 
effect on mosquito populations (see Chapter 7). There is no longer justifica-
tion to use mosquito nets other than LLINs. There are few endemic areas 
where ITNs or LLINs have not been tested, and the areas where they work 
well are mostly known. 
LLIN durability during emergencies is a current operational research 
issue. LLINs are expected to last for at least 2–3 years in non-emergency 
settings. Recent data from a number of endemic countries in Africa, suggest 
that the lifespan of certain LLINs may be less than 2 years in some settings. 
In emergency settings, their lifespan is likely to be shorter, but how much 
shorter has not been documented. LLINs are currently made from poly-
ester, polyethylene or polypropylene fibres; it is not known which is more 
suited to emergency conditions. WHO has developed standardized guide-
lines on assessing the durability of LLINs (residual efficacy and physical 
integrity), and information from emergency settings would be a valuable 
addition (WHO, 2011). 
LLINs work well against all African malaria vector species, if used regular-
ly and correctly, but are not effective in every epidemiological context. For 
example, many South-east Asian vector species bite predominantly in the 
evening and morning (e.g. An. minimus) and LLINs can only protect against 
malaria while people are sleeping under them. Additional research on 
malaria impact and adjunct protective strategies in such settings is needed. 
LLINs may be less effective in acute emergencies, unless communities are 
accustomed to using mosquito nets and shelters are suited to hanging them. 
However, evidence exists of their effectiveness in post-acute phase and in 
chronic emergencies (Kolaczinski et al., 2004). Ideally, before LLIN cov-
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erage is expanded in an emergency setting, a rapid assessment should be 
conducted to:
■• determine previous experiences with using mosquito nets within the 
displaced population, whether people want or would use LLINs, and 
the importance of protection against mosquito bites relative to other pri-
orities;
■• determine appropriate colour, sizes and shapes, a frequently neglected 
component of choosing the right LLIN brand;
■• develop appropriate health communications materials on net usage and 
care, including repairs by users;
As no alternatives to pyrethroids yet exist for LLINs, their disease-control 
impact should be monitored regularly, particularly in areas with pyrethroid 
or organochlorine resistance. Local resistance to pyrethroids can be mon-
itored using WHO susceptibility test kits or CDC bottle bioassays. Proce-
dures are described in the WHO revised test procedures for insecticide 
resistance monitoring (WHO, 2013). Operational research into these and 
other basic questions can help in determining the most cost-effective ways 
of achieving and maintaining high LLIN coverage and usage in post-acute 
or chronic emergency settings.
IRS – This has become more common for community malaria control 
during emergencies in certain countries. In areas of pyrethroid resistance, 
and where LLINs are also being deployed at high coverage, WHO recom-
mends that IRS with pyrethroids be replaced with alternative insecticides 
(e.g. carbamates, organophosphates), to curtail further selection of pyre-
throid resistance. IRS with any insecticide requires coverage of approxi-
mately 80% of dwellings to be effective and is generally not feasible during 
acute-phase emergencies (see Chapter 7). Prior to insecticide procurement, 
susceptibility of local vector populations should be tested using either 
WHO tube assay (see Annex X) or CDC bottle assay (http://www.cdc.
gov/ncidod/wbt/resistance/assay/bottle/index.htm). After insecticide is 
applied, it is desirable to monitor the duration of effectiveness using a WHO 
cone bioassay on live susceptible mosquitoes (Annex X) or one of the color-
imetric assays under development. 
Operational research has helped to formulate guiding principles on IRS, 
but more research is needed to determine how effective IRS with carba-
mates or organophosphates is and whether IRS with these compounds can 
have a sustained impact on malaria transmission in emergency settings. 
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Alternative protection methods
The utility of LLINs in emergencies should not be assumed if their accepta-
bility is uncertain, and they may be less practical when populations are liv-
ing in tents or other types of emergency shelter. In this case, operational 
research may be needed to assess the potential of alternative approaches, 
such as pyrethroid treatment of blankets/topsheets and ITPS (see Chapter 
7). One potential advantage is that these materials are already being distrib-
uted in acute emergencies, so if they could be rendered protective against 
malaria (in areas where local vectors are still susceptible to pyrethroids) this 
would provide dual benefits without placing extra demand on logistics. 
One study in West Africa indicated that, as with IRS, ITPS may provide 
community protection through a mass killing effect on mosquito popula-
tions (Burns et al. 2012). There is also good evidence from Asian and African 
trials for the effectiveness against malaria of in situ insecticide treatment of 
blankets/topsheets with permethrin in displacement settlements (Rowland 
et al., 1999). 
While there is some evidence to suggest the use of such materials in emer-
gencies, the evidence base is still weak compared to that for IRS and LLINs 
– which includes many community-randomized trials in different settings 
against different vectors. Commercial permethrin-treated blankets have 
not yet been tested in trial settings. Additionally, there have been no trials 
to date of ITPS and insecticide-treated blankets used together, despite both 
blankets and plastic tarpaulins being routinely distributed in emergencies 
for warmth and shelter. Both ITPS and permethrin-treated blankets are 
now produced commercially. However, at present there are not sufficient 
data for WHO to make a recommendation regarding these interventions. 
However, they are included in this handbook because they are currently 
being used in the context of humanitarian emergencies. Further research is 
required to assess:
■• the effectiveness of treated topsheets and blankets in different cultural, 
epidemiological and climatic settings in Africa and Asia;
■• the potential of ITPS in settings other than West Africa; 
■• whether there is increased effectiveness when the ITPS and perme-
thrin-treated blankets are used together as compared to either interven-
tion being used alone.
IPT – More than a decade ago, intermittent preventive treatment emerged 
as a new strategy, initially for use among pregnant women (IPTp), and then 
more recently for use in infants (IPTi). IPTp is normally delivered through 
MALARIA CONTROL IN HUMANITARIAN EMERGENCIES
148
antenatal care. Deployment of IPTp through generally weak African health 
systems has proven challenging and is the focus of operational research. 
As routine antenatal care may be weak or non-existent during humanitari-
an emergencies, research may be needed on alternative delivery strategies. 
Information on the effectiveness of IPT in these settings – measured as pre-
vention of severe anaemia and low birth-weight – in areas where it is imple-
mented, could inform the broader debate about use of IPT in areas with 
relatively high levels of SP resistance (see Chapter 6).
Seasonal malaria chemoprevention (SMC) is now recommended for 
incorporation into malaria programmes in countries with seasonal malaria 
and low resistance to SP. A complete treatment course of amodiaquine plus 
SP should be given to children aged between 3 and 59 months at monthly 
intervals, beginning at the start of the transmission season, to a maximum 
of four doses during the malaria transmission season. This recommendation 
is currently limited to the Sahel. 
No major studies of IPT or SMC have been conducted in emergency 
settings. However, both are logistically feasible in post-acute phase emer-
gencies as treatments are intermittent. Seasonal chemoprevention could be 
expected to be useful for other target groups (e.g. displaced populations), 
but has not yet been evaluated for this purpose.
Effective and sustainable delivery
While operational research is important to identify the best delivery strate-
gy during the different phases of emergencies, this should not be an excuse 
for not providing free services to attain universal coverage of interventions. 
It is therefore generally accepted that malaria services must be free-of-
charge to end-users during emergencies. Operational research can help to 
address questions related to maintaining effective delivery during changing 
emergency phases and conditions. These questions could include:
Accessibility
■• Which delivery strategies achieve best coverage and uptake during acute-
phase emergencies?
Demand creation
■• What is the best way to encourage appropriate use of prevention and 
treatment services?
■• Which communication methods work best in different emergency phas-
es (e.g. mass media, person-to-person)?
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Monitoring 
■• How can behaviour change and correct usage best be monitored?
■• What are the most effective behaviour change communication strategies 
for different emergency phases?
■• Does the inclusion of community focal persons (e.g. religious leaders, 
teachers) improve malaria treatment-seeking and use of preventive meas-
ures?
■• Does investment in lay health-workers (e.g. CHWs) in acute-phase emer-
gencies improve malaria outcomes?
■• What are the impacts of involving CHWs in case management?
Effective outbreak control
Surveillance can also be used as an operational research tool to evaluate 
the impact of outbreak control interventions (see Chapters 4 and 5). For 
example, it was suspected that IRS with lambda-cyhalothrin was no longer 
working effectively in Afghan refugee camps, but cross-sectional prevalence 
surveys before and after spraying confirmed that it was still controlling 
malaria effectively (Rowland et al., 1994). Other indicators that might be 
used for measuring control impact, depending on the resources available, 
include the number of malaria cases presenting at clinics, prevalence of 
anaemia, and mosquito population density.
Social and behavioural determinants of intervention uptake
Successful malaria control depends on community members understand-
ing and using prevention and treatment measures. It is vital to use informa-
tion on community beliefs and practices about malaria to improve uptake 
of interventions. Social and behavioural research is important for designing 
effective interventions and can help explain why a particular intervention 
fails to be accepted. 
Operational research on social and behavioural factors influencing inter-
vention uptake can strengthen planning, implementation, and monitoring 
by providing information about people’s beliefs and prevention and treat-
ment-seeking behaviours (see Chapter 7 and Annex IX). Questions can 
include:
Perceived importance of malaria and prevention
■• What perceptions do people have about causes of febrile illness?
■• What perceptions do people have about causes of malaria?
■• How do people traditionally protect themselves from mosquitoes?
■• How do people traditionally protect themselves from malaria?
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■• What measures are currently acceptable (e.g. LLINs, IRS, ITPS)?
■• What household items do people most value (e.g. are LLINs valued or 
are they sold)?
■• Who makes decisions about family protection/health care and could be 
targeted by health communications?
■• What are family sleeping arrangements (e.g. co-sleeping, shared rooms, 
average household size)?
■• If LLINs are used, who sleeps under them (e.g. gender or age differences 
in LLIN usage)?
■• If LLINs are used, how are they washed and how often?
■• Does help with hanging of LLINs improve usage rates?
Treatment-seeking and access
■• What influences treatment-seeking (e.g. who in the family decides, what 
is the decision process)?
■• What local or traditional treatments are used?
■• Where is treatment obtained (e.g. public services, private/informal prac-
titioners)?
■• When is treatment sought (e.g. is there delay, for how long, are tradition-
al treatments tried first)?
■• What access do people have to effective antimalarials (e.g. does the pri-
vate sector provide quality-assured ACTs, how is the supply of drugs 
regulated or maintained, do traditional/informal practitioners prescribe 
antimalarials)?
■• Do most people accept recommended malaria treatment? Is local anti-
malarial treatment policy different from their former experience of treat-
ment?
■• How do people feel about antimalarial safety and efficacy?
■• What are barriers to treatment and care (e.g. are services accessible, what 
role do intermediaries – such as other family members – play in accessing 
care)?
■• Do security concerns affect treatment-seeking or access to care?
■• Are some social groups excluded because of physical or political factors 
(e.g. gender, age, and ethnicity)?
Social and behavioural information can be collected through standardized 
social research methods, including key informant interviews (e.g. with 
community leaders, CHWs), in-depth interviews with community mem-
bers, household surveys, and participatory action research (see Chapter 7). 
Each of these methods is feasible in emergency settings, though large-scale 
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community surveys in particular pose logistical challenges and require 
technical assistance.
Economic research
The costs and cost-effectiveness of malaria control in acute-phase emergen-
cies are still poorly documented. Economic costing analyses of malaria con-
trol in emergencies are feasible, particularly using a provider perspective, 
because most agencies maintain detailed expenditure records for financial 
reporting to donors. More research is also needed to identify prevention 
and treatment approaches that will be financially sustainable post-emergen-
cy, after the withdrawal of humanitarian aid.
Operational research planning
Planning operational research
Malaria operational research and malaria control require similar processes 
of planning, design, choice of tools and indicators, as well as monitoring 
and evaluation. However, operational research differs from malaria control 
in that it starts from a position of uncertainty and aims to answer a specific 
question or identify the best solution to a problem – which may involve 
comparing results from a number of approaches. The steps needed in oper-
ational research remain the same whether the aim is to improve an existing 
malaria control strategy or to choose among available interventions (see 
Table 9.2). 
Good operational research planning and implementation are vital. If 
activities are not conducted properly or an outcome is not recorded prop-
erly, results may be incorrect and the interpretation of findings will be diffi-
cult or impossible. Important aspects of planning include:
■• agreeing on clearly-defined objectives and outcomes;
■• planning time-bound activities (e.g. including training data collectors 
and piloting);
■• establishing a systematic approach to evaluating outcomes with appro-
priate technical and process indicators; 
■• designing for evaluation from the beginning of study development.
It is necessary to plan at the design stage how data will be collected and 
analysed. Planning data collection helps to clarify activities (e.g. data collec-
tion, quality control checks, data management, analysis), minimize errors, 
avoid unnecessary delays, and organize human and material resources. 
Planning how data will be analysed helps to formulate clear and specific 
objectives and determine what information should be collected in the first 
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place. Pre-testing a particular research component or piloting the full meth-
odology with a small sample helps identify potential problems, allowing 
necessary revisions before research is implemented on a larger scale.
Designing operational research
Research conducted in humanitarian emergencies includes:
■• Research that is specific to local issues – which may need to be investigat-
ed in every emergency (e.g. cultural beliefs about disease causation, 
health-seeking behaviour); 
Table 9.2 Steps in planning operational research 
Questions Next steps Actions 
What is the problem? Formulate the 
research question.
Use existing literature to 
strengthen development of the 
research question.
What information is already 
available?
Review published and 
grey literature. 
Review clinical and/or social 
science literature, government 
reports, agency records.
What is the purpose? Formulate objectives. Develop 3–5 SMART objectives 
that can answer the research 
question.
What additional data are 
needed and how should 
data be collected?
Develop research 
methods.
Study type, study design, 
population, sampling, ethics, 
piloting, data collection, 
analysis, dissemination.
How will results be used? Determine how 
findings can inform 
implementation.
Do not collect research data 
without knowing how the 
results will be used to improve 
implementation. It is helpful to 
involve potential beneficiaries 
in research planning and 
implementation.
Who will do what and 
when?
Develop work plan. Appoint and train research 
staff, schedule implementation, 
monitoring and supervision.
What resources are 
needed?
Develop budget and 
resource allocation 
plan.
Mobilize funding, recruit staff, 
and procure necessary supplies 
and equipment.
How should research 
question and findings be 
disseminated to donors, 
authorities, partners, and 
communities?
Develop dissemination 
plan.
Establish a committee 
of experts to review the 
implementation of the 
dissemination plan including 
the sharing of research results. 
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The distinction between operational research in humanitarian and non-hu-
manitarian settings is not always clear and humanitarian agencies may be 
involved in both. For example, after a new prevention or treatment inter-
vention is developed it may need to be evaluated in emergency settings with 
different epidemiological and social conditions. The main approaches used 
in operational research are qualitative, quantitative, or a mixture of the two.
Qualitative research usually focuses on small purposively selected sam-
ples, to allow variables to be explored in depth. It is particularly useful 
for exploring attitudes, behaviours, and motivations, or characteristics of 
particular situations that may change over time. For example, qualitative 
research among Afghan families explored health attitudes and approaches 
to malaria prevention within the social constraints provided by the Taliban 
regime (Howard et al. 2010). It is often used as a precursor to quantitative 
research as it can help in developing a testable research question. 
Quantitative research is the standard experimental scientific approach, 
often using population samples and statistical analysis. The quantitative 
study of incidence, distribution and control of diseases such as malar-
ia is called epidemiology. It can be used for disproving discrete research 
hypotheses. For example, a quantitative study in Afghanistan showed the 
association between increased insecticide-treated net coverage and reduced 
malaria morbidity (Rowland et al., 2002; see Box 9.1). 
Quantitative operational research uses epidemiological principles and 
can be either descriptive or analytical. Descriptive studies use cross-sectional 
surveys or longitudinal follow-up of a cohort to systematically observe and 
describe the group or situation without attempting to influence outcomes 
(e.g. the frequency of malaria cases in a population by age or population 
group). Sources of descriptive data in emergencies include surveillance, 
health facility records, and household surveys. Analytical studies aim to 
investigate causal relationships between malaria mortality or related out-
comes and various exposures. These can be either observational or inter-
vention study designs. Observational study designs can be ecological, 
cross-sectional, cohort, or case-control. Cross-sectional (e.g. for descriptive 
analysis), case–control, and retrospective or prospective cohort studies are 
most commonly used in operational research. Intervention studies can be 
considered for particular operational research questions if the skills and 
resources are available to conduct them well.
■• Cross-sectional studies relate exposure status and outcome prevalence at 
one time-point from a random sample of the population of interest. For 
example, prevalence of severe malaria associated with living in a par-
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ticular displacement camp. They are relatively quick and easy, though it 
is difficult to know if exposure preceded outcome, and are often used in 
operational research to provide preliminary evidence of an association.
■• Cohort studies compare individuals with and without exposure to a risk 
factor to measure the occurrence of the outcome of interest over time. 
For example, measuring the incidence of severe malaria in pregnant and 
non-pregnant women. Cohort studies in which subjects are followed 
longitudinally can be time-consuming, labour-intensive and expen-
sive, making them more appropriate for stable settings (e.g. long-term 
displacement camps). Retrospective cohort studies, in which exposures 
and outcomes are assessed after they have occurred, are relatively less 
resource intensive and may be employed in some acute settings.
■• Case–control studies select individuals on the basis of outcome status and 
analyse whether they differ in terms of previous exposure. For example, 
malaria mortality among those who used ITPS versus those who used 
untreated tarpaulins. Case–control studies are relatively quick and inex-
pensive, and are therefore often favoured for outbreak investigations and 
estimating the impact of an intervention in emergency conditions. 
■• Intervention studies allocate a protective factor to individuals or groups 
and compare the frequency of the outcome of interest between those 
exposed and those unexposed. For example, comparing incidence of 
treatment failure between those given a new treatment drug and those 
given current treatment. Intervention studies can be slow, labour inten-
sive and expensive, but are the gold standard – particularly double-blind 
randomized controlled trials – for inferring causality with protective 
exposures. 
■• Mixed-methods research combines elements of qualitative and quantitative 
approaches. It is often used for addressing policy-focused questions. 
Selecting exposure and outcome measures
The main outcomes of interest in malaria operational research are:
■• disease incidence
■• disease prevalence
■• intermediate variables (e.g. vector density, human behaviour change).
In studies of malaria control interventions in emergencies, the difference in 
incidence or prevalence of disease in the intervention and control groups 
is the most relevant outcome. Once a disease surveillance and monitoring 
system is in place, it is simpler and more definitive to measure changes in 
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disease outcome than changes in intermediate outcomes (e.g. changes in 
knowledge or behaviour). However, intermediate outcomes can be useful 
for refining or improving an intervention or explaining how it works.
Exposures of interest can depend on study purpose and design. The 
main exposure of interest could be usage of a protective item (e.g. LLINs, 
IPT, ACT). Where intermediate variables are particularly technical, special-
ist advice should be sought from international or local experts.
Sampling
Quantitative operational research most often uses a sample population (e.g. 
of individuals, households, camps) and extrapolates findings to the target 
population (e.g. the crisis-affected population). To reduce selection bias, 
the study population should be representative, possessing all characteris-
tics of the target population from which it is drawn. To reduce the role of 
chance, the study population should be sufficiently large (e.g. if the study is 
too small it may estimate effects too inaccurately and if it is too large it will 
use more resources than necessary). 
Two important statistical concepts in calculating sample size are power 
and precision. Power is the probability of detecting an effect if it is real, 
while precision is the probability of detecting an effect if it is not real. A 
study should typically have 80–90% power and 5% precision (e.g. shown 
by p-values) to accurately detect an effect. Computer programmes can be 
used to calculate required sample sizes (e.g. EpiInfo, SPSS). In emergen-
cy settings, the sample size may need to be increased to allow for relative-
ly high losses to follow-up. Losses to follow-up are likely in displaced and 
crisis-affected populations. For example, during a 1-year study of insecti-
cide-treated topsheets in Kabul, Afghanistan, more than 30% of the study 
population moved because of security problems. The higher the rate of loss 
to follow-up, the less robust study results will be. Other factors that deter-
mine the size of a study include availability of staff, transport, laboratory 
capacity, time and money.
Once sample size has been calculated, subjects must be selected (i.e. 
sampled) from the target population. Subjects might be individuals (e.g. 
in drug trials), households (e.g. in an LLIN trial) or communities (e.g. in 
an IRS trial). Subjects are allocated randomly to eliminate potential bias 
due to unforeseen factors. The double-blind approach, in which neither the 
researcher not the participant is aware of who is allocated to the interven-
tion or control group, eliminates potential bias in the assessment of inter-
vention impact, but is not possible for all types of interventions. Random 
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sampling requires a sampling frame, or list, detailing all eligible members of 
the target population for selection. Sampling methods include:
■• Simple random sampling, in which each subject in the sampling frame has 
an equal chance of being selected (e.g. through random number tables). 
A simple random sample may be difficult because of logistics or problems 
of excluding neighbours;
■• Systematic sampling, in which subjects are selected at regular intervals (e.g. 
every fifth household) can avoid some of the difficulties with simple ran-
dom sampling. Stratified sampling selects representative subgroups (e.g. 
by age, ethnic groups) in proportion to the population structure.
If a sampling frame is not feasible or the population is widespread, other 
methods such as stratified, multi-stage, or cluster sampling may be used: 
■• Cluster sampling, in which a random sample of villages or camps is chosen 
and all target individuals (e.g. children under age five) are selected for 
Box 9.1 Case–control study in Afghanistan
The impact and coverage of insecticide-treated nets can be estimated using 
routine data collected by passive case detection at field clinics. Data from the 
microscopy registers of Behsud clinic in eastern Afghanistan were as follows:
ITN user status Falciparum-positive (cases)
Falciparum-negative 
(controls) Total
ITN user
Non-user
52 (a)
439 (c)
610 (b)
1958 (d)
662 (e)
2397 (f)
ITN non-user 439 (c) 1958 (d) 2397 (f)
Total 3059 (g)
These data were used to estimate individual effectiveness through a case–
control study. Those with slides positive for P. falciparum were considered to be 
cases, and those with slides that were negative were considered to be controls. 
The odds ratio (ad/bc) = 0.38, and individual protective effectiveness is 1– 
odds ratio = 0.62 or 62% (confidence interval 48–72%). Data were also used to 
estimate the proportion of the population using ITNs (e/g) = 0.22.
Thus, the impact on malaria morbidity in the population, or community 
effectiveness = individual effectiveness multiplied by coverage, which in 
this community is 0.62 x 0.22 = 14%. It was concluded, therefore, that 14% 
(confidence interval 11–16%) of the total number of malaria cases that would 
have occurred in the community, were prevented by the ITN distribution 
programme (Rowland et al., 2002).
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the intervention, is logistically feasible but more likely to be unrepresent-
ative. This risk can be reduced if the number of clusters is 20 or more.
Humanitarian research ethics
Operational research incurs ethical obligations, particularly in human-
itarian settings when working with vulnerable displaced and crisis-affect-
ed communities. Most operational research for malaria control is either 
etiological (e.g. what caused the malaria outbreak?), systems-related (e.g. 
which LLIN delivery strategy works better, which insecticide is most cost- 
effective?), or clinical (e.g. is this intervention effective?), and is addressed 
following the principles of biomedical and social research ethics. 
Guiding principles – WHO policy on research ethics states that all research 
involving human participants must be conducted in a manner that respects 
the dignity, safety and rights of research participants and recognizes the 
responsibilities of researchers. The fundamental  bioethical principles to 
apply are autonomy (i.e. right of refusal), beneficence (i.e. in-line with 
participants’ best interests), justice (i.e. equitable distribution of benefits), 
non-maleficence (i.e. do no harm), and human dignity (i.e. respect for per-
sons). 
All operational research should follow the guiding principles in the 
amended Helsinki Declaration of 1989, further elaborated for developing 
countries in the updated International ethical guidelines for biomedical research 
involving human subjects (CIOMS, 2002) and International Ethical Guidelines for 
Epidemiological Studies (CIOMS, 2008). The Economic and Social Research 
Council research ethics framework is particularly useful for social research 
(ESRC 2012). 
Ethical considerations – People affected by emergencies are particularly 
vulnerable. Key considerations before implementing operational research 
include:
■• purpose (e.g. who will benefit most – the community being studied, the 
global scientific community, or the researcher?);
■• selection (e.g. particular topics and participant groups, such as children 
under five and women, are studied more frequently than others and 
sometimes in accordance with research rather than community priori-
ties);
■• power (e.g. power imbalances such as differing social status of research-
ers and participants can affect consent, participation, validity of respons-
es, and even outcomes);
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■• risks (e.g. unintended consequences can be both social and psycholog-
ical, including recrimination, security breaches, stigmatization, and 
raised expectations);
■• consent (e.g. can participants understand study purpose, beneficiaries, 
implications of involvement, and choose whether or not to participate?);
■• confidentiality (e.g. concepts of privacy and participant identifiers can 
vary considerably);
■• dissemination (e.g. results that are not both locally and broadly dissem-
inated can lead to duplicated efforts, sometimes by different researchers 
using the same participants).
Operational research that provides a generalized benefit to populations 
affected by humanitarian emergencies is essential, but should not be con-
ducted without benefit to the community being studied. Similarly, vulner-
able socially and economically deprived individuals must not be used in 
research that will mainly benefit more privileged individuals. Intervention 
trials on refugees should be undertaken only when there is uncertainty 
about potential benefit. If a previous study provided evidence for a benefit, 
there is no justification for a trial unless there is good reason to believe that 
the results might be different in the present population or locality. 
Community participation is essential for most operational research. It 
is important to involve community leaders and representatives in research 
planning and design. Informed consent must be obtained from all partici-
pants and it is the investigator’s responsibility to ensure that participants are 
fully informed of the potential risks and benefits of participating in a study. 
Difficulties in ensuring informed consent include individual autonomy, 
hospitality norms, power imbalances and dependency. For example, indi-
vidual participants may feel pressured by cultural expectations of polite-
ness, by the hope of some tangible community benefit, or by community 
leaders’ expectations of their cooperation. 
Choice of control in intervention studies is difficult. The norm is that any 
new intervention should be compared with the best intervention currently 
available. Comparison with a placebo or a “no intervention” control group 
is acceptable only if no other effective intervention is known. Thus, if an 
intervention is already being used, its withdrawal for research purposes is 
unethical. However, if it is not clear whether an intervention in use remains 
effective, a randomized trial comparing a promising new treatment with 
the existing treatment is justified. If, as is often the case, there are insuffi-
cient resources to meet the needs of everyone, distribution might be rand-
omized to enable an unequivocal assessment to be made. Additionally, it is 
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acceptable to try a new intervention that is generally equivalent to the exist-
ing intervention if it is cheaper, easier to implement, more sustainable, asso-
ciated with fewer adverse reactions, or more acceptable to the community. 
It may be preferable to conduct comparative trials rather than randomized 
controlled trials to avoid the risk of withholding a beneficial treatment.
Ethical review procedures
Any research protocol that involves people should pass formal review by 
an ethics review committee. This is not only a basic prerequisite for jour-
nal publication, which is important for dissemination, but helps ensure that 
ethical ramifications have been addressed. Ethics review can be particu-
larly challenging in emergency settings as local ethics review boards may 
not exist and those traditional boards that do exist (e.g. in academic insti-
tutions) may not be able to provide timely approval. Some humanitarian 
organizations (e.g. MSF) have set up their own independent ethics review 
boards to help address this. 
Data collection and analysis
Data collection and analysis are not covered in this handbook. Since both of 
these often require specialist support, it is important to seek advice before 
data collection begins to ensure that the study adds to the evidence base 
rather than wasting time and resources. 
Disseminating and using findings
The ultimate relevance of operational research is whether it contributes to 
improving the effectiveness of interventions or influences policy change 
(Zacharia et al 2012). Dissemination requires identifying and targeting 
messages to an appropriate audience. The audience should include the 
community in which operational research was conducted and local and/
or international policy-makers depending on the generalizability of the 
research findings. Whether research findings are positive or negative, they 
must be reported to national health officials in the MOH, donor agencies, 
community leaders and participants, and implications for policy discussed. 
Increasingly, operational research is disseminated more broadly through 
publications in peer-reviewed scientific journals.
Using research findings to guide programme development is critical. 
Successful new interventions may need to be integrated into current con-
trol programmes, and strategies to do this may need to be developed. 
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ANNEX I
Sources and methods  
for collecting population data
Counting households
The total size of a population is estimated by multiplying the number of 
households by the average number of people per household: this informa-
tion can be obtained by exhaustive counting or systematic sampling.
Exhaustive counting of households
1. Count the total number of households in the area. This can be done on 
foot, from a vehicle, or by aerial photography. Because it is exhaustive, 
this method is most appropriate for small sites covering limited areas.
2. Calculate the average number of persons per household by conducting a 
small survey of sample households selected at random. A minimum of 30 
households should be selected.
3. Estimate the total population by multiplying the total number of house-
holds by the average number of persons per household.
Systematic sampling
1. This technique is particularly adapted to well-organized refugee camps. 
Using interval sampling and a departure number chosen at random, 
select a sample (and thus determine each household to be visited). This 
method assumes that households are arranged in such a way that interval 
sampling is possible and that their approximate number is known.
For example: 
Estimated no. of households = 4000
Convenient sample size chosen = 400
 Sample interval = 4000/400 = 10 (information on the number of person 
living in an household will be collected in every 10 habitats)
 If the randomly chosen departure point is 6 (i.e. the sixth household 
beginning at one extremity of the camp), the selected households are 
therefore number 6, then number 16 (6+10), then number 26 (16+10), 
etc.
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2. Estimate the total population by multiplying:
 (total no. of households visited) x (average no. of persons per household) 
x sample interval.
Mapping
The total size of a population is estimated by multiplying the total area of a 
site (m2) by the average population density per m2: this information can be 
obtained by the quadrate method or the T-square method.
Quadrate method 
1. Draw the camp boundary. This can be accomplished either by taking 
GPS points along the perimeter and drawing the map with software, or 
by hand with a compass and then on paper.
2. Select 30 systematically random locations within the site. This can also 
be accomplished by mapping software or by hand. In Figure I.1, six such 
points are shown.
3. Mark off a 25 m x 25 m quadrate, or block, physically with a rope or by 
using a telemeter at each point.
4. Count the population within each quadrate, and the number of persons 
and number of households for the 30 quadrates.
Site map, Beira
= 25 m x 25 m quadrate
1. Draw site boundary
2. Select 30 starting points
3. Mark 30 (25 m x 25 m) blocks
4. Count population in each block
5. Calculate average population/block
6. Estimate the total site population
25 m
25
 m
Source: MSF/Epicentre.
Figure I.1 Quadrate method for calculating population size
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5. Calculate the average population per quadrate.
6. Estimate the site population by extrapolating the average population per 
quadrate to the entire site surface. Confidence intervals are then calcu-
lated around the estimate.
T-square method
The T-square method “involves sampling a number of random points, meas-
uring the distance between each point and the nearest household or family 
unit, and then measuring the distance between that household and the next 
closest one, as a way of measuring population density”. It gives a more accu-
rate evaluation of the population size, but is more complicated to perform 
than the quadrate method.
Census or registration
Census
A census of the displaced population is the ideal method for ascertaining 
population data, if it is feasible. It involves visiting homes and counting 
how many people live in each. If security allows, it is best done early in 
the morning or in the evening when refugees or displaced people are more 
likely to be “at home”. However, as the following example illustrates, in an 
emergency situation, there may not be sufficient time or human resources 
to carry out a census.
Following the floods in Mozambique, a quick census was carried out by 
an agency in two temporary accommodation centres. The census was 
done at night when people were most likely to be at home. It was found 
that, although the number of residents had been estimated at 10 000, 
the actual number of people residing in the accommodation centres was 
around 6000. The reason for this discrepancy was that many people who 
were present in the camp during the day were actually returning to their 
villages at night.
Registration
Registration of refugees or displaced people when they arrive at a site can 
provide an opportunity to collect data about population size (and struc-
ture). Registration can also be combined with other activities, such as dis-
tribution of food cards, detection of malnutrition and vaccination against 
measles.
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Data from programme activities
Information from programme activities, such as a vaccine coverage survey 
of a specific age group (e.g. children aged 6–59 months), can be used to 
estimate the number of children in this age group as well as the total pop-
ulation.
For example: 
A measles vaccination survey estimates vaccination coverage among chil-
dren aged 6–59 months in a camp to be 80% (0.8) and 5000 measles vac-
cines were administered in this age group. Using these data, the number 
of children aged 6–59 months can be estimated: 5000/0.8 = 6250. If, from 
another survey, it is known that children in this age group represent 20% of 
the population in question, the total population can be estimated: 6250/0.2 
= 31 250.
Population structure
Since vulnerable groups need to be monitored, it is useful to know what 
proportion of the population are pregnant women and children under five. 
Population structure can be estimated based on the typical distribution of 
age groups in the general population.
Table I.1 Distribution standard by age of stable populations  
 in developing countries
Age group Proportion of total population
0–4 years
5–14 years
15–29 years
≥30 years
17%
28%
28%
27%
Total 100%
Humanitarian emergencies, however, can affect the normal age and sex 
structure of populations. For example, there may be proportionally fewer 
men and proportionally more women, young children and elderly people. 
It is therefore necessary to conduct a simple census or sample survey to find 
out about the age breakdown of the population.
As a minimum it is important to estimate the expected number of children 
under 5 years of age and pregnant women if the camp population were of the 
same composition as a normal population. Therefore, without a census of the 
population, it is reasonable to assume children under 5 years of age rep-
resent approximately 17% of the population. A quick way to estimate the 
169
number of pregnant women is to use the following calculation, with values 
based on typical values:
 total number of pregnant women = 
 total population x 
 proportion of women in a population (typically 51%) x 
 proportion of women of childbearing age (15–45 years) among all women 
in the population (typically 50%) x 
 chance of any woman aged 15–45 years being pregnant for a given fertility 
rate1 (approximately 20% for a fertility rate of 8)
 Therefore, total number of pregnant women = total population x (0.51 x 
0.50 x 0.20)
ANNEX I. SOURCES AND METHODS FOR COLLECTING POPULATION DATA
1 In a given population, the total fertility rate (per women 15–45 years) may be, for exam-
ple 5. If so, a woman is pregnant 5/30 years (16.7%) for 9/12 months (75%); from this, the 
chance of any woman aged 15–45 years being pregnant at a given time = 16.7% x 75% = 
12.5%. At a total fertility rate of 8 children per woman of 15–45 years, 20% of women of 
childbearing age can be expected to be pregnant at any given time.
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ANNEX II
Methods for collecting  
retrospective mortality data
Retrospective mortality data can help to assess how the current situation 
compares with the recent situation. This is useful for determining trends 
and the seriousness of the situation. Methods for estimating retrospective 
mortality include sample surveys and counting the number of recent graves.
Retrospective mortality survey
Death – the event being quantified – is relatively rare, and the sample there-
fore needs to be adequately large. For cluster sampling, 30 clusters of 30 
families (approximately 4000 individuals) is an appropriate sample size.
The head of each family surveyed is asked about the occurrence (or not) 
of death within the household during a defined period of time. To avoid 
recall bias and to limit difficulties in interpreting the results, this period 
of time should be as short as possible but long enough to allow a sufficient 
number of “death events” to have occurred.
To calculate the mortality rate in the surveyed population:
■• Divide the total number of deaths that have occurred in a sample (numer-
ator) by the total number of surveyed individuals alive plus the number 
who have died (denominator) during a given period of time.
■• Multiply the result by 10 000 and relate it to a period of one day to permit 
comparisons to be made.
For example: A survey of 5500 individuals showed that there were 49 deaths 
during the 28 days preceding the survey. The mortality rate was thus {[49/
(5500 + 49)] x 10 000} / 28 = 3.2 deaths/10 000 population per day.
Counting recent graves
In some situations it is possible to count the number of graves dug since the 
arrival of the refugee or displaced population. Although this method is approx-
imate, it provides some useful information when no other data are available.
For example: Six months after the arrival of a large number of displaced peo-
ple at Hoddur in Somalia, 5900 graves were counted among a population of 
25 000. Thus 5900/(5900 + 25 000) = 0.19 = 19% of the population died in 6 
months, an average of 10.4 deaths/10 000 population per day.
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ANNEX III
Overview of methods for conducting rapid 
assessments of malaria transmission1
Rapid assessments can be used to understand the level of malaria transmis-
sion in a given population. They can be carried out at health centre level or 
in the community. 
In acute emergencies, when case loads are unusually high, clinic-based 
surveys can provide a very useful initial indication of the relative impor-
tance of malaria as a cause of morbidity at facility level. In well set-up camps 
or settlements, where health care is provided free of charge, it may be that 
everyone has access to health care (usually 5–10 times more than in “normal” 
conditions). In less well-organized situations, only a minority of the people 
who are actually sick may attend facilities and it may be difficult to ascertain 
how many people would usually attend under more normal circumstances, 
potentially resulting in a skewed picture of the malaria situation.
Data from health facilities only provide information about people who 
seek treatment at those facilities and therefore the data may not be repre-
sentative of the overall population. Nevertheless, information from facilities 
may be used to give some idea of the level of transmission in the community 
if there is some understanding of the level of health care seeking behaviour 
and testing practices. If facility data is unavailable, a cross-sectional preva-
lence survey in the community may be necessary. The community survey 
may be conducted in different sites if there are reasons to suspect localized 
variations in malaria epidemiology.
Rapid clinic-based assessment
The purpose of a clinic-based assessment is to find out the prevalence of par-
asitaemia among symptomatic patients attending the clinic, i.e. the propor-
tion of febrile patients with malaria parasites. If the clinicians at the facilities 
serving the population are following recommended diagnostic testing for 
malaria (whereby every suspected malaria case should be tested for malar-
ia), clinic and laboratory records can be reviewed to assess the proportion 
of suspected malaria cases with confirmed malaria. If the diagnostic effort 
1 The methods described below are not intended to be a complete protocol for conduct-
ing a facility or community based survey of malaria. 
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at the facilities is uncertain, or if the emergency is at an early stage and diag-
nostic supplies have not yet been scaled up to recommended levels, the fol-
lowing survey approach can be used.
Conducting the survey
■• Choose microscopy or RDTs. In the absence of a team of skilled micros-
copists, quality malaria RDTs give accurate, reliable and rapid results (< 
30 minutes). Over a hundred RDTs are commercially available and vary 
by target species,1 format (cassette, card, dipsticks) and performance 
(sensitivity and specificity). RDTs should be selected based on their per-
formance in the WHO Malaria RDT Product Testing Programme and 
according to the WHO/GMP Information note on recommended selection cri-
teria for procurement of malaria rapid diagnostic tests (RDTs).2 Furthermore, 
if species specific prevalence of P. ovale, P. malariae and P. knowlesi is rele-
vant then microscopy is required. 
■• Microscopy through proper staining procedures and under supervision 
by skilled microscopists remains the gold standard for malaria diagnosis. 
Another advantage to microscopy is the fact that blood smears remain 
intact for months and can be checked (quality control assurance) by 
supervisors outside the population area. Whether microscopy or RDTs 
are selected performance is dependent upon end-users receiving train-
ing and regular supervision. 
■• Ensure there is sufficient staff to conduct the survey.
■• Health facility or clinics should be selected to ensure they represent, as 
far as possible, the facilities accessed by the population. If it is impractical 
to include all facilities serving the population, a simple sampling proce-
dure should be employed to select facilities.
■• In a given facility, test all patients presenting with a febrile illness, using 
microscopy or RDTs, up to 100 patients. If possible do this in one day.
■• Record the total number of outpatients seen at the clinic while the survey 
is being done.
■• Record the age, sex and place of origin of all patients and the pregnancy 
status of female patients.
■• Record the parasite rate or slide positivity rate (SPR) or RDT positive rate 
in patients with febrile disease or suspected malaria.
1 P. falciparum only; P. vivax only; combination of P. falciparum and non-P falcipar-
um species (pan, P. vivax or P.VOM-specific); or a single test line for all Plasmodium 
species (pan).
2 http://www.who.int/malaria/publications/atoz/rdt_selection_criteria/en/index.
html (accessed 16 April 2013)
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■• In the first few weeks of the acute phase, before diagnostic testing ser-
vices have been established and a disease surveillance system has been 
put in place, rapid assessment surveys among febrile patients could be 
repeated each week to monitor changes in malaria transmission.
Table III.1 Definitions
Confirmed malaria case 
A suspected malaria case in which malaria parasites have been demonstrated by 
microscopy or RDT.
Malaria test positivity rate (RDT and/or blood slide)
The proportion of confirmed malaria cases among patients receiving a parasitological 
test (i.e. the proportion of RDTs and/or blood slides showing parasites among those 
tested).
Analysis and interpretation of results
■• Record the total number of patients at the clinic, the total number of 
fever cases (suspected malaria), the proportion of fever cases among all 
outpatients, and the proportion of confirmed malaria cases among fever 
cases investigated (test positivity rate). Confirmed malaria cases and test 
positivity rates should be stratified by age <10 and >10 years of age, and 
by occurrence in host or displaced populations.
■• Present the results graphically by week and age group.
■• As mentioned above, facility data on malaria cases and test positivity 
rates can be used to assess the occurrence of malaria in the community; 
however, drawing conclusions about occurrence of malaria in the com-
munity from facility data should be done with an understanding of how 
facility data relates to occurrence of disease in the community. 
In the host population
■• If test positivity rates are less than 10% (parasites are found in fewer than 
10% of fever cases) among both those under 10 years and those 10 years 
or older, this is an indication of low transmission (children and adults 
usually at risk of disease).
■• If test positivity rates are greater than 50% in children aged under 10 years 
and less than 50% in those 10 years of age or older, this is an indication of 
high transmission (children most at risk).
■• If test positivity rates are more than 50% in children aged less than 10 
years and those 10 years or older, this is an indication of the possible 
onset of an outbreak.
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In the displaced population
Analysis in the displaced population is more complex, since the same results 
may reflect different scenarios or situations (as listed below), especially in 
the first few weeks of settlement. A high proportion of fever cases testing 
positive for malaria in refugees or displaced people is of great concern and 
should be further investigated. It may be an indication of:
■• High local malaria transmission:
 — If the incoming population is non-immune, high test positivity rates 
will be recorded in all age groups.
 — If the incoming population is semi-immune, children and pregnant 
women will have the highest test positivity rates.
■• High malaria endemicity in the area of origin:
 — If there is low transmission in the resettlement area, test positivity 
rates among the displaced population may be very high initially (and 
greater in children than in adults) reflecting the level of transmis-
sion in their area of origin; however, lower test positivity rates will 
be observed over time as the occurrence of malaria disease in the 
displaced population reflects the lower transmission potential in the 
resettlement area.
■• High malaria endemicity in areas the displaced population travelled 
through regardless of the level of transmission in the resettlement area:
 — If there is low transmission in the resettlement area, test positivity 
rates among the displaced population may be very high initially (and 
greater in children than in adults) reflecting the level of transmis-
sion in their area of origin; however, lower test positivity rates will 
be observed over time as the occurrence of malaria disease in the 
displaced population reflects the lower transmission potential in the 
resettlement area.
■• The beginning of a malaria outbreak among the refugees or displaced 
population if they have come from a low to a high transmission area.
Rapid cross-sectional fever and parasitological prevalence survey 
across the affected population
The purpose of a community cross-sectional prevalence survey is to:
■• provide pre-intervention baseline data;
■• ascertain the prevalence of symptomatic and asymptomatic malaria 
infection (with confirmed parasitaemia) across all age groups;
■• identify groups at risk and target interventions;
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■• gather information on the treatment-seeking behaviour of the popu-
lation, for example, whether they received treatment in the previous 7 
days, what treatment they received and where they received it.
Guiding principles
■• Highly precise survey results are usually not needed during acute emer-
gencies. The need is rather for acceptable precision in determining the 
level of malaria endemicity, particularly to distinguish between medi-
um/high endemicity (more than 10% of people in the general population 
are infected) and low endemicity (well under 10% of people are infect-
ed), since the interventions to be planned are quite different.
■• More precise survey data may be needed for operational research and for 
evaluating the impact of interventions over time and space.
In general, it can take 3–6 days to carry out a rapid cross-sectional malar-
ia prevalence survey and it should be planned accordingly. It is useful to 
collect baseline information about haemoglobin levels where possible, 
because malaria is often an important cause of severe anaemia (Hb <5 g/dl) 
in endemic areas.
Conducting the survey
■• Define the study population. If there are differences in malaria epidemiol-
ogy, it will be necessary to define a study population within each type 
of ecological area or to take separate samples of the same size from each 
area.
■• Determine the sample size. The required sample size depends on the expect-
ed prevalence of malaria illness and parasitaemia, on how precise the 
results need to be (i.e. how “wide” the 95% confidence interval can be 
allowed to be), on the sampling method (the “design effect”). For valid 
comparisons, a smaller sample is sufficient when the spleen or parasite 
rate is high in the investigated areas. For statistical validity of results, 
however, a large sample is required. The StatCalc program on EpiInfo, 
which can be downloaded free from http://www.cdc.gov/epiinfo, can 
be used to help in the calculation of sample size. 
For example: The prevalence is assumed to be 50%; 45% is used as the “lowest 
acceptable result”; the population is 25 000; the chosen confidence inter-
val is 95%. The desirable sample size using EpiInfo would be 378. With 
an assumed design effect of 2 (depending on the sampling method), the 
required sample size is 2 x 378 = 756.
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■• Confidence interval. A 95% confidence interval is a commonly used index 
of statistical variability when analysing survey data. It can be roughly 
interpreted to mean that there is a 95% chance that the true values will 
fall within this interval. The larger the sample size, the more accurate 
is the measured prevalence rate expected to be, and the narrower the 
95% confidence interval. Survey reports should preferably provide a 95% 
confidence interval in the results. Confidence intervals can become fairly 
wide when data need to be broken down by age – which is probably ade-
quate for purposes of planning malaria control programmes. However, 
to demonstrate a statistically significant change in prevalence associated 
with a particular intervention, the size of the effect would need to be 
very large to be detected. If the results from the study are to show that 
an intervention has been effective, a larger sample size may be needed. 
For example: If in a sample of 100 children parasites are found in 50, the 
parasite rate in the total population of children of the same age group lies 
between 40% and 60%, and this may be assumed with a 95% probability. 
With the same parasite rate result (50%) in a sample of 500 children, the 95% 
confidence interval would be 46–54% (Bruce-Chwatt, 1985). See Table III.2
Note: These figures are for random sampling, not for cluster sampling. Ran-
dom sampling selects sample units such that each possible unit has a fixed 
and determinate probability of selection (Last, 2001). Thus, each person has 
an equal chance of being selected out of the total study population. Ran-
dom sampling should not be confused with haphazard selection of study 
subjects. Random sampling follows a predetermined plan that is usually 
devised with the aid of a table of random numbers.
Table III.2 Confidence interval at 95% probability level for a standardized  
 sample of 100 and 500, using random sampling
Prevalence 60 50 40 10 5
95% confidence interval, with a 
sample size at random of 100
50–70 40–60 30–50 5–18 2–11
95% confidence interval, with a 
sample size at random of 500
56–64 46–54 36–44 8–13 3–7
■• Choose a sampling method. There are many sampling methods. For malar-
ia, everyone in the household is usually surveyed. Each household must 
have an equal chance of being selected. Methods of selecting households 
include random sampling, systematic sampling, and random cluster 
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sampling. However, in the acute phase of emergencies, households may 
not be stable or well defined, and the most appropriate method in the 
first few weeks of this phase may be random sampling.
■• Recruit and train survey team, selecting one person as team leader. The team 
should include:
 — one person to explain the procedure and obtain informed consent 
from the household. Ideally this person should be a community 
member;
 — one person to register the participants, record the axillary temper-
ature the RDT result, and information on treatment-seeking behav-
iour;
 — one person to take the axillary temperature and perform the RDT or 
make a malaria smear on a slide;
 — one person to measure spleen size (if this is to be done) or, more fea-
sibly in emergencies, to check for the presence of enlarged spleen;
 — one person to administer treatment (if this is given on the spot) and to 
provide advice about danger signs and follow-up.
■• Ensure adequate supplies. The following are essential:
 — rapid tests or microscope slides and associated consumables (e.g. lan-
cets, rubber gloves, alcohol for swabbing skin, cotton wool, suitable 
disposal facilities for sharps and contaminated materials);
 — referral forms for the nearest suitable clinic;
 — administrative equipment, e.g. log book, consent forms, record 
forms, pens, pencils and markers;
 — funds to pay for transport to the clinic if needed.
■• Repeat the survey. If malaria transmission is seasonal, it can be useful to 
repeat the survey in different seasons and compare the results. For exam-
ple, in some areas prevalence is lower at the end of the dry season than at 
the end of the wet season. In areas where malaria transmission is intense 
all year round, repeating the survey several months after the start of the 
emergency response can provide a good indication of the impact of inter-
ventions. In areas with marked seasonal peaks it may be useful to repeat 
the survey after 12 months (i.e. at the same time of year) to measure any 
impact of interventions.
Analysis and use of results
■• Prevalence of malaria. Calculate the proportion of people, out of the entire 
population, with fever or a history of fever who have a positive RDT (or 
slide) result. This will provide an estimate of the prevalence of malaria in 
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the study population at that specific point in time. Analyse the data by 
sex and by age group. The number of pregnant women in the sample will 
probably be too low to be statistically significant.
■• Endemicity. Calculate the proportion of people who have a positive RDT 
or slide result. Use the parasite rates to estimate the underlying endemic-
ity of malaria (see Table III.3).
Table III.3 Malaria endemicity according to spleen and parasite rates
Malaria endemicity
Parasite rate (PR)
Under 5 years Over 5 years
Meso and hyper-endemic (usually 
linked to transmission)
High (>50%), but lower 
than spleen rate
Low 
Hypoendemic (usually linked to 
low transmission
≤10%, always higher 
than spleen rate
In cross-sectional surveys, parasite and spleen rates are normally deter-
mined in children aged 2–9 years. In areas where malaria transmission is 
high, parasite and spleen rates are highest in children aged under 5 years 
and decline above that age. In areas where malaria transmission is low, para-
site and spleen rates are low and are equally distributed over all age groups.
■• Representativeness of the sample. Check the survey data to see whether there 
are many absentees, whether the sex and age of absentees are statistically 
different from the group sampled, and whether particular groups (e.g. 
children aged under 5 years) are underrepresented. Also review the sex 
and age groups of the sample to see whether the proportions are similar 
to those in the whole community.
■• Enter the data into a software programme to help with analysis.
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ANNEX V
Checklist for effective response  
to malaria epidemics
Preparedness and early detection
Pre-season preparedness and early identification provide the malaria man-
ager with an increasing number of tools to deal with an epidemic. Maintain 
a high-quality surveillance system, keep databases up-to-date, make and 
analyse regular reports. Think ahead – be prepared.
Source: WHO
Predictive indicators
e.g. meteorological
reports or population
 movements
Initial assessment
Establish the situation
through phone, radio, fax
and e-mail as appropriate
Maintain field
surveillance
Rapid investigation (24–48 hours)
An investigation to determine the
cause, effect and potential magnitude
and duration of the epidemic
Provide immediate support
Design and implement a response
following the guidelines overleaf
Sentinel site data
Rumours
Press reports
Epidemic suspected
Epidemic confirmed
N
o 
ep
id
em
ic
Epidemic
alert and
reports
Weekly
surveillance
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ANNEX V. CHECKLIST FOR EFFECTIVE RESPONSE TO MALARIA EPIDEMICS
Designing the response
At all epidemic stages
■• Ensure that all clinics and health facilities are operational and have suffi-
cient drugs, equipment and trained staff;
■• Establish treatment centres (e.g. temporary clinics, mobile clinics) in are-
as where access is a problem or health facility coverage is low;
■• Ensure that appropriate diagnostic testing and treatment is provided at 
all health facilities and at community level;
■• Promote outreach activities for early identification of malaria patients in 
the community, and organize necessary case management/referral;
■• Reinforce the referral system and consider the introduction of artesu-
nate suppositories or IM artemether as pre-referral treatment for severe 
malaria where these are not already used;
■• Intensify/maintain effective preventive measures for all at risk popula-
tions;
■• Reinforce health information systems for reporting and epidemic moni-
toring, preferably on a weekly basis;
■• Conduct specific epidemic health education campaigns;
■• Organize regular press releases, conferences, and articles for public 
information.
Review
Epidemic
Response
PreventionEarly warning
Forecasting
Preparedness
The epidemic cycle
for sustained action
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 d
et
ec
tio
n
an
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sp
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Epidemic start
In the early stages of an epidemic, in addi-
tion to reinforcing case management, it is 
still possible to reduce the potential impact 
of the epidemic using vector control inter-
ventions, such as IRS and/or LLINs (see 
Chapter 7).
Additional specific interventions include:
■• if the area is already protected by IRS, estab-
lish coverage and quality of vector con-
trol using techniques such as bioassays;
■• if the area is not already protected by IRS, but the malaria epidemiology, 
type of housing, and available logistics would allow rapid deployment of 
effective IRS, implement IRS in target areas;
■• consider distribution of LLINs if there is a history of LLIN use in the area 
and/or if the capacity exists to implement such a programme. 
Epidemic acceleration
Case management (see above) is the priority 
at this stage. Aiming to reduce the potential 
impact of the epidemic through IRS and 
other vector control methods is an option 
only if (i) there is considerable operational 
capacity trained and readily available, and 
(ii) preparedness levels have been high and 
sufficient resources are available for high 
coverage.
Additional specific interventions to con-
sider include:
■• establishing coverage and quality of vector control, using techniques 
such as bioassays, if the area has already been sprayed;
■• IRS if the area is not already protected;
■• introduce rotational use of insecticides for IRS even when observed 
vector susceptibility is high;
■• properly-timed fogging in highly populated areas such as refugee/dis-
placed persons camps, especially if shelters are small and IRS is not an 
option.
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ANNEX V. CHECKLIST FOR EFFECTIVE RESPONSE TO MALARIA EPIDEMICS
Epidemic peak
The epidemic has already begun to stabilize 
at this point and the number of new cases 
per day or week is stabilizing or beginning 
to decrease. Vector control interventions 
to reduce the potential impact of the epi-
demic will have limited public health value 
at this late stage. Resources should instead 
be directed at case management to reduce 
malaria mortality (see above).
Post-epidemic
Ensure that there is a lessons-learnt exercise that examines the programme 
and how it has performed. This will improve response in subsequent epi-
demics.
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ANNEX VI
Antimalarial treatment regimes
Treatment regimens for uncomplicated malaria
ACT options recommended by WHO are: 
■• Artemether plus lumefantrine (AL) 
■• Artesunate plus amodiaquine (AS+AQ ) 
■• Dihydroartemisinin plus piperaquine (DHA+PPQ )
■• Artesunate plus mefloquine (AS+MQ )
■• Artesunate plus sulfadoxine-pyramethamine (AS+SP)
Artemether plus lumefantrine (AL) 
Presentation: Artemether plus lumefantrine (AL) tablets 20 mg + 120 mg, 
also available as dispersible tablets.
AL is available as a prequalified fixed dose combination from a number 
of manufacturers. AL is particularly useful in humanitarian emergencies 
where there are no local data on the therapeutic efficacy of antimalarial 
medicines, as it provides high cure rates against falciparum malaria in most 
settings. 
The absorption of lumefantrine, a hydrophobic, lipophilic compound, 
is variable and increases when the drug is taken with food, particularly fat-
ty foods. Drug absorption therefore increases as the appetite returns with 
clinical recovery. Absorption is increased by more than 100% when AL is 
taken with a meal rich in fat. Patients should be advised to take the medica-
tion with food, and, if possible, the patient should be provided with milk or 
a similar drink to take with the tablets, particularly in the second and third 
day of treatment. AL needs to be taken twice a day for three days and in 
adults this requires four tablets per dose, up to a total of 24 tablets.
Side-effects: Although AL is generally well tolerated, reported side-effects 
include dizziness and fatigue, anorexia, nausea, vomiting, abdominal 
pain, palpitations, myalgia, sleep disorders, arthralgia, headache, and rash. 
Side-effects are generally mild and there is no indication of cardiotoxicity.
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Contraindications: 
 — Persons with known hypersensitivity to either component drug;
 — Severe malaria according to WHO definition. 
Safety in special groups. The safety of AL has not yet been established in chil-
dren of less than 5 kg body-weight, or in the first trimester of pregnancy. 
Its use in these groups is not recommended until more safety data becomes 
available. However if there are no other effective options available, it can be 
used under medical supervision. 
Weight/Age
Number of tablets and approximate dosing times
0 hours 8 hours 24 hours 36 hours 48 hours 60 hours
5–14.9 kg 
<3 years
1 1 1 1 1 1
15–24.9kg
3–8 years
2 2 2 2 2 2
25–34.9 kg
9–13 years
3 3 3 3 3 3
>35 kg
>14 years
4 4 4 4 4 4
To simplify the schedule: 
■• The 2nd dose can be given anytime from 8–12 hours after the first dose;
■• Thereafter, doses can be given twice a day morning and evening.
Artesunate plus Amodiaquine (AS+AQ)
Presentation: AS + AQ is available as FDC tablets in three strengths: 67.5 mg 
+ 25 mg, 135 mg + 50 mg, and 270 mg +100 mg. AS+AQ is available as a pre-
qualified fixed dose combination from a number of manufacturers.
Several co-blistered formulations are also available on the market, but 
wherever possible the fixed-dose combination should be used as preferred 
treatment to improve patience adherence to treatment. 
It is not necessary to take the tablets with food and the number of tab-
lets per dose is low: 1 tablet once daily in infants, children and adolescents 
and two tablets once daily for adults. Infant tablets can be dissolved in a 
small amount of liquid making them easy to administer. Efficacy of AS+AQ 
remains acceptably high in most settings of Western and Central sub-Saha-
ran Africa. 
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Side-effects: Those reported include nausea, vomiting, abdominal pain, diar-
rhoea, itching, and less commonly, bradycardia. 
Contraindications:
 — Persons with known hypersensitivity to either component drug; 
 — Severe malaria according to WHO definition;
 — Persons with hepatic disorders;
 — HIV-infected patients receiving zidovudine or efavirenz.
Safety in special groups. There is no data on the safety of AS+AQ in young 
children under 4.5 kg or during the first trimester of pregnancy. Its use in 
these groups is not recommended until more safety data becomes available.
Weight/Age 
AS+AQ FDC
(25 mg + 67.5 mg)
AS+AQ FDC
(50 mg + 135 mg)
AS+AQ FDC
(100 mg + 270 mg)
Day 1 Day 2 Day 3 Day 1 Day 2 Day 3 Day 1 Day 2 Day 3
≥4.5 to <9 kg 
2–11 months
1 1 1
≥9 to <18 kg 
1–5 years
1 1 1
≥18 to <36 kg 
6–13 years
1 1 1
≥36 kg 
14+ years 
2 2 2
Dihydroartemisinin plus Piperaquine (DHA+PPQ)
Presentation: Dihydroartemisinin (DHA) plus Piperaquine (PPQ ) is avail-
able as FDC tablets in two tablet strengths: 20 mg + 160 mg and 40 mg + 
320 mg. DHA + PPQ is generally well tolerated. In many countries, AL or 
AS + MQ, or DHA + PPQ may give the highest cure rates. A dose of DHA 
+ PPQ should be administered once daily (at the same time each day) over 
three consecutive days for a total of three doses. Each dose should be taken 
with water and without food.
Side effects: Reports include nausea, vomiting, abdominal pain, gastrointes-
tinal effects and dizziness. No serious adverse events have been reported.
Contraindications: 
 — Persons with known hypersensitivity to either component drug; 
 — Severe malaria according to WHO definition 
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Safety in special groups. There is no data on the safety of DHA + PPQ in young 
children under 5 kg or during the first trimester of pregnancy. Its use in 
these groups is not recommended until more safety data becomes available.
Weight (kg)
 
DHA+PPQ FDC
 (20 mg + 160 mg)
DHA+PPQ FDC
 (40 mg + 320 mg)
Day 1 Day 2 Day 3 Day 1 Day 2 Day 3
5 to <7 ½ ½ ½
7 to <13 1 1 1
13 to <24 1 1 1
24 to <36 2 2 2
36 to <75 3 3 3
75 to < 100 4 4 4
Artesunate plus Mefloquine (AS+MQ ) 
Presentation: Artesunate (AS) plus Mefloquine (MQ ) is available as FDC tab-
lets in two tablet strengths: 25 mg + 50 mg (mefloquine as hydrochloride) 
and 100 mg + 200 mg. Artesunate plus mefloquine is available as a prequal-
ified fixed dose combination from a single manufacturer. Several co-blis-
tered formulations are also available on the market, but wherever possible 
the fixed-dose combination should be used as the preferred treatment to 
improve patience adherence to treatment. As with AL and with DHA + 
PPQ, artesunate plus mefloquine is suitable for emergencies in areas where 
the efficacy of SP and amodiaquine is unknown.
Delivery: Vomiting especially in young children can be reduced if paraceta-
mol is given ½ hour before administration of the first dose. Mefloquine 
absorption is improved when the drug is taken with plenty of water or 
following food. AS + MQ should not be used in re-treatment within eight 
weeks of previous treatment. 
Side-effects: The most common side-effects for mefloquine are nausea, vom-
iting, dizziness, sleep disorders, anxiety and neurological symptoms. Seri-
ous adverse neuropsychiatric reactions have been reported in people taking 
mefloquine, including psychosis, toxic encephalopathy, convulsions and 
acute brain syndrome. The frequency of serious side-effects appears to be 
dose-related, with reported risk 7-fold higher among people who have been 
re-treated with mefloquine within 4 weeks of previous treatment. 
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Contraindications: 
 — Persons with known hypersensitivity to either component drug; 
 — Severe malaria according to WHO definition;
 — Persons with history of severe neuropsychiatric disease;
 — Persons who have received mefloquine in the previous 8 weeks;
Safety in special groups. There is no data on the safety of AS + MQ in young 
children under 5 kg or during the first trimester of pregnancy, or in patients 
weighing more than 69 kg. Its use in these groups is not recommended until 
more safety data becomes available.
Weight/Age 
AS+MQ FDC
(25 mg + 50 mg)
AS+MQ FDC
(100 mg + 200 mg)
Day 1 Day 2 Day 3 Day 1 Day 2 Day 3
≥5 to 8 kg 
6–11 months
1 1 1
≥9 to <18 kg  
1–5 years
2 2 2
≥18 to <30 kg  
6–13 years
1 1 1
≥30 kg 
14+ years 
2 2 2
Artesunate plus sulfadoxine–pyrimethamine (AS+SP)
Presentation: Artesunate (AS) tablets in two strengths (50 mg and 100 mg 
tablets) plus sulfadoxine/pyrimethamine (SP) tablets 25 mg + 500 mg, only 
available as co-blistered formulation. 
This combination is an option for use in emergencies in countries where 
it is the recommended 1st for treatment of malaria. Patients should not be 
treated with this ACT if they have received SP in the previous 4 weeks or if 
they have known hypersensitivity to sulfa drugs. While cutaneous reactions 
are quite rare, they are more common in PLHIV and this should be taken 
into account when dealing with known high-risk groups, especially during 
the chronic phase of the emergency where sexual abuse and sex work may 
be prevalent. 
Delivery: The practical operational advantage of SP over other co-blistered 
ACTs is that the full dose of SP is delivered under directly observed treat-
ment as a single dose on day 1, together with the first dose of artesunate. SP 
is less likely than mefloquine to cause vomiting in young children. 
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Side-effects. SP is generally well tolerated when used as recommended and 
severe adverse side-effects are rare. However, allergic reactions of varying 
severity have been reported and are more common after repeated dosing. 
Contraindications: 
 — persons with known hypersensitivity to either component drug; 
 — severe malaria according to WHO definition;
 — PLHIV receiving co-trimoxazole prophylaxis;
 — pregnant women who received SP for intermittent preventive treat-
ment (IPTp) within the previous 4 weeks;
 — patients with severe hepatic or renal dysfunction.
Safety in special groups. There is no data on the safety of AS + SP in young 
children under 5 kg, during the first trimester of pregnancy, or in patients 
weighing more than 69 kg. Its use in these groups is not recommended until 
more safety data becomes available.
Weight / Age
No of AS tablets 
(50 mg)
No of AS tablets 
(100 mg)
No of SP tablets 
(25 mg + 500 mg)
Day 1 Day2 Day 3 Day 1 Day2 Day 3 Day1 Day 2 Day 3
<10 kg 
5–11 months
½ ½ ½ ½
≥10 to <21 kg 
1–6 years
1 1 1 1
≥21 to <37 kg 
7–13 years
1 1 1 2
≥ 37 kg
14 years 
2 2 2 3
Quinine
Presentation: Tablets of quinine hydrochloride, quinine dihydrochloride 
and quinine sulfate containing 82%, 82%, 82.6% quinine base respectively. 
Generally available as quinine sulfate or hydrochloride tablets of 200 mg 
and 300 mg respectively, but can also be found in 100 mg and 500 mg tab-
lets. 
Delivery: Quinine should be given as 30 mg salt/kg/day in three divided 
doses at 8 hourly intervals for seven days and should be combined with 
doxycycline 100 mg twice a day for seven days. For pregnant women and 
children under 8 years of age, whereby doxycycline is contraindicated, 
quinine should be given combined with clindamycin 7–13 mg/kg every 
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8 hours for five days. Quinine with clindamycin is the treatment of choice 
for uncomplicated falciparum malaria during the 1st trimester. Adherence 
to treatment with quinine is problematic, particularly because of its poor 
tolerability. 
Side-effects. Administration of quinine causes complex symptoms known 
as cinchonism, which is characterized in its mild form by tinnitus, impaired 
high tone hearing, headache, nausea, dizziness and dysphoria, and some-
times disturbed vision. More severe manifestations include vomiting, 
abdominal pain, diarrhoea and severe vertigo. The most common adverse 
effect in the treatment of severe malaria is hyperinsulinaemic hypoglycae-
mia, particularly in late pregnancy. 
Contraindications: 
 — Persons with known hypersensitivity; 
 — Drugs that may prolong the QT interval should not be given with 
quinine. 
Weight (kg) Quinine salt 100 mg tabs (x 3 = daily dose)
Quinine salt 200 mg 
tabs (x 3 = daily dose)
Quinine salt 300 mg 
tabs (x 3 = daily dose)
3–6 ½
7–12 1 ½
13–17 1½ ½
18–25 2 1
26–35 1½ 1
36–50 2
>50 3 2
Chloroquine
Presentations: Available as chloroquine sulfate or phosphate 100 mg base tab-
lets,150 mg base tablets and 50 mg base/5 ml syrup. 
Chloroquine should only be used for the treatment of chloroquine- 
sensitive uncomplicated non-falciparum malaria, i.e. P. vivax, P. malariae 
and P. ovale. P. knowlesi is also sensitive to chloroquine. Only in Central 
America does P. falciparum remain sensitive to chloroquine. Chloroquine 
has a low safety margin and overdosage is very dangerous, particularly 
when the drug is being used for the treatment of rheumatoid arthritis. 
Dose: Total dose is 25 mg/kg given over three days (up to a total dose of 
1500 mg base for adults)
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Side-effects: At the doses used for the treatment of malaria, chloroquine is 
generally well tolerated. The key adverse side-effects are the unpleasant 
taste of the drug, which may upset children, and pruritus, which may be 
severe in dark-skinned patients. Other less common side effects include 
headache, various skin eruptions and gastrointestinal disturbances, such as 
nausea, vomiting and diarrhoea. 
Contraindications: 
 — Persons with known hypersensitivity; 
 — Drugs that may prolong the QT interval should not be given with 
chloroquine. 
Weight 
(kg) Age
Chloroquine base  
100 mg tabs
Chloroquine base  
150 mg tabs
Day 1 Day 2 Day 3 Day 1 Day 2 Day 3
5–6 <4 months ½ ½ ½ ½ ¼ ¼
7–10 4–11 months 1 1 ½ ½ ½ ½
11–14 1–2 years 1 ½ 1 ½ ½ 1 1 ½
15–18 3–4 years 2 2 ½ 1 1 1
19–24 5–7 years 2 ½ 2 ½ 1 1 ½ 1 ½ 1
25–35 8–10 years 3 ½ 3 ½ 2 2 ½ 2 ½ 1
36–50 11–13 years 5 5 2 ½ 3 3 2
>50 >14 6 6 3 4 4 2
Other recommended regimes: 
 — Initial dose: 10 mg base /kg (max 600 mg)
 — Followed by: 5 mg base/ kg (max 300 mg) at 6–8, 24 and 48 hours 
Primaquine 
Presentations: Primaquine (PQ ) is available as tablets containing 5 mg, 7.5 mg 
or 15 mg tablets as diphosphate. 
Primaquine is highly active against mature gametocytes (the sexual form 
of the parasite which transmits malaria) and against the hypnozoites of the 
relapsing malaria species, P. vivax and P. ovale. 
Dose: A single dose of 0.25 mg base/kg of primaquine is an effective gameto-
cytocide for P. falciparum. The standard anti-relapse treatment for the relaps-
ing malaria species, P. vivax and P. ovale, is 0.5 mg primaquine base/kg per 
day for 14 days in South-east Asia and Oceania, and 0.25 mg primaquine 
base/kg per day for 14 days in other areas. 
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Side-effects: The most important adverse effects are haemolytic anaemia in 
patients with G6PD deficiency. In patients with the African variant of G6PD 
deficiency, the standard course of primaquine generally produces a benign 
self-limiting anaemia. In the Mediterranean and Asian variants, haemolysis 
may be severe. Therapeutic doses may also cause abdominal pain if admin-
istered on an empty stomach. Larger doses can cause nausea and vomiting. 
Methaemoglobinaemia may occur. 
Contraindications: 
 — Persons with known hypersensitivity; 
 — Persons with G6PD deficiency
 — Pregnant women and infants below 1 year of age.
Resistance to primaquine is emerging in the Western Pacific region, South-
east Asia, South America and parts of Africa. Relapses occurring in patients 
taking the standard regime should be treated with an increased dose of 
30 mg/day for 14 days.
Where ACT is first-line treatment for P. falciparum, it can be used for 
P. vivax in combination with PQ for radical cure – but AS + SP will not be 
effective against P. vivax in many places.1 
Treatment regimens for severe malaria
Artesunate
Presentations: Artesunate is available in vials containing artesunate powder 
for injection, containing artesunate 30 mg, 60 mg and 120 mg, co-packed 
with 1 ampoule of 5% sodium bicarbonate injection (1 ml) and 1 ampoule of 
sodium chloride injection (5 ml).
Intravenous or intramuscular artesunate should be used in preference 
to parenteral quinine for the treatment of severe P. falciparum malaria, as 
it reduces significantly malaria mortality; is associated with a lower risk of 
hypoglycaemia; and does not differ in terms of risk of serious neurological 
sequelae. Moreover, artesunate offers a number of programmatic advantag-
es over quinine as it does not require rate-controlled infusion or cardiac 
monitoring.
Dose: Artesunate should be given at 2.4 mg/kg by direct IV (slow bolus, 
3–4 ml per minute) or IM injection at 0, 12 and 24 hours; then once daily 
until oral therapy is possible. As soon as the patient can swallow, a full ACT 
treatment course should be given. 
1 Recommend either of these regimens for anyone who was infected with P. vivax in 
Papua New Guinea or Indonesia.
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Delivery: The vial of artesunate powder should be mixed with 1 ml of 5% 
sodium bicarbonate  solution (provided) and shaken for 2–3 minutes for 
better dissolution. Then, 
1. for IV administration: add 5 ml of 5% glucose or normal saline to make 
the concentration of artesunate as 10  mg/ml and administer by slow 
bolus infusion; OR
2. for IM administration: add 2 ml of 5% glucose or normal saline to make 
the concentration of artesunate as 20 mg/ml 
The correct dose in ml of artesunate should be calculated on the basis of the 
patient’s body weight. 
■• The required dose in ml of artesunate solution for IV administration = 2.4 
x body weight (kg)/10
■• The required dose in ml of artesunate solution for IV administration = 2.4 
x body weight (kg)/20
Artemether 
Presentations: Available in ampoules containing artemether injectable solu-
tion for intramuscular injection containing 100 mg or 80 mg of artemether 
in 1 ml for adults, and 20 mg of artemether in 1 ml for paediatric use. 
Intramuscular artemether or intravenous quinine should only be given if 
artesunate is not available. 
Dose: IM: loading dose 3.2 mg/kg on Day 0, followed by a maintenance dose 
of 1.6 mg/kg daily for at least 2 more doses. As soon as the patient can swal-
low provide a full ACT treatment course. 
Delivery: Artemether should be administered in the antero-lateral thigh. 
The 20 mg/ml presentation and a 1ml syringe facilitates dosing in small chil-
dren. Artemether is not well absorbed in shock; an alternative treatment 
(parenteral or rectal artesunate, IV quinine) should be chosen.
The correct dose in ml of artemether should be calculated on the basis of 
the patient’s body weight. 
■• The required loading dose in mg of artemether for IM administration = 
3.2 x body weight (kg)
■• The required maintenance dose in mg of artemether for IM administra-
tion = 1.6 x body weight (kg)
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Quinine
Presentation: Injectable solutions of quinine hydrochloride, quinine dihy-
drochloride and quinine sulfate containing 82%, 82% and 82.6% quinine 
base respectively. Intravenous quinine or intramuscular artemether should 
only be given if artesunate is not available. 
Dose: A loading dose of 20 mg/kg salt, then 10 mg/kg salt every 8 hours. 
The correct dose in mg of quinine should be calculated on the basis of the 
patient’s body weight.
■• The required loading dose in mg of quinine is = 20 mg quinine salt x body 
weight (kg)
■• The required maintenance dose in mg of quinine is = 10 mg quinine salt 
x body weight (kg)
Caution: Omit the loading dose if the patient has received 3 or more doses of 
quinine in the last 48 hours, or mefloquine or halofantrine within the last  
3 days.
Delivery: The dose required is diluted with 5 or 10% glucose IV solution. 
Quinine is administered by rate-controlled low infusion over 4–8 hours, 
and the infusion rate should not exceed 5 mg salt/kg body weight per hour. 
In children under 20 kg: in a volume of 10 ml/kg infused over 4 hours; or 
20 ml/kg infused over 8 hours. In adults: in a volume of 250 ml infused 
over 4 hours; or 500 ml infused over 8 hours. Monitor for hypoglycaemia 
and fluid overload, especially in children. Fluid used to administer quinine 
should be included in calculated fluid requirements. Quinine may also be 
given intramuscularly into the anterior thigh (not the buttock) after dilution 
to 60–100 mg/ml.
When the patient has received at least 3 parenteral doses of quinine, and 
is able to swallow, switch to oral administration: a 3 day course of ACT (If 
the combination AS+MQ is used, wait 12 hours after the last dose of quinine 
before giving MQ. Do not use AS+MQ if the patient developed neurologi-
cal signs during the acute phase).
Rectal Artesunate
Presentation: Rectal capsules containing artesunate 50 mg and 200 mg
Recommended as pre-referral treatment of children with severe malaria 
where parenteral therapy with artesunate or quinine is not available or fea-
sible. Referral to a health centre or hospital is indicated for young children 
who cannot swallow antimalarial medicines reliably. If referral is expected 
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to take more than six hours, pre-referral treatment with rectal artesunate is 
indicated.
Dose: 10 mg/kg. The correct dose of rectal artesunate should be calculated 
on the basis of the patient’s body weight. 
Management of complications of severe malaria
Convulsions Treatment 
• maintain the airway;
• turn the patient on his or her side to reduce the risk of 
aspiration;
• do not attempt to force anything into the patient’s mouth;
• check blood glucose and treat if <2.2 mmol/l (see below);
• treat with:
— diazepam, 0.3 mg/kg (up to maximum 10 mg), as a 
slow IV injection over 2 minutes; or
— diazepam, 0.5 mg/kg, administered rectally by 
inserting a 1 ml syringe (without a needle);
• Diazepam may be repeated if seizure activity does not 
stop after 10min. Midazolam may be used (same dose) 
instead of diazepam by either the intravenous or buccal 
route;
• If the patient continues to convulse after 2 doses of 
diazepam, give phenytoin (18 mg/kg loading dose and then 
a maintenance dose of 5 mg/kg/day for 48 hours); 
• If these are not available or fail to control seizures, 
phenobarbitone may be used (15 mg/kg loading dose IM or 
slow IV infusion, then a maintenance dose of 5 mg/kg/day 
for 48 hours). When phenobarbitone is used, monitor the 
patient’s breathing carefully as ventilatory support may be 
needed. High dose (20 mg/kg) phenobarbitone may lead to 
respiratory depression and an increased risk of death. Be 
prepared to use ‘bag-and-mask’ manual ventilation if the 
patient breathes inadequately. 
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Hypoglycaemia Treatment 
Unconscious patients 
with threshold 
glycaemia below 
3 mmol/l (threshold for 
intervention)
Insert an IV line:
• Children: Correct hypoglycaemia with 200–500 mg/kg 
of glucose. Immediately give 5 ml/kg of 10% dextrose 
through a peripheral line, followed by a slow intravenous 
infusion of 5 ml/kg/h. If 10% dextrose is not available dilute 
each 0.4 ml/kg of 50% dextrose with 1.6 ml/kg infusion 
fluid to form a 10% solution (e.g. for a 10 kg baby, dilute 
4 ml of 50% with 16 ml of infusion fluid). Administration of 
hypertonic glucose (> 20%) is not recommended, as it is an 
irritant to peripheral veins.
• Adults: give 25 g of dextrose preferably as 10% dextrose 
over a few minutes. If 10% dextrose is not available, 50ml 
of 50% dextrose (25 g) diluted with 100 ml of infusion 
fluid may be used and infused over a period of about 
3–5 minutes. Follow with an intravenous infusion of 
200–500 mg/kg per hour of 5% or 10% dextrose.
• Recheck blood glucose with a rapid “stix” method 
15 minutes after the end of the infusion.
• If blood glucose is still <2.2 mmol/l, repeat glucose 
infusion as above.
• If it is not possible to insert an IV line and the patient is 
unconscious, give 1 ml/kg 50% dextrose via nasogastric 
tube
• Give oral fluids (breast milk or sugar solution) and food 
once the patient regains consciousness.
Unconscious patient, 
suspected clinically but 
not possible to check 
the blood glucose
• Give a presumptive intravenous infusion as described 
above.
Note: There is a marked risk of hypoglycaemia with the use of 
quinine in pregnant women 
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Severe anaemia Treatment
Children • Generally, in high transmission settings EVF of ≤12% or 
a haemoglobin concentration of ≤4 g/dl is an indication 
for blood transfusion, whatever the clinical condition of 
the child. In low-transmission settings a threshold of 20% 
haematocrit or a haemoglobin of 7g/dl, is recommended 
for blood transfusion:
— Give 10 ml of packed cells or 20 ml of screened, 
compatible whole blood per kg of body weight over a 
4-hour period. 
• For children with less severe anaemia (i.e. EVF 13–18%,  
Hb 4–6 g/dl), transfusion should be considered for 
high-risk patients with any one of the following clinical 
features: (i) respiratory distress (acidosis); (ii) impaired 
consciousness; (iii) hyperparasitaemia, >20%; (iv) shock; 
(v) heart failure.
• For children with severe anaemia and severe malnutrition 
(i.e. severe wasting plus oedema), give blood much more 
cautiously:
— Infuse 10 ml/kg blood over 3 hours.
— Give furosemide, 1 mg/kg IV, halfway through the 
transfusion to avoid circulatory overload.
• Follow-up of haemoglobin (haematocrit) levels after blood 
transfusion is essential, as many children need a further 
transfusion within the next few hours, days or weeks. 
Adults • Anaemia is common in severe malaria and may be 
associated with secondary bacterial infection. Blood 
transfusion is indicated in patients with EVF of ≤20% or 
with haemoglobin concentration <7 g/dl:
— 500 ml of screened, compatible fresh blood should be 
transfused over 6 hours. 
— Give a small intravenous dose of furosemide, 20 mg, 
during transfusion to avoid circulatory overload. 
ANNEX VI. ANTIMALARIAL TREATMENT REGIMES
MALARIA CONTROL IN HUMANITARIAN EMERGENCIES
198
Shock Treatment 
Children Common causes of shock include dehydration from diarrhoea, 
sepsis, anaemia. Classify the child as having SHOCK if the 
systolic blood pressure is < 50 mm Hg, pulse is weak and 
rapid (other signs include cold hands and/or feet AND 
capillary refill longer than 2 seconds). Shock in children with 
severe malaria is rare (<2% of cases of severe malaria).
Rapid administration of IV fluids for resuscitation of children in 
shock or with severe dehydration. 
• Children with severe dehydration should be given rapid 
IV rehydration followed by oral rehydration therapy. The 
best IV fluid solution is Ringer’s lactate solution (also called 
Hartmann’s solution for injection). If Ringer’s lactate is not 
available, normal saline solution (0.9% NaCl) can be used. 
5% glucose (dextrose) solution on its own is not effective 
and should not be used. 
• Rapid fluid boluses are contraindicated in severe malaria 
resuscitation.
• Give 100ml/kg of the chosen solution as follows: In 
children <12 months old give 30 ml/kg body weight in 
1 hour, then 70 ml/kg bw over the next 5 hours. While in 
children ≥12 months old, give 30 ml/kg over 30 mins, then 
70 ml/kg over next 2 hours. Repeat the first dose of  
30 ml/kg if the radial pulse is still very weak or not 
detectable.
— Correct hypovolaemia with maintenance fluids at 
3–4 ml/kg per hour.
— Keep an accurate record of fluid intake and output. 
Remember to include the volume of transfused cells 
or blood in calculating fluid balance. Monitor blood 
pressure, urine volume (every hour) and jugular 
venous pressure.
— Improve oxygenation by clearing the airway, increasing 
the concentration of inspired oxygen and supporting 
ventilation artificially, if necessary.
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Adults Some patients are admitted in a state of collapse, with a 
systolic blood pressure < 80 mm Hg in the supine position; 
cold, clammy, cyanotic skin; constricted peripheral veins; 
and a rapid, feeble pulse. This clinical picture may indicate 
complicating septicaemia, and possible sites of associated 
bacterial infection should be sought, e.g. meningitis, 
pneumonia, urinary tract infection (especially if there is an 
indwelling catheter) or intravenous injection site infection.
Rapid administration of IV fluids for resuscitation of patients in 
shock or with dehydration.
• Give only isotonic fluid (0.9% saline) by slow intravenous 
infusion to restore the circulating volume, but avoid 
circulatory overload, which may rapidly precipitate fatal 
pulmonary oedema.
— Monitor blood pressure, urine volume (every hour) and 
jugular venous pressure.
— Improve oxygenation by clearing the airway, increasing 
the concentration of inspired oxygen and supporting 
ventilation artificially, if necessary.
Coma Treatment
• Maintain a clear airway
• Position the child in the lateral or semi-prone position to 
avoid aspiration of fluid (in case of trauma, stabilize neck 
first so that it does not move)
• If possible, insert a nasogastric tube and aspirate the 
stomach contents to minimize the risk of aspiration 
pneumonia, which is a potentially fatal complication that 
must be dealt with immediately.
• Assess level of consciousness using a paediatric scale (e.g. 
for children use the Blantyre coma scale, for adults use the 
Glasgow coma scale Annex VIII).
• Give intravenous (IV) glucose.
• Suspect raised intracranial pressure in patients with 
irregular respiration, abnormal posturing, worsening coma, 
unequal or dilated pupils, elevated blood pressure and 
falling heart rate, or papilloedema. In all such cases, nurse 
the patient in a supine posture with the head of the bed 
raised.
• Manage the underlying cause of loss of consciousness in 
children WITH fever:
— malaria, meningitis, sepsis.
• Manage the underlying cause of loss of consciousness in 
children WITHOUT fever:
— dehydration, anaemia, poisoning.
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ANNEX VII
Assessment and treatment of danger signs
Signs Check If: Treatmenta
 Duration Lasts >5 minutes Diazepam IV or per  
   rectum 
 Blood glucose <2.2 mmol/l or test not  Give 50% dextrose IV 
  possible 
 Malaria slide or RDT Positive or test not  Start antimalarial drugs 
  possible  
 Lumbar puncture (LP)b CSF evidence of menin- Start antibiotics for 
  gitisc or LP not possible meningitis
 Circulation Any sign positive  Start rapid IV fluids 
 Capillary refill >3  (indicates shock) and   Give oxygen 
  secondsd no evidence of 
 Weak, fast pulse  severe malnutrition 
 Cold hands 
 Hydration Any sign positive  Start rapid IV fluids or 
 Sunken eyes (indicates dehydration)  insert nasogastric (NG) 
 Lax skin turgore and no evidence of  tube and start oral  
  severe malnutrition rehydration solution 
 Nutrition Any sign positive  Transfer to therapeutic 
 Visible severe wasting (indicates severe   feeding centre 
 AND/OR malnutrition) 
 Flaking skin and  
  oedema of both feet   
 Blood glucose <2.2 mmol/l or test not  Give 50% dextrose IV 
  possible 
 Lumbar puncture CSF evidence of  Start antibiotics for 
 If none of the above  meningitisc or LP not  meningitis 
 signs is present,  possible 
 perform LP
 Malaria slide or RDT Positive or test not  Start antimalarials 
  possible 
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ANNEX VII. ASSESSMENT AND TREATMENT OF DANGER SIGNS
 Blood glucose <2.2 mmol/l or test not  Give dextrose 50% IV 
  possible 
 Perform LP CSF evidence of  Start antibiotics for 
  meningitisc or LP not  meningitis 
  possible   
 Malaria slide Positivef or test not  Start IV or IM 
 or RDT possible antimalarials 
 All comatose patients  Insert NG tube, aspirate 
   stomach contents
 Palmar pallor Hb <5g/dl Give immediate blood 
 Check Hb  transfusion 
 Hydration Any sign positive and  Start rapid IV fluids 
 Lethargy no evidence of severe  
 Sunken eyes malnutrition 
 Lax skin turgore   
 Circulation Any sign positive and  Insert IV and start rapid 
 Capillary refill >3  no evidence of severe  IV fluids 
  seconds malnutrition 
 Weak, fast pulse 
 Cold hands
 Listen to chest Chest crackles Verify pulmonary 
   oedema;g start anti- 
   biotics for pneumonia
a For treatment details see “Management of severe P. falciparum malaria” in chapter 6 of this document.
b Lumbar puncture should be performed if the patient is still unconscious more than 30 minutes after the end 
of a convulsion.
c CSF evidence of meningitis: CSF: blood glucose ratio <0.5, CSF protein >0.6 g/litre, bacteria seen on Gram 
stain. When measurement of glucose and protein is not possible, cloudy CSF should be taken as indicative 
of meningitis.
d Capillary refill: apply pressure for 3 seconds to whiten the fingernail; determine the capillary refill time from 
the moment of release to recovery of original nail colour.
e Skin turgor: pinch the skin of abdomen halfway between the umbilicus and the side for 1 second, then 
release and observe; if the skin takes >2 seconds to return, this indicates dehydration.
f In all cases of suspected severe malaria, parenteral antimalarial chemotherapy must be started immedi-
ately. If the cause of coma is in doubt, also test for (and treat) other locally prevalent causes of coma, e.g. 
bacterial, fungal or viral meningoencephalitis. If the malaria slide/RDT is negative it must be repeated, and 
the Giemsa-stained slide must be examined for indirect signs of parasitaemia (pigment in neutrophils).
g If pulmonary oedema is suspected, position the patient upright, give oxygen, stop IV fluids and give frusem-
ide, 0.6 mg/kg IV. If there is no response, increase the dose progressively to a maximum of 200 mg. 
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ANNEX VIII
Assessment of level of consciousness
Children aged 5 years and below
The Blantyre coma scale1 is a means of rapidly assessing and monitoring the 
level of consciousness in children. A score of 5 indicates full consciousness, 
while a score <3 indicates unrousable coma. Ideally, the assessment should 
be carried out 4-hourly in all unconscious children.
Response Score
Motor Localizes paina
Withdraws limb from painb
Nonspecific or absent response
2
1
0
Verbal Appropriate cry
Moan or inappropriate cry
None
2
1
0
Eyes Gaze oriented
Gaze not oriented
1
0
Total
Maximum 5 (fully conscious)
Minimum 0 (deep coma)
a Apply sternal pressure (the examiner should press firmly on the child’s sternum using the knuckles of one 
hand). A child who is able to localize pain makes an attempt to remove the examiner’s hand.
b Pressure applied with pencil to nail bed.
1 Molyneux M et al. Clinical features and prognostic indicators in paediatric cerebral 
malaria: a study of 131 comatose Malawian children. Quarterly Journal of Medicine, 1989, 
71(265): 441–459.
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Children over 5 years of age and adults
Consciousness level should be assessed using the Glasgow coma scale:
Response Score
Eyes open Spontaneously
To speech
To pain
Never
4
3
2
1
Best verbal response Oriented
Confused
Inappropriate words
Incomprehensible sounds
None
5
4
3
2
1
Best motor response Obeys commands
Localizes paina
Withdraws to pain
Flexion to pain 
Extension to pain
None
6
5
4
3
2
1
Total
Minimum 3; 
Maximum 15b
a Apply sternal pressure (the examiner should press firmly on the patient’s sternum using the knuckles of one 
hand). A patient who is able to localize pain makes an attempt to remove the examiner’s hand.
b Unrousable coma is defined as a score of <11.
Ideally, the assessment should be carried out 4-hourly in all unconscious 
patients, to monitor the level of consciousness.
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ANNEX IX
Rapid qualitative assessment of social, 
economic and cultural aspects of malaria
Introduction
This annex is intended as a guide only. The questions that will need to be 
asked to understand what community members know about, and how 
they respond to malaria, will depend on the local situation and on cultural 
norms. In addition, the approach used will depend on the subject group 
– key informants, householders, small groups, etc. In some settings there 
may be a need to focus just on treatment-seeking behaviours or on the use of 
preventive measures, while in other settings a more complete understand-
ing of what malaria means to a community and what their priorities are may 
be needed. The approach should therefore be context specific. Translation 
of questionnaires (if necessary) can often be problematic. Pre-testing and 
validation of the questionnaire is also necessary.
The purpose of the rapid qualitative assessment is to provide information 
that will assist in making sound programmatic decisions related to malaria 
control. 
Basic demographic data
Data on the age, gender, socio-economic status (such as education, liter-
acy levels, etc) of the respondent should be collected. These data can be 
important explanatory variables, describing, for example, how knowledge 
varies by literacy. This, in turn, may influence the approach to public health 
awareness campaigns.
Community perceptions and knowledge of malaria
Community perceptions and knowledge of malaria can influence aspects 
of control. For example, in some areas of Africa, malaria is seen in the 
context of local beliefs of “magic” or “curses”. This may heavily influence 
the impact public health messages have and the uptake of services such as 
treatment-seeking. Identifying local perceptions can therefore be useful 
in designing public health messages or strengthening informal treatment 
practices.
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Some example questions to assess community perceptions and knowl-
edge of malaria are given below, but these are only a guide and should be 
adapted to the local context.
1 What are the common illnesses in the community?
 Allow the person to list all illnesses, even if malaria or a malaria-like illness is not 
mentioned.
2. Which of these illnesses are considered to be the most important and 
why (prevalence, severity, mortality)?
3. Which of these illnesses affect children? Which affect adults?
4. What is the local name for “febrile illness”? 
 Probe for terms for febrile illness.
5. Are there different types of febrile illness?
a) If yes: What are the local names of these illnesses?
b) Which of the febrile illnesses that you have described to me is consid-
ered to be the most dangerous?
c) How do you know when a child/an adult has this type of illness?
 Identify which of the terms used for the illness most closely resembles the bio-
medical definition of malaria, then use that term for the questions below. In 
some cultures, fever with convulsions is considered to be a different type of 
malaria and one that is best suited for treatment by traditional or spiritual 
healers. If this is not mentioned, you could add a question such as, “Is there 
a different illness when the child/adult has fever and also convulsions (shak-
ing)?”
6. Who is most at risk for [local term for malaria]?
7. What causes [local term for malaria]?
a) Can malaria be spread?
b) If yes: How is it spread?
 If mosquitoes are not mentioned, probe with questions like: “Can this illness be 
carried by mosquitoes?”
Treatment-seeking 
These questions can be used to identify the channels through which treat-
ment is sought. Treatment could, for example, be dominated by traditional/
spiritual healers or by local pharmacies or drug shops, which can be includ-
ed in programming to improve practices. The questions can also be used to 
identify barriers to access to appropriate treatment, such as cost.
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8. How is [local term for malaria] treated?
 Probe to ensure that all treatments are mentioned, including use of self-medica-
tion.
a) Can you please tell me the steps of treatment once you notice that 
somebody in your household/community is sick with [malaria]?
b) If use of health care services is mentioned:
■• Ask about the last case in the household/community. For exam-
ple, “I see you mentioned going to the [dispensary/clinic/hospital] 
to receive care. From the time that you knew that your child/the 
adult was sick, how long did you wait before going to the health 
care facility?”
■• What do you do for treatment during times when the [dispensa-
ry/clinic/health post] might be closed (such as weekends, nights, 
holidays)?
■• Is there an ambulance service to help you with a really sick person? 
If the answer is no: probe to find out how they transfer a sick individual to 
a health care facility.
c) If multiple treatments are listed: Did you use some of these treat-
ments at the same time (for example, see a traditional healer for herb-
al treatments while taking antimalarials)?
d) Which of these treatments are considered to be the most effective?
e) From whom do you normally receive advice about how to treat illness 
in a child/adult?
f) If not previously mentioned: 
■• Do you use the services of traditional healers or spiritualists for 
malaria?
■• Do traditional healers ever give you antimalarial drugs?
g) Can you easily obtain drugs to treat [malaria] here in the camp/ set-
tlement area?
■• If yes: Where do you get these drugs?
h) Can you please tell me about any problems you might experience 
when seeking care from a health care facility in the camp/settlement 
area?
 Probe for things such as lack of referrals, no assistance to transport a sick 
patient, long waiting periods for care, political/cultural differences with health 
care staff, perceived poor communication between staff and patients or car-
egivers, lack of drugs or other supplies.
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i) I would like to ask you about the cost of an episode of [malaria]. For 
the last case of malaria in the family, could you tell me how much 
money you spent on the following?
■• transport to or from a health facility
■• consultation with a doctor/nurse/traditional healer
■• diagnosis of the disease by a laboratory
■• drugs to treat the disease
■• other items (such as syringes, drips, etc)
■• food or other special items that were needed to help the patient
■• were there any other costs that you can remember?
Prevention
Perceptions on prevention of malaria are important because some areas will 
be used to conventional prevention methods (e.g. bednets) but some are-
as may never have been exposed to such interventions and people may be 
resistant to their use or inexperienced about how to use them effectively. 
Lack of previous exposure to malaria control interventions may result in 
misconceptions concerning their safety or effectiveness. Some locally used 
prevention methods may have no proven effect on malaria control and may 
actually be harmful (e.g. burning dung as a repellent). Collecting informa-
tion on local perceptions of prevention can help in the understanding of: 
why certain public health messages do or do not work; the usage of inter-
ventions; and receptiveness to IRS.
9. Can [local term for malaria] be prevented?
a) If yes: How can you prevent it?
 Probe for use of insecticides, bednets or other insecticide-treated materials, 
coils, repellents, etc.
b) Of these methods, which ones do you personally use?
c) Why do you use these particular methods?
d) Which of the methods that you mentioned do you think are the most 
effective?
Insecticide-treated materials
10. Where you live, can you estimate for me how many households use 
LLINs?
a) Would you say that where you live is similar to other parts of the set-
tlement area?
b) Did people bring the LLINs with them from their previous homes or 
did they receive them while they were in camp?
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c) If a net was mentioned in response to question 9b): Where and when 
did you get your LLIN?
■• Do you know whether your net was treated with insecticide?
■• Have you ever had a LLIN while in the settlement that you needed 
to sell in order to buy something else, for example food or water?
■• If the interview is done at home and if the respondent states that 
they have a LLIN: Could you please show me your net?
Look to see what type of net it is, for example, is it polyester, polyethylene or 
polypropylene? What is the condition of the net – is it dirty, is it very clean, 
does it have holes in it?
d) If a LLIN was not mentioned in response to question 9b): “I see that 
you did not mention using a LLIN. Why is this?”
 Probe for reasons of cost (cannot afford), lack of availability (such as distri-
bution only to vulnerable populations), theft of nets, needed to sell the LLIN, 
dislike due to heat.
e) Why do people use LLINs?
 Probe for prevention of nuisance biting, prevention of malaria, prestige, priva-
cy.
f) In your house, who sleeps under the LLIN?
■• Why does that person/those persons sleep under the LLIN?
g) Are there any times when households in this area do not use LLINs if 
they have them?
 Probe for example, if people sleep outside because it is too hot, do they sleep 
under the LLINs?
h) Do people always sleep indoors – or outside, or in fields? Does this 
change with the season?
 i) Are LLINs supported by poles or are they suspended from ceilings?
 j) What sizes and shapes of LLINs would best fit your sleeping arrange-
ments?
Indoor residual spraying (IRS)
11. Have you ever had your house sprayed with insecticide to prevent mos-
quitoes/malaria?
a) If yes: What did you think about that malaria control measure?
 Probe: Ask whether they like the control measure; did they fear the insecticide 
being in the house.
12. Do you think that this method works to control mosquitoes?
13. Was there anything that you did not like about IRS?
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14. Once your house was sprayed with insecticide, did you replaster the 
walls? (How much time elapsed between the spraying of the walls and 
replastering?)
Experience with malaria control
Some communities will be highly sensitized to malaria control from past 
experiences, but some may be naive about the methods commonly used for 
control. This will influence the approach to implementation.
15. Did you have [local term for malaria] in your home area?
a) If yes: What was your experience with malaria control?
 Probes: Ask whether they ever had indoor residual spraying done in their 
home; whether the health care facilities dispensed antimalarials; whether there 
were net distribution or insecticide re-treatment programmes taking place?
■• Was the community involved in trying to control malaria? If yes: 
What did they do?
16. Can you please give me some ideas for what you would like to see here 
to improve malaria control?
ANNEX IX. SOCIAL, ECONOMIC AND CULTURAL ASPECTS OF MALARIA
210
ANNEX X
Tube and cone assays for  
insecticide testing of adult mosquitoes
Figure X.1 The WHO tube assay
A. Plastic aspirator tube B.
C. Holding tube D. 
Holding tube
Exposure tube
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ANNEX X. TUBE AND CONE ASSAYS FOR INSECTICIDE TESTING
The WHO tube test kit consists of two plastic tubes (125 mm in length, 
44 mm in diameter), with each tube fitted at one end with a 16-mesh screen. 
One tube (exposure tube) is marked with a red dot, the other (holding 
tube) with a green dot. The holding tube is screwed to a slide unit with a 
20 mm hole into which an aspirator will fit for introducing mosquitoes into 
the holding tube. The exposure tube is then screwed to the other side of the 
slide unit. Sliding the partition in this unit opens an aperture between the 
tubes so that the mosquitoes can be gently blown into the exposure tube to 
start the treatment and then blown back to the holding tube after the timed 
exposure (generally one hour). The filter-papers are held in position against 
the walls of the tubes by four spring wire clips: two steel clips for attaching 
the plain paper to the walls of the holding tube and two copper clips for 
attaching the insecticidal paper inside the exposure tube. The purpose of 
this test is to determine if the local malaria vectors are susceptible to insec-
ticides for treated nets and for IRS. See revised thresholds for recording 
resistance – http://www.who.int/malaria/vector_control/ivm/gpirm/en/
index.html.
WHO cone assay
WHO cone assays should be conducted on 25 cm x 25 cm pieces cut from 
positions 2, 3, 4 and 5 of each sampled net (see Figure X.2), which should 
be adjacent to the places from which the netting for chemical assay was col-
lected. 
Figure X.2 Sampling pattern for LLINs
1
2
3
4
5
5
1 2
3
4
Rectangular net
Sidepanels
Roof panel
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Position 1 should be excluded, as it may be exposed to excessive abra-
sion in routine use, as this portion of the net is frequently handled when it 
is being tucked under the bed or mattress. Two standard WHO cones are 
fixed with a plastic manifold onto each of the four netting pieces (Figure 
X.2) or in the case of IRS, fixed on sprayed wall surfaces. Between 5–20 sus-
ceptible, non-blood-fed, 2–5-day-old female Anopheles (species to be stated 
in the test report) are exposed for 3 min in each cone and then held for 
24 h with access to sugar solution. Two replicates should be placed at each 
position. Knock-down is measured 60 min after exposure, and mortality is 
measured after 24 hours. A negative control, from an untreated net, should 
be included in each round of cone bioassay testing. If the mortality in the 
control is between 5% and 20%, the data should be adjusted with Abbott’s 
formula. 
If the mortality in the control is >20%, all the tests should be discarded 
for that day. Bioassays should be carried out at 27 ± 2 °C and 80 ± 10% rel-
ative humidity. The bioassay results for the netting pieces from each sam-
pled LN should be pooled to determine if the net meets the WHO efficacy 
requirement, i.e. ≥80% mortality or ≥95% knock-down. If the net fails these 
criteria, a tunnel test should be conducted on one of the four net samples 
that caused mortality closest to the average mortality in the cone bioassay. 
Finding out more
■• WHO. (1998). Test procedures for insecticide resistance monitoring in malaria 
vectors, bio-efficacy and persistence of insecticides on treated surfaces. Geneva, 
World Health Organization, 1998 (WHO/CDS/CPC/MAL/98.12).
■• WHO. (2011). Guidelines for monitoring the durability of long-lasting insec-
ticidal mosquito nets under operational conditions. Geneva. World Health 
Organization.
■• WHO (2012). Global Plan for Insecticide Resistance Management in malaria 
vectors. Geneva, Switzerland. World Health Organization
■• WHO (2013). Test procedures for insecticide resistance monitoring in mosquitoes. 
Geneva. World Health Organization.
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Figure X.3 Example form for cone bioassay of LLINs collected in houses
Name of person performing bioassays: ............................................................................
1. Date of test (dd/mm/yyyy):....../......./..................
2. LN code: ....../....../....../....../....../....../....../......
3. Temperature: ....../...... °C        Relative humidity: ....../....../...... %
4. Test mosquito species:
5. Age of mosquitoes: ...... days
6. Test start time (h/min): ....../......   End time (h/min): ....../......       
Net 
position
Replicatesa No. of 
mosquitoes 
exposedb
No. 
knocked 
down 
after 1 h
No. dead 
after 
24 h
No. alive 
after 
24 h
% 
knocked 
down
% 
mortality
1c 1
2
2 1
2
3 1
2
4 1
2
5 1
2
Control 1
2
a Two cones on each net sample (replicates 1 and 2)
b Usually, five mosquitoes per cone; exposure time, 3 min
c Net position 1 should be tested only in baseline bioassay
214
ANNEX XI
Example: malaria outbreak form
Table 4.1 Example of malaria outbreak form
Place: .......................................................  Reported by: .......................................
From:....../......./......... (day/month/year) To: ....../......./......... (day/month/year)
Case definition “malaria” and “malaria death”:
Date Day
New malaria cases New malaria deaths
<5 
years
≥5
Years
Pregnant 
women Total
<5 
years
≥5
Years
Pregnant 
women Total
1
2
3
4
5
6
7
Total
Daily mortality rate (number of “malaria” deaths/10 000 population per day): ...........................
Weekly attack rate (number of “malaria” cases/1000 population per week): .............................
Weekly case-fatality rate (number of “malaria” deaths/number of “malaria” cases x 100): ...........
Geographical areas affected (e.g. villages, districts, camps where malaria patients are 
currently living):
..................................................................................................................................................................
..................................................................................................................................................................
215
Locality Estimated total 
pop. in locality
No. of malaria 
cases from locality 
(specify day, week, 
time period)
No. of malaria 
deaths from 
locality (specify day, 
week, time period)
Comments: ……………………………………………………………………………………………………
………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………...........…
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Index
Note: page numbers in bold type 
indicate main discussions. 
advocacy, 11–2
amodiaquine, 63, 78, 95, 148, 184,  
  187
anaemia, severe, 19, 57, 61, 67, 68,  
  69, 95
 in children, 69
 in pregnant women, 6, 73–6
 prevalence of, 149, 175
 treatment of, 69–70, 197
antibiotic treatment, 56, 63, 66–8,  
  75, 77, 189–90, 200–1
antimalarial treatment (see also  
  individual drugs), 184–99
 administration of, 63–4, 67, 77,  
  130, 132, 136, 140
 availability of, 25, 40, 62–3, 133,  
  150
 choice of, 61, 66, 143
 communication on, 124–5
 efficacy of, 41, 65, 143
 first-line, 24–5, 54, 56, 65
 resistance to (see also resistance,  
  to drugs), 62, 78, 143
 second-line, 65
artemether, 50, 76, 181, 193
artemisinin-based combination  
  therapy (ACT), 184–99
 choice of, 62–3
 quality of, 62, 65, 144, 150
 treatment failure with, 65
 treatment with, 67, 72, 75–8
 use of in outbreaks, 48–50
artesunate, 26, 50, 56, 63, 65, 67,  
  76, 181, 187, 188, 192–5
bednet (see also insecticide-treated  
  net, long-lasting insecticidal  
  net), 36, 121, 207
behaviour change communication,  
  85, 89, 96, 105, 120–4, 134–7,  
  139, 149, 154–5
breeding sites, of vectors, xv,  
  7, 18–20, 21, 24, 45–6,  
  99–100, 107–8, 110, 112–4
case definition, xv, 33, 36, 38,  
  49–50, 61, 214
case detection
 active, 29, 49, 132
 passive, 29, 156
case fatality rate, xv, 37, 40, 44, 48,  
  51, 214
case management, 6–7, 20, 40, 48,  
  53–80, 122, 127, 130–1, 137,  
  140, 149, 181–3
children
 anaemia in, 69–70
 as at-risk group, 6, 18, 20, 54,  
  173
 febrile, management of, 55–7,  
  63–4
 level of consciousness in, 202–3
 mortality among, 3, 53
 prevention for, 84, 87–8, 93 , 95, 
  120–2, 124–5, 135–6
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 research on, 156–7, 168, 176, 178
 treatment of, 61, 64, 66–7, 69,  
  73, 95, 130–2, 148, 185–90,  
  191, 193–4, 196–9
 vulnerability of, 3, 8, 43, 55, 61,  
  120, 126, 174
chloroquine, 63, 72, 77, 190–1
cluster 
 approach, 10, 48, 126
 sampling, xv, 156–7, 170, 176–7
community, participation of, 11,  
  26, 32, 37, 45, 88, 107, 119–38, 
  142, 145, 149–50, 158–9,  
  204–5, 209
community health worker (CHW), 
  xv, 32, 37, 40, 121, 125, 128,  
  130, 133, 142, 149–50
confirmation 
 of malaria, 7, 19, 29, 34–8, 41,  
  44, 47, 49, 53–61, 63, 65, 70,  
  75, 142, 171, 173
 of an outbreak, 45, 47, 50, 180
consciousness, level of, 55, 202–3
coordination, 3, 9, 10–4, 17, 23,  
  122–3, 125, 141
 inter-agency, 29–31, 44, 48
danger signs of severe malaria, 42,  
  54, 64, 121, 130, 134, 177,  
  200–1
deltamethrin, 86, 98, 100
displaced populations, 2, 8, 19, 24,  
  26, 96, 99, 119, 134, 173
 information on, 16–8, 23, 29,  
  167, 170, 174
 participation of, 120, 125, 127–8, 
  133, 146
 prevention of malaria in, 96,  
  102, 104, 107, 125, 147–8, 182
 registration of, 167
 research on, 141, 154–5, 157
 vulnerability of, 7, 8, 43, 73, 78
drugs (see antimalarial treatment)
endemicity, xvii, xx, 6, 177
 and communication, 120
 and population displacement,  
  134, 174
 and pregnancy, 74–5
 information on, 15, 175, 178
 malaria-endemic areas, 7, 18, 26, 
  39, 43, 51, 53, 60, 61, 69, 72,  
  83
 mixed, 78
epidemic, xvii, 6, 22, 37, 43, 45–8,  
  182–3
 curve, 47, 93, 182–3
 response to, 51, 180–3
 risk for, 43, 78, 120–1
 threshold, 44
 use of RDTs in, 50
 vector control in, 51, 182
epidemiological survey, 6, 18, 19,  
  20, 24, 41, 54, 107, 153, 171–8
fever, 3, 17, 38, 44, 45, 56, 57, 63,  
  120, 174
 in vivax malaria, 5
 measurement of, 19
 screening for, 49, 56, 173, 174,  
  177
 treatment of, 50, 55, 56, 61, 122,  
  135, 199
glucose-6-phosphate  
  dehydrogenase (G6PD)  
  deficiency, 73, 192
health communication, 91, 134–7,  
  146, 150
health education, 26, 82, 119–20,  
  122, 130, 134–7, 181
HIV infection
 as at-risk group, 3, 6, 43, 54,  
  73–4, 88
 screening for, 67
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 treatment of malaria in people  
  with, 75, 78, 186, 188–9
indoor residual spraying (IRS), 24,  
  50–1, 82–3, 90–4, 99, 100,  
  102, 104–8, 110, 114–6, 132,  
  146, 182
 communication on, 122, 124,  
  127, 137, 207–9
infants
 intermittent preventive  
  treatment of, 95, 147
 treatment of, 64, 70, 185, 192
insecticide-treated net (ITN, see  
  also long-lasting insecticidal  
  net, bed net), xxiii, 103–6,  
  121, 132, 145, 153, 156
insecticide-treated plastic sheeting, 
  50, 83, 96–8, 104–6, 147, 150, 
  154
intermittent preventive treatment 
 in infants, 95, 147
 in pregnancy, 74–6, 95, 147
larval control, 16, 99–101, 103,  
  108, 110
long-lasting insecticidal net (LLIN; 
  see also insecticide-treated net, 
  bednet), 84–90
 acceptability of, 82, 145–7, 150,  
  182
 communication on, 89, 122, 127, 
  134–7, 207–8
 distribution of, 49–51, 73–4,  
  130, 132
 durability of, 84, 98, 145
 efficacy of, 99, 145–6, 112,  
  114–6, 121–2
 hanging of, 85, 88–90, 96, 145,  
  150
 monitoring use of, 39–40, 89,  
  137
 testing of, 211, 213
 use of in prevention, 82–90,  
  102, 104–6, 108
lumefantrine, 26, 184
malaria
 knowlesi, 3, 5, 72, 172, 190
 malariae, 3, 5, 60, 72, 172, 190
 non-falciparum, 60, 72, 75, 190
 ovale, 3, 5, 60, 72, 75, 172, 190–1
 severe falciparum, 3, 66, 192
 uncomplicated falciparum, 60,  
  62–4, 74–5, 190
 vivax, 3, 5, 37, 60, 63, 72–3, 75,  
  98, 103, 172, 190–2
malnutrition, and malaria, 8, 17,  
  43, 54, 62, 64, 69, 73, 77–8,  
  167, 197, 200–1
mapping, 5, 30, 129, 166–7
mefloquine, 62, 65, 184, 187–8, 194
microscopy, light
 availability of, 22, 177
 comparison of with RDTs,  
  58–9, 141–2
 for confirmation of malaria, 19,  
  29, 36, 47, 50, 53, 57–60, 63,  
  70, 77, 142–3, 177–8
 in rapid epidemiological  
  surveys, 20, 172
 positivity rate, 36–9, 173
 quality control of, 39
 use of in surveys, 172
monitoring and evaluation, xx, 9,  
  12, 15, 22, 39–41, 51, 88–9,  
  94, 102, 107, 123, 133, 137,  
  139–61
mortality, from malaria, 3, 5, 13, 37, 
  53, 73, 74, 76, 192, 214
 in displaced populations, 43, 122
 information on, 17, 19, 28, 30,  
  32, 33, 37, 45, 48, 51, 170
 of Anopheles, 212–3
mosquito biology and behaviour,  
  109–16
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operational planning, 14–27
operational research, 139–161
 ethical aspects of, 140–1, 152,  
  157–9
outbreaks, malaria, 43–52
 communication on, 123
 control of, 140, 149
 form, 214–5
 information on, 21
 investigation of, 45–7, 154
 indoor residual spraying in, 93
 predicting, 6, 8, 16, 18, 28, 36,  
  103, 108, 139, 173
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